BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl MC, Kim J, Reardon B, Ng PK, Jeong KJ, Cao S, Wang Z, Gao J, Gao Q, Wang F, Liu EM, Mularoni L, Rubio-Perez C, Nagarajan N, Cortés-Ciriano I, Zhou DC, Liang WW, Hess JM, Yellapantula VD, Tamborero D, Gonzalez-Perez A, Suphavilai C, Ko JY, Khurana E, Park PJ, Van Allen EM, Liang H, Lawrence MS, Godzik A, Lopez-Bigas N, Stuart J, Wheeler D, Getz G, Chen K, Lazar AJ, Mills GB, Karchin R, Ding L; MC3 Working Group., Cancer Genome Atlas Research Network. Comprehensive Characterization of Cancer Driver Genes and Mutations. Cell 2018;173:371-385.e18. [PMID: 29625053 DOI: 10.1016/j.cell.2018.02.060] [Cited by in Crossref: 768] [Cited by in F6Publishing: 604] [Article Influence: 256.0] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Ngan HL, Liu Y, Chan HHY, Poon PHY, Yeung CK, Peng Y, Lam WY, Li BX, He Y, Lui VWY. Comprehensive Exome Analysis of Immunocompetent Metastatic Head and Neck Cancer Models Reveals Patient Relevant Landscapes. Cancers (Basel) 2020;12:E2935. [PMID: 33053752 DOI: 10.3390/cancers12102935] [Reference Citation Analysis]
2 Wu Y, Biswas D, Swanton C. Impact of cancer evolution on immune surveillance and checkpoint inhibitor response. Semin Cancer Biol 2021:S1044-579X(21)00042-0. [PMID: 33631295 DOI: 10.1016/j.semcancer.2021.02.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wolpaw AJ, Dang CV. MYC-induced metabolic stress and tumorigenesis. Biochim Biophys Acta Rev Cancer 2018;1870:43-50. [PMID: 29791870 DOI: 10.1016/j.bbcan.2018.05.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
4 Jiang Z, Liao G, Yang Y, Lan Y, Xu L, Yan M, Zhou Y, Zhu J, Liu W, Bai J, Xiao Y, Li X. Analysis of Mutations and Dysregulated Pathways Unravels Carcinogenic Effect and Clinical Actionability of Mutational Processes. Front Cell Dev Biol 2021;9:768981. [PMID: 34901014 DOI: 10.3389/fcell.2021.768981] [Reference Citation Analysis]
5 Gan Y, Li N, Xin Y, Zou G. TriPCE: A Novel Tri-Clustering Algorithm for Identifying Pan-Cancer Epigenetic Patterns. Front Genet 2019;10:1298. [PMID: 32010182 DOI: 10.3389/fgene.2019.01298] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Galmiche A, Saidak Z, Bouaoud J, Mirghani H, Page C, Dakpé S, Clatot F. Genomics and precision surgery for head and neck squamous cell carcinoma. Cancer Lett 2020;481:45-54. [PMID: 32272147 DOI: 10.1016/j.canlet.2020.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Kim D, Han SK, Lee K, Kim I, Kong J, Kim S. Evolutionary coupling analysis identifies the impact of disease-associated variants at less-conserved sites. Nucleic Acids Res 2019;47:e94. [PMID: 31199866 DOI: 10.1093/nar/gkz536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Luo P, Ding Y, Lei X, Wu FX. deepDriver: Predicting Cancer Driver Genes Based on Somatic Mutations Using Deep Convolutional Neural Networks. Front Genet 2019;10:13. [PMID: 30761181 DOI: 10.3389/fgene.2019.00013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
9 Nelson LJ, Wright HJ, Dinh NB, Nguyen KD, Razorenova OV, Heinemann FS. Src Kinase Is Biphosphorylated at Y416/Y527 and Activates the CUB-Domain Containing Protein 1/Protein Kinase C δ Pathway in a Subset of Triple-Negative Breast Cancers. Am J Pathol 2020;190:484-502. [PMID: 31843498 DOI: 10.1016/j.ajpath.2019.10.017] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Keenan TE, Burke KP, Van Allen EM. Genomic correlates of response to immune checkpoint blockade. Nat Med 2019;25:389-402. [PMID: 30842677 DOI: 10.1038/s41591-019-0382-x] [Cited by in Crossref: 154] [Cited by in F6Publishing: 142] [Article Influence: 51.3] [Reference Citation Analysis]
11 Dou Y, Jiang X, Xie H, He J, Xiao S. The Jun N-terminal kinases signaling pathway plays a "seesaw" role in ovarian carcinoma: a molecular aspect. J Ovarian Res 2019;12:99. [PMID: 31639019 DOI: 10.1186/s13048-019-0573-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
12 Freire PP, Fernandez GJ, de Moraes D, Cury SS, Dal Pai-Silva M, Dos Reis PP, Rogatto SR, Carvalho RF. The authors reply: Comment on "The expression landscape of cachexia-inducing factors in human cancers" by Freire et al. J Cachexia Sarcopenia Muscle 2020;11:1854-7. [PMID: 32996709 DOI: 10.1002/jcsm.12635] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Arbab M, Shen MW, Mok B, Wilson C, Matuszek Ż, Cassa CA, Liu DR. Determinants of Base Editing Outcomes from Target Library Analysis and Machine Learning. Cell 2020;182:463-480.e30. [PMID: 32533916 DOI: 10.1016/j.cell.2020.05.037] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 21.5] [Reference Citation Analysis]
14 Malik N, Yan H, Yang HH, Ayaz G, DuBois W, Tseng YC, Kim YI, Jiang S, Liu C, Lee M, Huang J. CBFB cooperates with p53 to maintain TAp73 expression and suppress breast cancer. PLoS Genet 2021;17:e1009553. [PMID: 33945523 DOI: 10.1371/journal.pgen.1009553] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Bracken AP, Brien GL, Verrijzer CP. Dangerous liaisons: interplay between SWI/SNF, NuRD, and Polycomb in chromatin regulation and cancer. Genes Dev 2019;33:936-59. [PMID: 31123059 DOI: 10.1101/gad.326066.119] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 20.7] [Reference Citation Analysis]
16 Qin G, Du L, Ma Y, Yin Y, Wang L. Gene biomarker prediction in glioma by integrating scRNA-seq data and gene regulatory network. BMC Med Genomics 2021;14:287. [PMID: 34863158 DOI: 10.1186/s12920-021-01115-6] [Reference Citation Analysis]
17 Mateo L, Guitart-Pla O, Duran-Frigola M, Aloy P. Exploring the OncoGenomic Landscape of cancer. Genome Med 2018;10:61. [PMID: 30071882 DOI: 10.1186/s13073-018-0571-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Kyrochristos ID, Ziogas DE, Goussia A, Glantzounis GK, Roukos DH. Bulk and Single-Cell Next-Generation Sequencing: Individualizing Treatment for Colorectal Cancer. Cancers (Basel) 2019;11:E1809. [PMID: 31752125 DOI: 10.3390/cancers11111809] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
19 Fujii M, Clevers H, Sato T. Modeling Human Digestive Diseases With CRISPR-Cas9-Modified Organoids. Gastroenterology. 2019;156:562-576. [PMID: 30476497 DOI: 10.1053/j.gastro.2018.11.048] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 12.0] [Reference Citation Analysis]
20 Izzi V, Koivunen J, Rappu P, Heino J, Pihlajaniemi T. Integration of Matrisome Omics: Towards System Biology of the Tumor Matrisome. In: Ricard-blum S, editor. Extracellular Matrix Omics. Cham: Springer International Publishing; 2020. pp. 131-56. [DOI: 10.1007/978-3-030-58330-9_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Xie F, Zhang J, Wang J, Reuben A, Xu W, Yi X, Varn FS, Ye Y, Cheng J, Yu M, Wang Y, Liu Y, Xie M, Du P, Ma K, Ma X, Zhou P, Yang S, Chen Y, Wang G, Xia X, Liao Z, Heymach JV, Wistuba II, Futreal PA, Ye K, Cheng C, Xia T. Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy. Clin Cancer Res 2020;26:2908-20. [PMID: 31911545 DOI: 10.1158/1078-0432.CCR-19-1744] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
22 Huang T, Li J, Wang SM. Core promoter mutation contributes to abnormal gene expression in bladder cancer. BMC Cancer 2022;22:68. [PMID: 35033028 DOI: 10.1186/s12885-022-09178-z] [Reference Citation Analysis]
23 Vasudevan A, Baruah PS, Smith JC, Wang Z, Sayles NM, Andrews P, Kendall J, Leu J, Chunduri NK, Levy D, Wigler M, Storchová Z, Sheltzer JM. Single-Chromosomal Gains Can Function as Metastasis Suppressors and Promoters in Colon Cancer. Dev Cell 2020;52:413-428.e6. [PMID: 32097652 DOI: 10.1016/j.devcel.2020.01.034] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 12.5] [Reference Citation Analysis]
24 Wang L, Shilatifard A. UTX Mutations in Human Cancer. Cancer Cell 2019;35:168-76. [PMID: 30753822 DOI: 10.1016/j.ccell.2019.01.001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 14.0] [Reference Citation Analysis]
25 Hallal M, Braga-Lagache S, Jankovic J, Simillion C, Bruggmann R, Uldry AC, Allam R, Heller M, Bonadies N. Inference of kinase-signaling networks in human myeloid cell line models by Phosphoproteomics using kinase activity enrichment analysis (KAEA). BMC Cancer 2021;21:789. [PMID: 34238254 DOI: 10.1186/s12885-021-08479-z] [Reference Citation Analysis]
26 [DOI: 10.1101/686295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
27 Moorthy K, Jaber AN, Ismail MA, Ernawan F, Mohamad MS, Deris S. Missing-Values Imputation Algorithms for Microarray Gene Expression Data. In: Bolón-canedo V, Alonso-betanzos A, editors. Microarray Bioinformatics. New York: Springer; 2019. pp. 255-66. [DOI: 10.1007/978-1-4939-9442-7_12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
28 Mateo L, Duran-Frigola M, Gris-Oliver A, Palafox M, Scaltriti M, Razavi P, Chandarlapaty S, Arribas J, Bellet M, Serra V, Aloy P. Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns. Genome Med 2020;12:78. [PMID: 32907621 DOI: 10.1186/s13073-020-00774-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Wilson FH, Politi K. ERBB Signaling Interrupted: Targeting Ligand-Induced Pathway Activation. Cancer Discov 2018;8:676-8. [PMID: 29858224 DOI: 10.1158/2159-8290.CD-18-0368] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
30 ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature. 2020;578:82-93. [PMID: 32025007 DOI: 10.1038/s41586-020-1969-6] [Cited by in Crossref: 662] [Cited by in F6Publishing: 398] [Article Influence: 331.0] [Reference Citation Analysis]
31 Schultheis AM, de Bruijn I, Selenica P, Macedo GS, da Silva EM, Piscuoglio S, Jungbluth AA, Park KJ, Klimstra DS, Wardelmann E, Hartmann W, Gerharz CD, von Petersdorff M, Buettner R, Reis-Filho JS, Weigelt B. Genomic characterization of small cell carcinomas of the uterine cervix. Mol Oncol 2021. [PMID: 33830625 DOI: 10.1002/1878-0261.12962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 [DOI: 10.1101/590547] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Zhao Z, Xu Q, Wei R, Huang L, Wang W, Wei G, Ni T. Comprehensive characterization of somatic variants associated with intronic polyadenylation in human cancers. Nucleic Acids Res 2021;49:10369-81. [PMID: 34508351 DOI: 10.1093/nar/gkab772] [Reference Citation Analysis]
34 Patel SA, Rodrigues P, Wesolowski L, Vanharanta S. Genomic control of metastasis. Br J Cancer 2021;124:3-12. [PMID: 33144692 DOI: 10.1038/s41416-020-01127-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Tang J, Jiang W, Liu D, Luo J, Wu X, Pan Z, Ding P, Li Y. The comprehensive molecular landscape of the immunologic co-stimulator B7 and TNFR ligand receptor families in colorectal cancer: immunotherapeutic implications with microsatellite instability. Oncoimmunology. 2018;7:e1488566. [PMID: 30288357 DOI: 10.1080/2162402x.2018.1488566] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
36 Hu F, Wang Q, Yang Z, Zhang Z, Liu X. Network-based identification of biomarkers for colon adenocarcinoma. BMC Cancer 2020;20:668. [PMID: 32680494 DOI: 10.1186/s12885-020-07157-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Barel G, Herwig R. NetCore: a network propagation approach using node coreness. Nucleic Acids Res 2020;48:e98. [PMID: 32735660 DOI: 10.1093/nar/gkaa639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Hlavac V, Mohelnikova-Duchonova B, Lovecek M, Ehrmann J, Brynychova V, Kolarova K, Soucek P. Targeted Sequencing of Pancreatic Adenocarcinomas from Patients with Metachronous Pulmonary Metastases. Genes (Basel) 2020;11:E1391. [PMID: 33255265 DOI: 10.3390/genes11121391] [Reference Citation Analysis]
39 Chai AWY, Lim KP, Cheong SC. Translational genomics and recent advances in oral squamous cell carcinoma. Seminars in Cancer Biology 2020;61:71-83. [DOI: 10.1016/j.semcancer.2019.09.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 14.5] [Reference Citation Analysis]
40 Hargadon KM, Győrffy B, Strong EW. The prognostic significance of FOXC2 gene expression in cancer: A comprehensive analysis of RNA-seq data from the cancer genome atlas. Cancer Genet 2021;254-255:58-64. [PMID: 33636524 DOI: 10.1016/j.cancergen.2021.02.005] [Reference Citation Analysis]
41 Wang R, Song S, Harada K, Ghazanfari Amlashi F, Badgwell B, Pizzi MP, Xu Y, Zhao W, Dong X, Jin J, Wang Y, Scott A, Ma L, Huo L, Vicente D, Blum Murphy M, Shanbhag N, Tatlonghari G, Thomas I, Rogers J, Kobayashi M, Vykoukal J, Estrella JS, Roy-Chowdhuri S, Han G, Zhang S, Mao X, Song X, Zhang J, Gu J, Johnson RL, Calin GA, Peng G, Lee JS, Hanash SM, Futreal A, Wang Z, Wang L, Ajani JA. Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response. Gut 2020;69:18-31. [PMID: 31171626 DOI: 10.1136/gutjnl-2018-318070] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
42 Chatrath A, Przanowska R, Kiran S, Su Z, Saha S, Wilson B, Tsunematsu T, Ahn JH, Lee KY, Paulsen T, Sobierajska E, Kiran M, Tang X, Li T, Kumar P, Ratan A, Dutta A. The pan-cancer landscape of prognostic germline variants in 10,582 patients. Genome Med 2020;12:15. [PMID: 32066500 DOI: 10.1186/s13073-020-0718-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
43 Liu H, Zhang Y, Li L, Cao J, Guo Y, Wu Y, Gao W. Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target? Mol Ther Oncolytics 2021;20:240-64. [PMID: 33614909 DOI: 10.1016/j.omto.2020.12.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
44 Priestley P, Baber J, Lolkema MP, Steeghs N, de Bruijn E, Shale C, Duyvesteyn K, Haidari S, van Hoeck A, Onstenk W, Roepman P, Voda M, Bloemendal HJ, Tjan-Heijnen VCG, van Herpen CML, Labots M, Witteveen PO, Smit EF, Sleijfer S, Voest EE, Cuppen E. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 2019;575:210-6. [PMID: 31645765 DOI: 10.1038/s41586-019-1689-y] [Cited by in Crossref: 220] [Cited by in F6Publishing: 178] [Article Influence: 73.3] [Reference Citation Analysis]
45 Wan WX, Chen Y, Zhang J, Shen F, Luo L, Deng SH, Xiao H, Zhou W, Deng OP, Yang H, Xiao YL, Huang CR, Tian D, He JS, Wang YJ. Mechanism-based structure-activity relationship (SAR) analysis of aromatic amines and nitroaromatics carcinogenicity via statistical analyses based on CPDB. Toxicol In Vitro 2019;58:13-25. [PMID: 30878698 DOI: 10.1016/j.tiv.2019.03.017] [Reference Citation Analysis]
46 O'Mara TA, Spurdle AB, Glubb DM; Endometrial Cancer Association Consortium. Analysis of Promoter-Associated Chromatin Interactions Reveals Biologically Relevant Candidate Target Genes at Endometrial Cancer Risk Loci. Cancers (Basel) 2019;11:E1440. [PMID: 31561579 DOI: 10.3390/cancers11101440] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 6.3] [Reference Citation Analysis]
47 Wang S, Qiu Y, Bai B. The Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer. Front Oncol 2019;9:614. [PMID: 31355137 DOI: 10.3389/fonc.2019.00614] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
48 Cocco E, Lopez S, Santin AD, Scaltriti M. Prevalence and role of HER2 mutations in cancer. Pharmacol Ther 2019;199:188-96. [PMID: 30951733 DOI: 10.1016/j.pharmthera.2019.03.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
49 Ebata K, Yamashiro S, Iida K, Okada M. Building patient-specific models for receptor tyrosine kinase signaling networks. FEBS J 2021. [PMID: 33755310 DOI: 10.1111/febs.15831] [Reference Citation Analysis]
50 Liu Z, Lin Y, Gao X, Mai R, Piao X, Ye J, Liang R. Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes. Front Genet 2020;11:634. [PMID: 32670354 DOI: 10.3389/fgene.2020.00634] [Reference Citation Analysis]
51 Shimada K, Bachman JA, Muhlich JL, Mitchison TJ. shinyDepMap, a tool to identify targetable cancer genes and their functional connections from Cancer Dependency Map data. Elife 2021;10:e57116. [PMID: 33554860 DOI: 10.7554/eLife.57116] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Li X, Warner JL. A Review of Precision Oncology Knowledgebases for Determining the Clinical Actionability of Genetic Variants. Front Cell Dev Biol 2020;8:48. [PMID: 32117976 DOI: 10.3389/fcell.2020.00048] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
53 Raimondi F, Inoue A, Kadji FMN, Shuai N, Gonzalez JC, Singh G, de la Vega AA, Sotillo R, Fischer B, Aoki J, Gutkind JS, Russell RB. Rare, functional, somatic variants in gene families linked to cancer genes: GPCR signaling as a paradigm. Oncogene 2019;38:6491-506. [PMID: 31337866 DOI: 10.1038/s41388-019-0895-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
54 Wang H, Wang T, Zhao X, Wu H, You M, Sun Z, Mao F. AI-Driver: an ensemble method for identifying driver mutations in personal cancer genomes. NAR Genom Bioinform 2020;2:lqaa084. [PMID: 33575629 DOI: 10.1093/nargab/lqaa084] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 López S, Lim EL, Horswell S, Haase K, Huebner A, Dietzen M, Mourikis TP, Watkins TBK, Rowan A, Dewhurst SM, Birkbak NJ, Wilson GA, Van Loo P, Jamal-Hanjani M, Swanton C, McGranahan N; TRACERx Consortium. Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution. Nat Genet 2020;52:283-93. [PMID: 32139907 DOI: 10.1038/s41588-020-0584-7] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 27.0] [Reference Citation Analysis]
56 Brien GL, Remillard D, Shi J, Hemming ML, Chabon J, Wynne K, Dillon ET, Cagney G, Van Mierlo G, Baltissen MP, Vermeulen M, Qi J, Fröhling S, Gray NS, Bradner JE, Vakoc CR, Armstrong SA. Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma. Elife 2018;7:e41305. [PMID: 30431433 DOI: 10.7554/eLife.41305] [Cited by in Crossref: 52] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
57 Wang T, Ruan S, Zhao X, Shi X, Teng H, Zhong J, You M, Xia K, Sun Z, Mao F. OncoVar: an integrated database and analysis platform for oncogenic driver variants in cancers. Nucleic Acids Res 2021;49:D1289-301. [PMID: 33179738 DOI: 10.1093/nar/gkaa1033] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
58 Vicens A, Posada D. Selective Pressures on Human Cancer Genes along the Evolution of Mammals. Genes (Basel) 2018;9:E582. [PMID: 30487452 DOI: 10.3390/genes9120582] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
59 An HJ, Kim Y, Chang S, Kim H, Song J, Park H, Choi I. High-spatial and colourimetric imaging of histone modifications in single senescent cells using plasmonic nanoprobes. Nat Commun 2021;12:5899. [PMID: 34625566 DOI: 10.1038/s41467-021-26224-9] [Reference Citation Analysis]
60 Zong X, Zhang Y, Peng X, Cao D, Yu M, Wang J, Li H, Guo X, Liang H, Yang J. Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance. Nat Commun 2021;12:3579. [PMID: 34117242 DOI: 10.1038/s41467-021-23681-0] [Reference Citation Analysis]
61 Olivier M, Asmis R, Hawkins GA, Howard TD, Cox LA. The Need for Multi-Omics Biomarker Signatures in Precision Medicine. Int J Mol Sci 2019;20:E4781. [PMID: 31561483 DOI: 10.3390/ijms20194781] [Cited by in Crossref: 67] [Cited by in F6Publishing: 51] [Article Influence: 22.3] [Reference Citation Analysis]
62 Arechederra M, Recalde M, Gárate-Rascón M, Fernández-Barrena MG, Ávila MA, Berasain C. Epigenetic Biomarkers for the Diagnosis and Treatment of Liver Disease. Cancers (Basel) 2021;13:1265. [PMID: 33809263 DOI: 10.3390/cancers13061265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
63 Colaprico A, Olsen C, Bailey MH, Odom GJ, Terkelsen T, Silva TC, Olsen AV, Cantini L, Zinovyev A, Barillot E, Noushmehr H, Bertoli G, Castiglioni I, Cava C, Bontempi G, Chen XS, Papaleo E. Interpreting pathways to discover cancer driver genes with Moonlight. Nat Commun 2020;11:69. [PMID: 31900418 DOI: 10.1038/s41467-019-13803-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
64 Kakiuchi N, Ogawa S. Clonal expansion in non-cancer tissues. Nat Rev Cancer 2021;21:239-56. [DOI: 10.1038/s41568-021-00335-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
65 Xia Y, Fan C, Hoadley KA, Parker JS, Perou CM. Genetic determinants of the molecular portraits of epithelial cancers. Nat Commun 2019;10:5666. [PMID: 31827079 DOI: 10.1038/s41467-019-13588-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
66 Montazeri H, Coto-Llerena M, Bianco G, Zangene E, Taha-Mehlitz S, Paradiso V, Srivatsa S, de Weck A, Roma G, Lanzafame M, Bolli M, Beerenwinkel N, von Flüe M, Terracciano LM, Piscuoglio S, Ng CKY. Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens. Nucleic Acids Res 2021:gkab627. [PMID: 34313788 DOI: 10.1093/nar/gkab627] [Reference Citation Analysis]
67 Schachter NF, Adams JR, Skowron P, Kozma KJ, Lee CA, Raghuram N, Yang J, Loch AJ, Wang W, Kucharczuk A, Wright KL, Quintana RM, An Y, Dotzko D, Gorman JL, Wojtal D, Shah JS, Leon-Gomez P, Pellecchia G, Dupuy AJ, Perou CM, Ben-Porath I, Karni R, Zacksenhaus E, Woodgett JR, Done SJ, Garzia L, Sorana Morrissy A, Reimand J, Taylor MD, Egan SE. Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer. Nat Commun 2021;12:5238. [PMID: 34475389 DOI: 10.1038/s41467-021-25467-w] [Reference Citation Analysis]
68 Birkbak NJ, McGranahan N. Cancer Genome Evolutionary Trajectories in Metastasis. Cancer Cell 2020;37:8-19. [PMID: 31935374 DOI: 10.1016/j.ccell.2019.12.004] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 23.0] [Reference Citation Analysis]
69 Su S, Chang L, Lin C, Chen M, Yu C, Chung W, Yang S. Mutational signatures and mutagenic impacts associated with betel quid chewing in oral squamous cell carcinoma. Hum Genet 2019;138:1379-89. [DOI: 10.1007/s00439-019-02083-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
70 Luo Z, Liu W, Sun P, Wang F, Feng X. Pan-cancer analyses reveal regulation and clinical outcome association of the shelterin complex in cancer. Brief Bioinform 2021:bbaa441. [PMID: 33497432 DOI: 10.1093/bib/bbaa441] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
71 Jiang L, Zheng J, Kwan JSH, Dai S, Li C, Li MJ, Yu B, To KF, Sham PC, Zhu Y, Li M. WITER: a powerful method for estimation of cancer-driver genes using a weighted iterative regression modelling background mutation counts. Nucleic Acids Res 2019;47:e96. [PMID: 31287869 DOI: 10.1093/nar/gkz566] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
72 Sato M. Phenotypic screening using large-scale genomic libraries to identify drug targets for the treatment of cancer. Oncol Lett 2020;19:3617-26. [PMID: 32391087 DOI: 10.3892/ol.2020.11512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
73 Malhis N, Jacobson M, Jones SJM, Gsponer J. LIST-S2: taxonomy based sorting of deleterious missense mutations across species. Nucleic Acids Res 2020;48:W154-61. [PMID: 32352516 DOI: 10.1093/nar/gkaa288] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
74 Fontana D, Ramazzotti D, Aroldi A, Redaelli S, Magistroni V, Pirola A, Niro A, Massimino L, Mastini C, Brambilla V, Bombelli S, Bungaro S, Morotti A, Rea D, Stagno F, Martino B, Campiotti L, Caocci G, Usala E, Merli M, Onida F, Bregni M, Elli EM, Fumagalli M, Ciceri F, Perego RA, Pagni F, Mologni L, Piazza R, Gambacorti-Passerini C. Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia. Hemasphere 2020;4:e497. [PMID: 33196013 DOI: 10.1097/HS9.0000000000000497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
75 Tokheim C, Karchin R. CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers. Cell Syst 2019;9:9-23.e8. [PMID: 31202631 DOI: 10.1016/j.cels.2019.05.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 14.3] [Reference Citation Analysis]
76 Kumar S, Clarke D, Gerstein MB. Leveraging protein dynamics to identify cancer mutational hotspots using 3D structures. Proc Natl Acad Sci U S A 2019;116:18962-70. [PMID: 31462496 DOI: 10.1073/pnas.1901156116] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
77 Vivarelli S, Falzone L, Ligresti G, Candido S, Garozzo A, Magro GG, Bonavida B, Libra M. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets. Int J Mol Sci 2020;21:E6446. [PMID: 32899428 DOI: 10.3390/ijms21176446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Douville C, Moinova HR, Thota PN, Shaheen NJ, Iyer PG, Canto MI, Wang JS, Dumot JA, Faulx A, Kinzler KW, Papadopoulos N, Vogelstein B, Markowitz SD, Bettegowda C, Willis JE, Chak A. Massively Parallel Sequencing of Esophageal Brushings Enables an Aneuploidy-Based Classification of Patients With Barrett's Esophagus. Gastroenterology 2021;160:2043-2054.e2. [PMID: 33493502 DOI: 10.1053/j.gastro.2021.01.209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
79 Karczmarski J, Goryca K, Pachlewski J, Dabrowska M, Pysniak K, Paziewska A, Kulecka M, Lenarcik M, Mroz A, Mikula M, Ostrowski J. Mutation Profiling of Premalignant Colorectal Neoplasia. Gastroenterol Res Pract 2019;2019:2542640. [PMID: 31781186 DOI: 10.1155/2019/2542640] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
80 Cai Y, Tian Y, Wang J, Wei W, Tang Q, Lu L, Luo Z, Li W, Lu Y, Pu J, Yang Z. Identification of Driver Genes Regulating the T-Cell-Infiltrating Levels in Hepatocellular Carcinoma. Front Genet 2020;11:560546. [PMID: 33381145 DOI: 10.3389/fgene.2020.560546] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
81 Bilder D, Ong K, Hsi TC, Adiga K, Kim J. Tumour-host interactions through the lens of Drosophila. Nat Rev Cancer 2021. [PMID: 34389815 DOI: 10.1038/s41568-021-00387-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Chatsirisupachai K, Lesluyes T, Paraoan L, Van Loo P, de Magalhães JP. An integrative analysis of the age-associated multi-omic landscape across cancers. Nat Commun 2021;12:2345. [PMID: 33879792 DOI: 10.1038/s41467-021-22560-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
83 Chang YS, Tu SJ, Chen YC, Liu TY, Lee YT, Yen JC, Fang HY, Chang JG. Mutation profile of non-small cell lung cancer revealed by next generation sequencing. Respir Res 2021;22:3. [PMID: 33407425 DOI: 10.1186/s12931-020-01608-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Mall R, Saad M, Roelands J, Rinchai D, Kunji K, Almeer H, Hendrickx W, M Marincola F, Ceccarelli M, Bedognetti D. Network-based identification of key master regulators associated with an immune-silent cancer phenotype. Brief Bioinform 2021:bbab168. [PMID: 33979427 DOI: 10.1093/bib/bbab168] [Reference Citation Analysis]
85 Foltz SM, Gao Q, Yoon CJ, Sun H, Yao L, Li Y, Jayasinghe RG, Cao S, King J, Kohnen DR, Fiala MA, Ding L, Vij R. Evolution and structure of clinically relevant gene fusions in multiple myeloma. Nat Commun 2020;11:2666. [PMID: 32471990 DOI: 10.1038/s41467-020-16434-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
86 Chen HN, Shu Y, Liao F, Liao X, Zhang H, Qin Y, Wang Z, Luo M, Liu Q, Xue Z, Cao M, Zhang S, Zhang WH, Hou Q, Xia X, Luo H, Zhang Y, Yang L, Hu JK, Fu X, Liu B, Hu H, Huang C, Peng Y, Cheng W, Dai L, Yang L, Zhang W, Dong B, Li Y, Wei Y, Xu H, Zhou ZG. Genomic evolution and diverse models of systemic metastases in colorectal cancer. Gut 2021:gutjnl-2020-323703. [PMID: 33632712 DOI: 10.1136/gutjnl-2020-323703] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
87 Xie T, Li Y, Ying J, Cai W, Li J, Lee KY, Ricciuti B, Pacheco J, Xing P. Whole exome sequencing (WES) analysis of transformed small cell lung cancer (SCLC) from lung adenocarcinoma (LUAD). Transl Lung Cancer Res 2020;9:2428-39. [PMID: 33489804 DOI: 10.21037/tlcr-20-1278] [Reference Citation Analysis]
88 Källberg D, Vidman L, Rydén P. Comparison of Methods for Feature Selection in Clustering of High-Dimensional RNA-Sequencing Data to Identify Cancer Subtypes. Front Genet 2021;12:632620. [PMID: 33719342 DOI: 10.3389/fgene.2021.632620] [Reference Citation Analysis]
89 Lee CJ, Ahn H, Jeong D, Pak M, Moon JH, Kim S. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer. BMC Med Genomics 2020;13:27. [PMID: 32093698 DOI: 10.1186/s12920-020-0659-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
90 Sayaman RW, Saad M, Thorsson V, Hu D, Hendrickx W, Roelands J, Porta-Pardo E, Mokrab Y, Farshidfar F, Kirchhoff T, Sweis RF, Bathe OF, Heimann C, Campbell MJ, Stretch C, Huntsman S, Graff RE, Syed N, Radvanyi L, Shelley S, Wolf D, Marincola FM, Ceccarelli M, Galon J, Ziv E, Bedognetti D. Germline genetic contribution to the immune landscape of cancer. Immunity. 2021;54:367-386.e8. [PMID: 33567262 DOI: 10.1016/j.immuni.2021.01.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
91 Alharbi AB, Schmitz U, Marshall AD, Vanichkina D, Nagarajah R, Vellozzi M, Wong JJ, Bailey CG, Rasko JE. Ctcf haploinsufficiency mediates intron retention in a tissue-specific manner. RNA Biol 2021;18:93-103. [PMID: 32816606 DOI: 10.1080/15476286.2020.1796052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Fojo T, Huff L, Litman T, Im K, Edgerly M, Del Rivero J, Pittaluga S, Merino M, Bates SE, Dean M. Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape. BMC Med Genomics 2020;13:165. [PMID: 33148256 DOI: 10.1186/s12920-020-00809-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
93 Hsiehchen D, Hsieh A. Nearing saturation of cancer driver gene discovery. J Hum Genet 2018;63:941-3. [DOI: 10.1038/s10038-018-0481-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
94 Krause A, Roma L, Lorber T, Habicht J, Lardinois D, De Filippo MR, Prince SS, Piscuoglio S, Ng C, Bubendorf L. Deciphering the clonal relationship between glandular and squamous components in adenosquamous carcinoma of the lung using whole exome sequencing. Lung Cancer 2020;150:132-8. [PMID: 33137577 DOI: 10.1016/j.lungcan.2020.10.013] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
95 Gorlov IP, Xia X, Tsavachidis S, Gorlova OY, Amos CI. Tumor somatic mutations also existing as germline polymorphisms may help to identify functional SNPs from genome-wide association studies. Carcinogenesis 2020;41:1353-62. [PMID: 32681635 DOI: 10.1093/carcin/bgaa077] [Reference Citation Analysis]
96 Saito Y, Koya J, Kataoka K. Multiple mutations within individual oncogenes. Cancer Sci 2021;112:483-9. [PMID: 33073435 DOI: 10.1111/cas.14699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
97 Belyavsky A, Petinati N, Drize N. Hematopoiesis during Ontogenesis, Adult Life, and Aging. Int J Mol Sci 2021;22:9231. [PMID: 34502137 DOI: 10.3390/ijms22179231] [Reference Citation Analysis]
98 Wong AK, Sealfon RSG, Theesfeld CL, Troyanskaya OG. Decoding disease: from genomes to networks to phenotypes. Nat Rev Genet 2021. [PMID: 34341555 DOI: 10.1038/s41576-021-00389-x] [Reference Citation Analysis]
99 Gui P, Bivona TG. Evolution of metastasis: new tools and insights. Trends Cancer 2021:S2405-8033(21)00228-4. [PMID: 34872888 DOI: 10.1016/j.trecan.2021.11.002] [Reference Citation Analysis]
100 Huang D, Wang X, Liu Y, Huang Z, Hu X, Hu W, Li Q, Chan H, Zou Y, Ho IHT, Wang Y, Cheng ASL, Kang W, To KF, Wang MHT, Wong SH, Yu J, Gin T, Zhang Q, Li Z, Shen J, Zhang L, Chan MTV, Liu X, Wu WKK. Multi-omic analysis suggests tumor suppressor genes evolved specific promoter features to optimize cancer resistance. Brief Bioinform 2021:bbab040. [PMID: 33783485 DOI: 10.1093/bib/bbab040] [Reference Citation Analysis]
101 Rashidieh B, Molakarimi M, Mohseni A, Tria SM, Truong H, Srihari S, Adams RC, Jones M, Duijf PHG, Kalimutho M, Khanna KK. Targeting BRF2 in Cancer Using Repurposed Drugs. Cancers (Basel) 2021;13:3778. [PMID: 34359683 DOI: 10.3390/cancers13153778] [Reference Citation Analysis]
102 Lee JS, Choi YE, Kim S, Han JY, Goh SH. ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCί. Int J Mol Sci 2021;22:12287. [PMID: 34830169 DOI: 10.3390/ijms222212287] [Reference Citation Analysis]
103 Arshad Z, McDonald JF. Changes in gene-gene interactions associated with cancer onset and progression are largely independent of changes in gene expression. iScience 2021;24:103522. [PMID: 34917899 DOI: 10.1016/j.isci.2021.103522] [Reference Citation Analysis]
104 Kohsaka S, Tatsuno K, Ueno T, Nagano M, Shinozaki-Ushiku A, Ushiku T, Takai D, Ikegami M, Kobayashi H, Kage H, Ando M, Hata K, Ueda H, Yamamoto S, Kojima S, Oseto K, Akaike K, Suehara Y, Hayashi T, Saito T, Takahashi F, Takahashi K, Takamochi K, Suzuki K, Nagayama S, Oda Y, Mimori K, Ishihara S, Yatomi Y, Nagase T, Nakajima J, Tanaka S, Fukayama M, Oda K, Nangaku M, Miyazono K, Miyagawa K, Aburatani H, Mano H. Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens. Cancer Sci 2019;110:1464-79. [PMID: 30737998 DOI: 10.1111/cas.13968] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
105 Richard M, Decamps C, Chuffart F, Brambilla E, Rousseaux S, Khochbin S, Jost D. PenDA, a rank-based method for personalized differential analysis: Application to lung cancer. PLoS Comput Biol 2020;16:e1007869. [PMID: 32392248 DOI: 10.1371/journal.pcbi.1007869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
106 Kang J, Lee A, Lee YS. Prediction of PIK3CA mutations from cancer gene expression data. PLoS One 2020;15:e0241514. [PMID: 33166334 DOI: 10.1371/journal.pone.0241514] [Reference Citation Analysis]
107 Quinton RJ, DiDomizio A, Vittoria MA, Kotýnková K, Ticas CJ, Patel S, Koga Y, Vakhshoorzadeh J, Hermance N, Kuroda TS, Parulekar N, Taylor AM, Manning AL, Campbell JD, Ganem NJ. Whole-genome doubling confers unique genetic vulnerabilities on tumour cells. Nature 2021;590:492-7. [PMID: 33505027 DOI: 10.1038/s41586-020-03133-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 22.0] [Reference Citation Analysis]
108 Garofoli A, Paradiso V, Montazeri H, Jermann PM, Roma G, Tornillo L, Terracciano LM, Piscuoglio S, Ng CKY. PipeIT: A Singularity Container for Molecular Diagnostic Somatic Variant Calling on the Ion Torrent Next-Generation Sequencing Platform. J Mol Diagn 2019;21:884-94. [PMID: 31229654 DOI: 10.1016/j.jmoldx.2019.05.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
109 Ou X, Cao J, Cheng A, Peppelenbosch MP, Pan Q. Errors in translational decoding: tRNA wobbling or misincorporation? PLoS Genet 2019;15:e1008017. [PMID: 30921315 DOI: 10.1371/journal.pgen.1008017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
110 Schutt CR, Sun H, Pradhan JS, Saenger Y, Ley J, Adkins D, Ingham M, Ding L, Van Tine BA. Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma. Oncotarget 2021;12:534-48. [PMID: 33796222 DOI: 10.18632/oncotarget.27907] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
111 Danesi R, Fogli S, Indraccolo S, Del Re M, Dei Tos AP, Leoncini L, Antonuzzo L, Bonanno L, Guarneri V, Pierini A, Amunni G, Conte P. Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards. ESMO Open 2021;6:100040. [PMID: 33540286 DOI: 10.1016/j.esmoop.2020.100040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
112 Credendino SC, Neumayer C, Cantone I. Genetics and Epigenetics of Sex Bias: Insights from Human Cancer and Autoimmunity. Trends Genet 2020;36:650-63. [PMID: 32736810 DOI: 10.1016/j.tig.2020.06.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
113 Ishaque N, Abba ML, Hauser C, Patil N, Paramasivam N, Huebschmann D, Leupold JH, Balasubramanian GP, Kleinheinz K, Toprak UH, Hutter B, Benner A, Shavinskaya A, Zhou C, Gu Z, Kerssemakers J, Marx A, Moniuszko M, Kozlowski M, Reszec J, Niklinski J, Eils J, Schlesner M, Eils R, Brors B, Allgayer H. Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer. Nat Commun 2018;9:4782. [PMID: 30429477 DOI: 10.1038/s41467-018-07041-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 11.8] [Reference Citation Analysis]
114 Gargiulo G. Next-Generation in vivo Modeling of Human Cancers. Front Oncol 2018;8:429. [PMID: 30364119 DOI: 10.3389/fonc.2018.00429] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
115 Lin J, Peng X, Dong K, Long J, Guo X, Li H, Bai Y, Yang X, Wang D, Lu X, Mao Y, Sang X, Ji X, Zhao H, Liang H. Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer. Nat Commun 2021;12:4753. [PMID: 34362903 DOI: 10.1038/s41467-021-25012-9] [Reference Citation Analysis]
116 Qian C, Dai N, Xu M, Luo H, Feng Y, Zhang M, Chen R, Wang D. ctDNA facilitated the diagnosis of a patient with synchronous urothelial carcinoma and non-small cell lung cancer: case report. Ann Transl Med 2020;8:1323. [PMID: 33209903 DOI: 10.21037/atm-20-6552] [Reference Citation Analysis]
117 Ahmed R, Erten C, Houdjedj A, Kazan H, Yalcin C. A Network-Centric Framework for the Evaluation of Mutual Exclusivity Tests on Cancer Drivers. Front Genet 2021;12:746495. [PMID: 34899838 DOI: 10.3389/fgene.2021.746495] [Reference Citation Analysis]
118 Yin S, Xi R, Wu A, Wang S, Li Y, Wang C, Tang L, Xia Y, Yang D, Li J, Ye B, Yu Y, Wang J, Zhang H, Ren F, Zhang Y, Shen D, Wang L, Ying X, Li Z, Bu Z, Ji X, Gao X, Jia Y, Jia Z, Li N, Li Z, Ji JF, Xi JJ. Patient-derived tumor-like cell clusters for drug testing in cancer therapy. Sci Transl Med 2020;12:eaaz1723. [PMID: 32581131 DOI: 10.1126/scitranslmed.aaz1723] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
119 Dong Y, Wang J, Ji W, Zheng M, Wang P, Liu L, Li S. Preclinical Application of Conditional Reprogramming Culture System for Laryngeal and Hypopharyngeal Carcinoma. Front Cell Dev Biol 2021;9:744969. [PMID: 34778255 DOI: 10.3389/fcell.2021.744969] [Reference Citation Analysis]
120 Debaize L, Troadec MB. The master regulator FUBP1: its emerging role in normal cell function and malignant development. Cell Mol Life Sci 2019;76:259-81. [PMID: 30343319 DOI: 10.1007/s00018-018-2933-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
121 Zahir N, Sun R, Gallahan D, Gatenby RA, Curtis C. Characterizing the ecological and evolutionary dynamics of cancer. Nat Genet 2020;52:759-67. [DOI: 10.1038/s41588-020-0668-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
122 Sepich-poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The microbiome and human cancer. Science 2021;371:eabc4552. [DOI: 10.1126/science.abc4552] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 27.0] [Reference Citation Analysis]
123 Dai Z, Ramesh V, Locasale JW. The evolving metabolic landscape of chromatin biology and epigenetics. Nat Rev Genet 2020;21:737-53. [PMID: 32908249 DOI: 10.1038/s41576-020-0270-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 19.0] [Reference Citation Analysis]
124 Dorstyn L, Hackett-Jones E, Nikolic A, Norris MD, Lim Y, Toubia J, Haber M, Kumar S. Transcriptome profiling of caspase-2 deficient EμMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signaling. Cell Death Dis 2019;10:56. [PMID: 30670683 DOI: 10.1038/s41419-018-1296-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
125 Cario CL, Chen E, Leong L, Emami NC, Lopez K, Tenggara I, Simko JP, Friedlander TW, Li PS, Paris PL, Carroll PR, Witte JS. A machine learning approach to optimizing cell-free DNA sequencing panels: with an application to prostate cancer. BMC Cancer 2020;20:820. [PMID: 32859160 DOI: 10.1186/s12885-020-07318-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Wu P, Hou L, Zhang Y, Zhang L. Phylogenetic Tree Inference: A Top-Down Approach to Track Tumor Evolution. Front Genet 2019;10:1371. [PMID: 32117420 DOI: 10.3389/fgene.2019.01371] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
127 Ahn S, Lim J, Park SY, Kim H, Kwon HJ, Han YB, Lee CT, Cho S, Chung JH. Genetic Alterations in Preinvasive Lung Synchronous Lesions. Cancer Res Treat 2020;52:1120-34. [PMID: 32599981 DOI: 10.4143/crt.2020.307] [Reference Citation Analysis]
128 Kawaji H, Kubo M, Yamashita N, Yamamoto H, Kai M, Kajihara A, Yamada M, Kurata K, Kaneshiro K, Harada Y, Hayashi S, Shimazaki A, Mori H, Akiyoshi S, Oki E, Oda Y, Baba E, Mori M, Nakamura M. Comprehensive molecular profiling broadens treatment options for breast cancer patients. Cancer Med 2021;10:529-39. [PMID: 33274848 DOI: 10.1002/cam4.3619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Peri A, Greenstein E, Alon M, Pai JA, Dingjan T, Reich-Zeliger S, Barnea E, Barbolin C, Levy R, Arnedo-Pac C, Kalaora S, Dassa B, Feldmesser E, Shang P, Greenberg P, Levin Y, Benedek G, Levesque MP, Adams DJ, Lotem M, Wilmott JS, Scolyer RA, Jönsson GB, Admon A, Rosenberg SA, Cohen CJ, Niv MY, Lopez-Bigas N, Satpathy AT, Friedman N, Samuels Y. Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma. J Clin Invest 2021;131:e129466. [PMID: 34651586 DOI: 10.1172/JCI129466] [Reference Citation Analysis]
130 Pajkos M, Zeke A, Dosztányi Z. Ancient Evolutionary Origin of Intrinsically Disordered Cancer Risk Regions. Biomolecules 2020;10:E1115. [PMID: 32731489 DOI: 10.3390/biom10081115] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
131 Hötzel KJ, Havnar CA, Ngu HV, Rost S, Liu SD, Rangell LK, Peale FV. Synthetic Antigen Gels as Practical Controls for Standardized and Quantitative Immunohistochemistry. J Histochem Cytochem 2019;67:309-34. [PMID: 30879407 DOI: 10.1369/0022155419832002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
132 Aikin TJ, Peterson AF, Pokrass MJ, Clark HR, Regot S. MAPK activity dynamics regulate non-cell autonomous effects of oncogene expression. Elife 2020;9:e60541. [PMID: 32940599 DOI: 10.7554/eLife.60541] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
133 Xiong Y, Lei J, Zhao J, Lu Q, Feng Y, Qiao T, Xin S, Han Y, Jiang T. A gene-based survival score for lung adenocarcinoma by multiple transcriptional datasets analysis. BMC Cancer 2020;20:1046. [PMID: 33129284 DOI: 10.1186/s12885-020-07473-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
134 Kong F, Kong D, Yang X, Yuan D, Zhang N, Hua X, You H, Zheng K, Tang R. Integrative analysis of highly mutated genes in hepatitis B virus-related hepatic carcinoma. Cancer Med 2020;9:2462-79. [PMID: 32017470 DOI: 10.1002/cam4.2903] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
135 Lu M, Zhang X, Zhao J, You Q, Jiang Z. A hydrogen peroxide responsive prodrug of Keap1-Nrf2 inhibitor for improving oral absorption and selective activation in inflammatory conditions. Redox Biol 2020;34:101565. [PMID: 32422540 DOI: 10.1016/j.redox.2020.101565] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
136 Smith ES, Da Cruz Paula A, Cadoo KA, Abu-Rustum NR, Pei X, Brown DN, Ferrando L, Sebastiao APM, Riaz N, Robson ME, Soslow RA, Reis-Filho JS, Mandelker D, Weigelt B. Endometrial Cancers in BRCA1 or BRCA2 Germline Mutation Carriers: Assessment of Homologous Recombination DNA Repair Defects. JCO Precis Oncol 2019;3:PO. [PMID: 32914019 DOI: 10.1200/PO.19.00103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
137 López-Cortés A, Paz-Y-Miño C, Guerrero S, Jaramillo-Koupermann G, León Cáceres Á, Intriago-Baldeón DP, García-Cárdenas JM, Guevara-Ramírez P, Armendáriz-Castillo I, Leone PE, Quiñones LA, Cayún JP, Soria NW. Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer. Pharmacogenomics J 2020;20:136-58. [PMID: 31616044 DOI: 10.1038/s41397-019-0102-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
138 Banerjee S, Raman K, Ravindran B. Sequence Neighborhoods Enable Reliable Prediction of Pathogenic Mutations in Cancer Genomes. Cancers (Basel) 2021;13:2366. [PMID: 34068918 DOI: 10.3390/cancers13102366] [Reference Citation Analysis]
139 Scholl C, Fröhling S. Exploiting rare driver mutations for precision cancer medicine. Curr Opin Genet Dev 2019;54:1-6. [PMID: 30844512 DOI: 10.1016/j.gde.2019.02.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
140 Schulte-sasse R, Budach S, Hnisz D, Marsico A. Integration of multiomics data with graph convolutional networks to identify new cancer genes and their associated molecular mechanisms. Nat Mach Intell 2021;3:513-26. [DOI: 10.1038/s42256-021-00325-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
141 Teng H, Wei W, Li Q, Xue M, Shi X, Li X, Mao F, Sun Z. Prevalence and architecture of posttranscriptionally impaired synonymous mutations in 8,320 genomes across 22 cancer types. Nucleic Acids Res 2020;48:1192-205. [PMID: 31950163 DOI: 10.1093/nar/gkaa019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
142 Lomberk G, Dusetti N, Iovanna J, Urrutia R. Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine. Nat Commun 2019;10:3875. [PMID: 31462645 DOI: 10.1038/s41467-019-11812-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
143 Jaravine V, Balmford J, Metzger P, Boerries M, Binder H, Boeker M. Annotation of Human Exome Gene Variants with Consensus Pathogenicity. Genes (Basel) 2020;11:E1076. [PMID: 32938008 DOI: 10.3390/genes11091076] [Reference Citation Analysis]
144 Peinado P, Andrades A, Martorell-Marugán J, Haswell JR, Slack FJ, Carmona-Sáez P, Medina PP. The SWI/SNF complex regulates the expression of miR-222, a tumor suppressor microRNA in lung adenocarcinoma. Hum Mol Genet 2021:ddab187. [PMID: 34240140 DOI: 10.1093/hmg/ddab187] [Reference Citation Analysis]
145 Chang HR, Jung E, Cho S, Jeon YJ, Kim Y. Targeting Non-Oncogene Addiction for Cancer Therapy. Biomolecules 2021;11:129. [PMID: 33498235 DOI: 10.3390/biom11020129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Margres MJ, Ruiz-Aravena M, Hamede R, Chawla K, Patton AH, Lawrance MF, Fraik AK, Stahlke AR, Davis BW, Ostrander EA, Jones ME, McCallum H, Paddison PJ, Hohenlohe PA, Hockenbery D, Storfer A. Spontaneous Tumor Regression in Tasmanian Devils Associated with RASL11A Activation. Genetics 2020;215:1143-52. [PMID: 32554701 DOI: 10.1534/genetics.120.303428] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
147 Angaroni F, Chen K, Damiani C, Caravagna G, Graudenzi A, Ramazotti D. PMCE: efficient inference of expressive models of cancer evolution with high prognostic power. Bioinformatics 2021:btab717. [PMID: 34647978 DOI: 10.1093/bioinformatics/btab717] [Reference Citation Analysis]
148 Jiang CK, Ma JQ, Liu YF, Chen JD, Ni DJ, Chen L. Identification and distribution of a single nucleotide polymorphism responsible for the catechin content in tea plants. Hortic Res 2020;7:24. [PMID: 32140233 DOI: 10.1038/s41438-020-0247-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
149 Vozdova M, Kubickova S, Pal K, Fröhlich J, Fictum P, Rubes J. Recurrent gene mutations detected in canine mast cell tumours by next generation sequencing. Vet Comp Oncol 2020;18:509-18. [PMID: 31999054 DOI: 10.1111/vco.12572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
150 Dos Santos W, Sobanski T, de Carvalho AC, Evangelista AF, Matsushita M, Berardinelli GN, de Oliveira MA, Reis RM, Guimarães DP. Mutation profiling of cancer drivers in Brazilian colorectal cancer. Sci Rep 2019;9:13687. [PMID: 31548566 DOI: 10.1038/s41598-019-49611-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
151 Craig DJ, Morrison T, Khuder SA, Crawford EL, Wu L, Xu J, Blomquist TM, Willey JC. Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells. BMC Cancer 2019;19:1081. [PMID: 31711466 DOI: 10.1186/s12885-019-6313-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
152 Ren X, Long M, Li Z, Wu B, Jin T, Tu C, Qi L, Yang M. Oncogene PRR14 promotes breast cancer through activation of PI3K signal pathway and inhibition of CHEK2 pathway. Cell Death Dis 2020;11:464. [PMID: 32541902 DOI: 10.1038/s41419-020-2640-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
153 Baeesa SS, Hussein D, Altalhy A, Bakhaidar MG, Alghamdi FA, Bangash M, Abuzenadah A. Malignant Transformation and Spine Metastasis of an Intracranial Grade I Meningioma: In Situ Immunofluorescence Analysis of Cancer Stem Cells Case Report and Literature Review. World Neurosurg 2018;120:274-89. [PMID: 30205223 DOI: 10.1016/j.wneu.2018.09.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
154 Remmerie M, Janssens V. Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late. Int J Mol Sci 2018;19:E2380. [PMID: 30104481 DOI: 10.3390/ijms19082380] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
155 Tokutomi N, Nakai K, Sugano S. Extreme value theory as a framework for understanding mutation frequency distribution in cancer genomes. PLoS One 2021;16:e0243595. [PMID: 34424899 DOI: 10.1371/journal.pone.0243595] [Reference Citation Analysis]
156 Koteluk O, Wartecki A, Mazurek S, Kołodziejczak I, Mackiewicz A. How Do Machines Learn? Artificial Intelligence as a New Era in Medicine. J Pers Med 2021;11:32. [PMID: 33430240 DOI: 10.3390/jpm11010032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
157 Liu C, Zhao J, Lu W, Dai Y, Hockings J, Zhou Y, Nussinov R, Eng C, Cheng F. Individualized genetic network analysis reveals new therapeutic vulnerabilities in 6,700 cancer genomes. PLoS Comput Biol 2020;16:e1007701. [PMID: 32101536 DOI: 10.1371/journal.pcbi.1007701] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
158 Yurkovich JT, Tian Q, Price ND, Hood L. A systems approach to clinical oncology uses deep phenotyping to deliver personalized care. Nat Rev Clin Oncol 2020;17:183-94. [DOI: 10.1038/s41571-019-0273-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
159 Shao XM, Bhattacharya R, Huang J, Sivakumar IKA, Tokheim C, Zheng L, Hirsch D, Kaminow B, Omdahl A, Bonsack M, Riemer AB, Velculescu VE, Anagnostou V, Pagel KA, Karchin R. High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets. Cancer Immunol Res 2020;8:396-408. [PMID: 31871119 DOI: 10.1158/2326-6066.CIR-19-0464] [Cited by in Crossref: 29] [Cited by in F6Publishing: 13] [Article Influence: 9.7] [Reference Citation Analysis]
160 Kang TZE, Zhu L, Yang D, Ding D, Zhu X, Wan YCE, Liu J, Ramakrishnan S, Chan LL, Chan SY, Wang X, Gan H, Han J, Ishibashi T, Li Q, Chan KM. The elevated transcription of ADAM19 by the oncohistone H2BE76K contributes to oncogenic properties in breast cancer. J Biol Chem 2021;296:100374. [PMID: 33548228 DOI: 10.1016/j.jbc.2021.100374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
161 Grassmann F, Pawitan Y, Czene K. A systems genomics approach to uncover the molecular properties of cancer genes. Sci Rep 2020;10:18392. [PMID: 33110144 DOI: 10.1038/s41598-020-75400-2] [Reference Citation Analysis]
162 Kumazaki M, Shimomura I, Kiyono T, Ochiya T, Yamamoto Y. Cell-type specific tumorigenesis with Ras oncogenes in human lung epithelial cells. Biochemical and Biophysical Research Communications 2020;525:483-90. [DOI: 10.1016/j.bbrc.2020.02.113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
163 Fukumoto T, Fatkhutdinov N, Zundell JA, Tcyganov EN, Nacarelli T, Karakashev S, Wu S, Liu Q, Gabrilovich DI, Zhang R. HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer. Cancer Res 2019;79:5482-9. [PMID: 31311810 DOI: 10.1158/0008-5472.CAN-19-1302] [Cited by in Crossref: 42] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
164 Kumar S, Harmanci A, Vytheeswaran J, Gerstein MB. SVFX: a machine learning framework to quantify the pathogenicity of structural variants. Genome Biol 2020;21:274. [PMID: 33168059 DOI: 10.1186/s13059-020-02178-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
165 Mashtalir N, Suzuki H, Farrell DP, Sankar A, Luo J, Filipovski M, D'Avino AR, St Pierre R, Valencia AM, Onikubo T, Roeder RG, Han Y, He Y, Ranish JA, DiMaio F, Walz T, Kadoch C. A Structural Model of the Endogenous Human BAF Complex Informs Disease Mechanisms. Cell 2020;183:802-817.e24. [PMID: 33053319 DOI: 10.1016/j.cell.2020.09.051] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
166 Voukantsis D, Kahn K, Hadley M, Wilson R, Buffa FM. Modeling genotypes in their microenvironment to predict single- and multi-cellular behavior. Gigascience 2019;8:giz010. [PMID: 30715320 DOI: 10.1093/gigascience/giz010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
167 Martínez-jiménez F, Muiños F, Sentís I, Deu-pons J, Reyes-salazar I, Arnedo-pac C, Mularoni L, Pich O, Bonet J, Kranas H, Gonzalez-perez A, Lopez-bigas N. A compendium of mutational cancer driver genes. Nat Rev Cancer 2020;20:555-72. [DOI: 10.1038/s41568-020-0290-x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 75] [Article Influence: 47.0] [Reference Citation Analysis]
168 Surdez D, Zaidi S, Grossetête S, Laud-Duval K, Ferre AS, Mous L, Vourc'h T, Tirode F, Pierron G, Raynal V, Baulande S, Brunet E, Hill V, Delattre O. STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma. Cancer Cell 2021;39:810-826.e9. [PMID: 33930311 DOI: 10.1016/j.ccell.2021.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
169 Mourikis TP, Benedetti L, Foxall E, Temelkovski D, Nulsen J, Perner J, Cereda M, Lagergren J, Howell M, Yau C, Fitzgerald RC, Scaffidi P; Oesophageal Cancer Clinical and Molecular Stratification (OCCAMS) Consortium, Ciccarelli FD. Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma. Nat Commun. 2019;10:3101. [PMID: 31308377 DOI: 10.1038/s41467-019-10898-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
170 Galka-Marciniak P, Urbanek-Trzeciak MO, Nawrocka PM, Kozlowski P. A pan-cancer atlas of somatic mutations in miRNA biogenesis genes. Nucleic Acids Res 2021;49:601-20. [PMID: 33406242 DOI: 10.1093/nar/gkaa1223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
171 Sander M, Herranz H. MicroRNAs in Drosophila Cancer Models. Adv Exp Med Biol 2019;1167:157-73. [PMID: 31520354 DOI: 10.1007/978-3-030-23629-8_9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
172 Zhu C, Boutros PC. Sex Differences in Cancer Genomes: Much Learned, More Unknown. Endocrinology 2021;162:bqab170. [PMID: 34402895 DOI: 10.1210/endocr/bqab170] [Reference Citation Analysis]
173 Arici MK, Tuncbag N. Performance Assessment of the Network Reconstruction Approaches on Various Interactomes. Front Mol Biosci 2021;8:666705. [PMID: 34676243 DOI: 10.3389/fmolb.2021.666705] [Reference Citation Analysis]
174 Richart L, Margueron R. Drugging histone methyltransferases in cancer. Current Opinion in Chemical Biology 2020;56:51-62. [DOI: 10.1016/j.cbpa.2019.11.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
175 Liu G, Zeng H, Zhang C, Xu J. Key genes associated with diabetes mellitus and hepatocellular carcinoma. Pathology - Research and Practice 2019;215:152510. [DOI: 10.1016/j.prp.2019.152510] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
176 Yi J, Shi X, Xuan Z, Wu J. Histone demethylase UTX/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma. Cancer Lett 2021;499:188-200. [PMID: 33253789 DOI: 10.1016/j.canlet.2020.11.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
177 Cai H, Chew SK, Li C, Tsai MK, Andrejka L, Murray CW, Hughes NW, Shuldiner EG, Ashkin EL, Tang R, Hung KL, Chen LC, Lee SYC, Yousefi M, Lin WY, Kunder CA, Cong L, McFarland CD, Petrov DA, Swanton C, Winslow MM. A Functional Taxonomy of Tumor Suppression in Oncogenic KRAS-Driven Lung Cancer. Cancer Discov 2021;11:1754-73. [PMID: 33608386 DOI: 10.1158/2159-8290.CD-20-1325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
178 Althubaiti S, Karwath A, Dallol A, Noor A, Alkhayyat SS, Alwassia R, Mineta K, Gojobori T, Beggs AD, Schofield PN, Gkoutos GV, Hoehndorf R. Ontology-based prediction of cancer driver genes. Sci Rep 2019;9:17405. [PMID: 31757986 DOI: 10.1038/s41598-019-53454-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
179 Logotheti S, Marquardt S, Richter C, Sophie Hain R, Murr N, Takan I, Pavlopoulou A, Pützer BM. Neural Networks Recapitulation by Cancer Cells Promotes Disease Progression: A Novel Role of p73 Isoforms in Cancer-Neuronal Crosstalk. Cancers (Basel) 2020;12:E3789. [PMID: 33339112 DOI: 10.3390/cancers12123789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
180 Shen GQ, Aleassa EM, Walsh RM, Morris-Stiff G. Next-Generation Sequencing in Pancreatic Cancer. Pancreas 2019;48:739-48. [PMID: 31206465 DOI: 10.1097/MPA.0000000000001324] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
181 Perez-Rathke A, Mali S, Du L, Liang J. Alterations in Chromatin Folding Patterns in Cancer Variant-Enriched Loci. IEEE EMBS Int Conf Biomed Health Inform 2019;2019. [PMID: 34085045 DOI: 10.1109/bhi.2019.8834565] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
182 [DOI: 10.1101/612762] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
183 Garg A, Hazra JP, Sannigrahi MK, Rakshit S, Sinha S. Variable Mutations at the p53-R273 Oncogenic Hotspot Position Leads to Altered Properties. Biophys J 2020;118:720-8. [PMID: 31952808 DOI: 10.1016/j.bpj.2019.12.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
184 Kankanamge D, Tennakoon M, Weerasinghe A, Cedeno-Rosario L, Chadee DN, Karunarathne A. G protein αq exerts expression level-dependent distinct signaling paradigms. Cell Signal 2019;58:34-43. [PMID: 30849518 DOI: 10.1016/j.cellsig.2019.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
185 Schaafsma E, Fugle CM, Wang X, Cheng C. Pan-cancer association of HLA gene expression with cancer prognosis and immunotherapy efficacy. Br J Cancer 2021;125:422-32. [PMID: 33981015 DOI: 10.1038/s41416-021-01400-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Li D, Pan S, Zhang H, Fu Y, Peng Z, Zhang L, Peng S, Xu F, Huang H, Shi R, Zheng H, Peng Y, Tan Z. A comprehensive microsatellite landscape of human Y-DNA at kilobase resolution. BMC Genomics 2021;22:76. [PMID: 33482734 DOI: 10.1186/s12864-021-07389-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Paul D. Cancer as a form of life: Musings of the cancer and evolution symposium. Prog Biophys Mol Biol 2021:S0079-6107(21)00041-9. [PMID: 33991584 DOI: 10.1016/j.pbiomolbio.2021.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
188 Mueller SA, Gauthier MA, Ashford B, Gupta R, Gayevskiy V, Ch’ng S, Palme CE, Shannon K, Clark JR, Ranson M, Cowley MJ. Mutational Patterns in Metastatic Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology 2019;139:1449-1458.e1. [DOI: 10.1016/j.jid.2019.01.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
189 Winters IP, Murray CW, Winslow MM. Towards quantitative and multiplexed in vivo functional cancer genomics. Nat Rev Genet 2018;19:741-55. [PMID: 30267031 DOI: 10.1038/s41576-018-0053-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
190 Yang L, Zhang X, Zhang J, Liu Y, Ji T, Mou J, Fang X, Wang S, Chen J. Low expression of TFF3 in papillary thyroid carcinoma may correlate with poor prognosis but high immune cell infiltration. Future Oncol 2021. [PMID: 34756116 DOI: 10.2217/fon-2020-1183] [Reference Citation Analysis]
191 Couto-Vieira J, Nicolau-Neto P, Costa EP, Figueira FF, Simão TA, Okorokova-Façanha AL, Ribeiro Pinto LF, Façanha AR. Multi-cancer V-ATPase molecular signatures: A distinctive balance of subunit C isoforms in esophageal carcinoma. EBioMedicine 2020;51:102581. [PMID: 31901859 DOI: 10.1016/j.ebiom.2019.11.042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
192 Huang T, Liang Y, Zhang H, Chen X, Wei H, Sun W, Wang Y. CSMD1 Mutations Are Associated with Increased Mutational Burden, Favorable Prognosis, and Anti-Tumor Immunity in Gastric Cancer. Genes (Basel) 2021;12:1715. [PMID: 34828321 DOI: 10.3390/genes12111715] [Reference Citation Analysis]
193 Chauhan PS, Chen K, Babbra RK, Feng W, Pejovic N, Nallicheri A, Harris PK, Dienstbach K, Atkocius A, Maguire L, Qaium F, Szymanski JJ, Baumann BC, Ding L, Cao D, Reimers MA, Kim EH, Smith ZL, Arora VK, Chaudhuri AA. Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort study. PLoS Med 2021;18:e1003732. [PMID: 34464379 DOI: 10.1371/journal.pmed.1003732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
194 Xue J, Guo X, Wang X, Xiao Y. Density functional theory studies on cytosine analogues for inducing double-proton transfer with guanine. Sci Rep 2020;10:9671. [PMID: 32541653 DOI: 10.1038/s41598-020-66530-8] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
195 Martínez-jiménez F, Muiños F, López-arribillaga E, Lopez-bigas N, Gonzalez-perez A. Systematic analysis of alterations in the ubiquitin proteolysis system reveals its contribution to driver mutations in cancer. Nat Cancer 2020;1:122-35. [DOI: 10.1038/s43018-019-0001-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 3.3] [Reference Citation Analysis]
196 Liu PCC, Koblish H, Wu L, Bowman K, Diamond S, DiMatteo D, Zhang Y, Hansbury M, Rupar M, Wen X, Collier P, Feldman P, Klabe R, Burke KA, Soloviev M, Gardiner C, He X, Volgina A, Covington M, Ruggeri B, Wynn R, Burn TC, Scherle P, Yeleswaram S, Yao W, Huber R, Hollis G. INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models. PLoS One 2020;15:e0231877. [PMID: 32315352 DOI: 10.1371/journal.pone.0231877] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
197 Kim R, Kwon M, An M, Kim ST, Smith SA, Loembé AB, Mortimer PGS, Armenia J, Lukashchuk N, Shah N, Dean E, Park WY, Lee J. Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced/metastatic melanoma who have failed prior anti-PD-1 therapy. Ann Oncol 2021:S0923-7534(21)04545-2. [PMID: 34710570 DOI: 10.1016/j.annonc.2021.10.009] [Reference Citation Analysis]
198 Luo H, Liao X, Qin Y, Hou Q, Xue Z, Liu Y, Shen F, Wang Y, Jiang Y, Song L, Chen H, Zhang L, Wei T, Dai L, Yang L, Zhang W, Li Z, Xu H, Zhu J, Shu Y. Longitudinal Genomic Evolution of Conventional Papillary Thyroid Cancer With Brain Metastasis. Front Oncol 2021;11:620924. [PMID: 34249677 DOI: 10.3389/fonc.2021.620924] [Reference Citation Analysis]
199 Kobayashi A. Roles of NRF3 in the Hallmarks of Cancer: Proteasomal Inactivation of Tumor Suppressors. Cancers (Basel) 2020;12:E2681. [PMID: 32962187 DOI: 10.3390/cancers12092681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
200 Guercio BJ, Iyer G, Rosenberg JE. Developing Precision Medicine for Bladder Cancer. Hematol Oncol Clin North Am 2021;35:633-53. [PMID: 33958155 DOI: 10.1016/j.hoc.2021.02.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
201 Enfield KSS, Marshall EA, Anderson C, Ng KW, Rahmati S, Xu Z, Fuller M, Milne K, Lu D, Shi R, Rowbotham DA, Becker-Santos DD, Johnson FD, English JC, MacAulay CE, Lam S, Lockwood WW, Chari R, Karsan A, Jurisica I, Lam WL. Epithelial tumor suppressor ELF3 is a lineage-specific amplified oncogene in lung adenocarcinoma. Nat Commun 2019;10:5438. [PMID: 31780666 DOI: 10.1038/s41467-019-13295-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
202 Parekh U, McDonald D, Dailamy A, Wu Y, Cordes T, Zhang K, Tipps A, Metallo C, Mali P. Charting oncogenicity of genes and variants across lineages via multiplexed screens in teratomas. iScience 2021;24:103149. [PMID: 34646987 DOI: 10.1016/j.isci.2021.103149] [Reference Citation Analysis]
203 Barrera G, Cucci MA, Grattarola M, Dianzani C, Muzio G, Pizzimenti S. Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role. Antioxidants (Basel) 2021;10:510. [PMID: 33805928 DOI: 10.3390/antiox10040510] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
204 Bröckelmann PJ, de Jong MRW, Jachimowicz RD. Targeting DNA Repair, Cell Cycle, and Tumor Microenvironment in B Cell Lymphoma. Cells 2020;9:E2287. [PMID: 33066395 DOI: 10.3390/cells9102287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
205 Chang S, Yim S, Park H. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. Exp Mol Med. 2019;51:1-17. [PMID: 31221981 DOI: 10.1038/s12276-019-0230-6] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 14.3] [Reference Citation Analysis]
206 Hao Z, Guo D. EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study. BMC Cancer 2019;19:1184. [PMID: 31801484 DOI: 10.1186/s12885-019-6384-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
207 Mészáros B, Hajdu-Soltész B, Zeke A, Dosztányi Z. Mutations of Intrinsically Disordered Protein Regions Can Drive Cancer but Lack Therapeutic Strategies. Biomolecules 2021;11:381. [PMID: 33806614 DOI: 10.3390/biom11030381] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
208 Salvadores M, Mas-Ponte D, Supek F. Passenger mutations accurately classify human tumors. PLoS Comput Biol 2019;15:e1006953. [PMID: 30986244 DOI: 10.1371/journal.pcbi.1006953] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
209 Devarakonda S, Li Y, Martins Rodrigues F, Sankararaman S, Kadara H, Goparaju C, Lanc I, Pepin K, Waqar SN, Morgensztern D, Ward J, Masood A, Fulton R, Fulton L, Gillette MA, Satpathy S, Carr SA, Wistuba I, Pass H, Wilson RK, Ding L, Govindan R. Genomic Profiling of Lung Adenocarcinoma in Never-Smokers. J Clin Oncol 2021;39:3747-58. [PMID: 34591593 DOI: 10.1200/JCO.21.01691] [Reference Citation Analysis]
210 Zhao W, Yang J, Wu J, Cai G, Zhang Y, Haltom J, Su W, Dong MJ, Chen S, Wu J, Zhou Z, Gu X. CanDriS: posterior profiling of cancer-driving sites based on two-component evolutionary model. Brief Bioinform 2021:bbab131. [PMID: 33876217 DOI: 10.1093/bib/bbab131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
211 Pan H, Renaud L, Chaligne R, Bloehdorn J, Tausch E, Mertens D, Fink AM, Fischer K, Zhang C, Betel D, Gnirke A, Imielinski M, Moreaux J, Hallek M, Meissner A, Stilgenbauer S, Wu CJ, Elemento O, Landau DA. Discovery of Candidate DNA Methylation Cancer Driver Genes. Cancer Discov 2021;11:2266-81. [PMID: 33972312 DOI: 10.1158/2159-8290.CD-20-1334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Zhao B, Lin J, Rong L, Wu S, Deng Z, Fatkhutdinov N, Zundell J, Fukumoto T, Liu Q, Kossenkov A, Jean S, Cadungog MG, Borowsky ME, Drapkin R, Lieberman PM, Abate-Shen CT, Zhang R. ARID1A promotes genomic stability through protecting telomere cohesion. Nat Commun 2019;10:4067. [PMID: 31492885 DOI: 10.1038/s41467-019-12037-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
213 Williams MS, Basma NJ, Amaral FMR, Williams G, Weightman JP, Breitwieser W, Nelson L, Taylor SS, Wiseman DH, Somervaille TCP. Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in cancer. BMC Cancer 2020;20:1075. [PMID: 33167906 DOI: 10.1186/s12885-020-07571-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
214 Shendure J, Findlay GM, Snyder MW. Genomic Medicine-Progress, Pitfalls, and Promise. Cell 2019;177:45-57. [PMID: 30901547 DOI: 10.1016/j.cell.2019.02.003] [Cited by in Crossref: 69] [Cited by in F6Publishing: 45] [Article Influence: 34.5] [Reference Citation Analysis]
215 Mohammad TA, Chen Y. Approaching RNA-seq for Cell Line Identification. Bio Protoc 2020;10:e3507. [PMID: 33163581 DOI: 10.21769/BioProtoc.3507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
216 Wu S, Turner KM, Nguyen N, Raviram R, Erb M, Santini J, Luebeck J, Rajkumar U, Diao Y, Li B, Zhang W, Jameson N, Corces MR, Granja JM, Chen X, Coruh C, Abnousi A, Houston J, Ye Z, Hu R, Yu M, Kim H, Law JA, Verhaak RGW, Hu M, Furnari FB, Chang HY, Ren B, Bafna V, Mischel PS. Circular ecDNA promotes accessible chromatin and high oncogene expression. Nature 2019;575:699-703. [PMID: 31748743 DOI: 10.1038/s41586-019-1763-5] [Cited by in Crossref: 84] [Cited by in F6Publishing: 69] [Article Influence: 28.0] [Reference Citation Analysis]
217 Lyu J, Li JJ, Su J, Peng F, Chen YE, Ge X, Li W. DORGE: Discovery of Oncogenes and tumoR suppressor genes using Genetic and Epigenetic features. Sci Adv 2020;6:eaba6784. [PMID: 33177077 DOI: 10.1126/sciadv.aba6784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
218 Fabi F, Adam P, Parent S, Tardif L, Cadrin M, Asselin E. Pharmacologic inhibition of Akt in combination with chemotherapeutic agents effectively induces apoptosis in ovarian and endometrial cancer cell lines. Mol Oncol 2021;15:2106-19. [PMID: 33338300 DOI: 10.1002/1878-0261.12888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
219 Collier O, Stoven V, Vert JP. LOTUS: A single- and multitask machine learning algorithm for the prediction of cancer driver genes. PLoS Comput Biol 2019;15:e1007381. [PMID: 31568528 DOI: 10.1371/journal.pcbi.1007381] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
220 Tian R, Cui Z, He D, Tian X, Gao Q, Ma X, Yang J, Wu J, Das BC, Severinov K, Hitzeroth II, Debata PR, Xu W, Zhong H, Fan W, Chen Y, Jin Z, Cao C, Yu M, Xie W, Huang Z, Bao Y, Xie H, Yao S, Hu Z. Risk stratification of cervical lesions using capture sequencing and machine learning method based on HPV and human integrated genomic profiles. Carcinogenesis 2019;40:1220-8. [DOI: 10.1093/carcin/bgz094] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
221 Khaliq M, Fallahi-Sichani M. Epigenetic Mechanisms of Escape from BRAF Oncogene Dependency. Cancers (Basel) 2019;11:E1480. [PMID: 31581557 DOI: 10.3390/cancers11101480] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
222 Kancherla J, Rao S, Bhuvaneshwar K, Riggins RB, Beckman RA, Madhavan S, Corrada Bravo H, Boca SM. Evidence-Based Network Approach to Recommending Targeted Cancer Therapies. JCO Clin Cancer Inform 2020;4:71-88. [PMID: 31990579 DOI: 10.1200/CCI.19.00097] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
223 Huang C, Li G, Wu J, Liang J, Wang X. Identification of pathogenic variants in cancer genes using base editing screens with editing efficiency correction. Genome Biol 2021;22:80. [PMID: 33691754 DOI: 10.1186/s13059-021-02305-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
224 Zhang Y, Liao G, Bai J, Zhang X, Xu L, Deng C, Yan M, Xie A, Luo T, Long Z, Xiao Y, Li X. Identifying Cancer Driver lncRNAs Bridged by Functional Effectors through Integrating Multi-omics Data in Human Cancers. Mol Ther Nucleic Acids 2019;17:362-73. [PMID: 31302496 DOI: 10.1016/j.omtn.2019.05.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
225 Jauregui-Lozano J, Bakhle K, Weake VM. In vivo tissue-specific chromatin profiling in Drosophila melanogaster using GFP-tagged nuclei. Genetics 2021:iyab079. [PMID: 34022041 DOI: 10.1093/genetics/iyab079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
226 Lõhmussaar K, Boretto M, Clevers H. Human-Derived Model Systems in Gynecological Cancer Research. Trends Cancer 2020;6:1031-43. [PMID: 32855097 DOI: 10.1016/j.trecan.2020.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
227 Kather JN, Heij LR, Grabsch HI, Loeffler C, Echle A, Muti HS, Krause J, Niehues JM, Sommer KAJ, Bankhead P, Kooreman LFS, Schulte JJ, Cipriani NA, Buelow RD, Boor P, Ortiz-Brüchle NN, Hanby AM, Speirs V, Kochanny S, Patnaik A, Srisuwananukorn A, Brenner H, Hoffmeister M, van den Brandt PA, Jäger D, Trautwein C, Pearson AT, Luedde T. Pan-cancer image-based detection of clinically actionable genetic alterations. Nat Cancer 2020;1:789-99. [PMID: 33763651 DOI: 10.1038/s43018-020-0087-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 26.0] [Reference Citation Analysis]
228 Taylor AMR, Rothblum-Oviatt C, Ellis NA, Hickson ID, Meyer S, Crawford TO, Smogorzewska A, Pietrucha B, Weemaes C, Stewart GS. Chromosome instability syndromes. Nat Rev Dis Primers 2019;5:64. [PMID: 31537806 DOI: 10.1038/s41572-019-0113-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 15.7] [Reference Citation Analysis]
229 Kobren SN, Chazelle B, Singh M. PertInInt: An Integrative, Analytical Approach to Rapidly Uncover Cancer Driver Genes with Perturbed Interactions and Functionalities. Cell Syst 2020;11:63-74.e7. [PMID: 32711844 DOI: 10.1016/j.cels.2020.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
230 Jiang J, Xu Y, Chang L, Ru G, Xia X, Yang L, Yi X, Chen Z, Huang DS, Yang L. Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma. Front Oncol 2021;11:771247. [PMID: 34733795 DOI: 10.3389/fonc.2021.771247] [Reference Citation Analysis]
231 Li A, Geyer FC, Blecua P, Lee JY, Selenica P, Brown DN, Pareja F, Lee SSK, Kumar R, Rivera B, Bi R, Piscuoglio S, Wen HY, Lozada JR, Gularte-Mérida R, Cavallone L, Rezoug Z, Nguyen-Dumont T, Peterlongo P, Tondini C, Terkelsen T, Rønlund K, Boonen SE, Mannerma A, Winqvist R, Janatova M, Rajadurai P, Xia B, Norton L, Robson ME, Ng PS, Looi LM, Southey MC, Weigelt B, Soo-Hwang T, Tischkowitz M, Foulkes WD, Reis-Filho JS; kConFab Investigators. Homologous recombination DNA repair defects in PALB2-associated breast cancers. NPJ Breast Cancer 2019;5:23. [PMID: 31428676 DOI: 10.1038/s41523-019-0115-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
232 Pantziarka P, Bouche G, André N. "Hard" Drug Repurposing for Precision Oncology: The Missing Link? Front Pharmacol 2018;9:637. [PMID: 29962954 DOI: 10.3389/fphar.2018.00637] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
233 Kobayashi A, Waku T. New addiction to the NRF2-related factor NRF3 in cancer cells: Ubiquitin-independent proteolysis through the 20S proteasome. Cancer Sci 2020;111:6-14. [PMID: 31742837 DOI: 10.1111/cas.14244] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
234 Petković M, Slavkov I, Kocev D, Džeroski S. Biomarker discovery by feature ranking: Evaluation on a case study of embryonal tumors. Comput Biol Med 2021;128:104143. [PMID: 33307385 DOI: 10.1016/j.compbiomed.2020.104143] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
235 Iyer A, Hennessey D, O'Keefe S, Patterson J, Wang W, Wong GK, Gniadecki R. Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma. Blood Adv 2020;4:2489-500. [PMID: 32502269 DOI: 10.1182/bloodadvances.2020001441] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
236 Cutigi JF, Evangelista AF, Simao A. Approaches for the identification of driver mutations in cancer: A tutorial from a computational perspective. J Bioinform Comput Biol 2020;18:2050016. [PMID: 32698724 DOI: 10.1142/S021972002050016X] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
237 Schrank B, Gautier J. Assembling nuclear domains: Lessons from DNA repair. J Cell Biol 2019;218:2444-55. [PMID: 31324649 DOI: 10.1083/jcb.201904202] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
238 Hao Q, Wei P, Shu Y, Zhang YG, Xu H, Zhao JN. Improvement of Neoantigen Identification Through Convolution Neural Network. Front Immunol 2021;12:682103. [PMID: 34113354 DOI: 10.3389/fimmu.2021.682103] [Reference Citation Analysis]
239 Tokheim C, Wang X, Timms RT, Zhang B, Mena EL, Wang B, Chen C, Ge J, Chu J, Zhang W, Elledge SJ, Brown M, Liu XS. Systematic characterization of mutations altering protein degradation in human cancers. Mol Cell 2021;81:1292-1308.e11. [PMID: 33567269 DOI: 10.1016/j.molcel.2021.01.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
240 Geistlinger L, Csaba G, Santarelli M, Ramos M, Schiffer L, Turaga N, Law C, Davis S, Carey V, Morgan M, Zimmer R, Waldron L. Toward a gold standard for benchmarking gene set enrichment analysis. Brief Bioinform 2021;22:545-56. [PMID: 32026945 DOI: 10.1093/bib/bbz158] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
241 Reiter JG, Makohon-Moore AP, Gerold JM, Heyde A, Attiyeh MA, Kohutek ZA, Tokheim CJ, Brown A, DeBlasio RM, Niyazov J, Zucker A, Karchin R, Kinzler KW, Iacobuzio-Donahue CA, Vogelstein B, Nowak MA. Minimal functional driver gene heterogeneity among untreated metastases. Science 2018;361:1033-7. [PMID: 30190408 DOI: 10.1126/science.aat7171] [Cited by in Crossref: 135] [Cited by in F6Publishing: 111] [Article Influence: 33.8] [Reference Citation Analysis]
242 Chibuk J, Flory A, Kruglyak KM, Leibman N, Nahama A, Dharajiya N, van den Boom D, Jensen TJ, Friedman JS, Shen MR, Clemente-Vicario F, Chorny I, Tynan JA, Lytle KM, Holtvoigt LE, Murtaza M, Diaz LA Jr, Tsui DWY, Grosu DS. Horizons in Veterinary Precision Oncology: Fundamentals of Cancer Genomics and Applications of Liquid Biopsy for the Detection, Characterization, and Management of Cancer in Dogs. Front Vet Sci 2021;8:664718. [PMID: 33834049 DOI: 10.3389/fvets.2021.664718] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
243 Gao Q, Liang WW, Foltz SM, Mutharasu G, Jayasinghe RG, Cao S, Liao WW, Reynolds SM, Wyczalkowski MA, Yao L, Yu L, Sun SQ, Chen K, Lazar AJ, Fields RC, Wendl MC, Van Tine BA, Vij R, Chen F, Nykter M, Shmulevich I, Ding L; Fusion Analysis Working Group., Cancer Genome Atlas Research Network. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Cell Rep 2018;23:227-238.e3. [PMID: 29617662 DOI: 10.1016/j.celrep.2018.03.050] [Cited by in Crossref: 192] [Cited by in F6Publishing: 172] [Article Influence: 64.0] [Reference Citation Analysis]
244 Khella CA, Mehta GA, Mehta RN, Gatza ML. Recent Advances in Integrative Multi-Omics Research in Breast and Ovarian Cancer. J Pers Med 2021;11:149. [PMID: 33669749 DOI: 10.3390/jpm11020149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
245 Qu N, Shi X, Zhao JJ, Guan H, Zhang TT, Wen SS, Liao T, Hu JQ, Liu WY, Wang YL, Huang S, Shi RL, Wang Y, Ji QH. Genomic and Transcriptomic Characterization of Sporadic Medullary Thyroid Carcinoma. Thyroid 2020;30:1025-36. [PMID: 32031055 DOI: 10.1089/thy.2019.0531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
246 Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509-W514. [PMID: 32442275 DOI: 10.1093/nar/gkaa407] [Cited by in Crossref: 239] [Cited by in F6Publishing: 316] [Article Influence: 119.5] [Reference Citation Analysis]
247 Hernández-Llodrà S, Segalés L, Safont A, Juanpere N, Lorenzo M, Fumadó L, Rodríguez-Vida A, Cecchini L, Bellmunt J, Lloreta-Trull J. SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer. Prostate 2019;79:1156-65. [PMID: 31090082 DOI: 10.1002/pros.23830] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
248 Zheng X, Amos CI, Frost HR. Cancer prognosis prediction using somatic point mutation and copy number variation data: a comparison of gene-level and pathway-based models. BMC Bioinformatics 2020;21:467. [PMID: 33081688 DOI: 10.1186/s12859-020-03791-0] [Reference Citation Analysis]
249 Cheng F, Zhao J, Wang Y, Lu W, Liu Z, Zhou Y, Martin WR, Wang R, Huang J, Hao T, Yue H, Ma J, Hou Y, Castrillon JA, Fang J, Lathia JD, Keri RA, Lightstone FC, Antman EM, Rabadan R, Hill DE, Eng C, Vidal M, Loscalzo J. Comprehensive characterization of protein-protein interactions perturbed by disease mutations. Nat Genet 2021;53:342-53. [PMID: 33558758 DOI: 10.1038/s41588-020-00774-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
250 Westrick RJ, Røjkjaer LP, Yang AY, Roh MH, Siebert AE, Ginsburg D. Deficiency of plasminogen activator inhibitor-2 results in accelerated tumor growth. J Thromb Haemost 2020;18:2968-75. [PMID: 32780555 DOI: 10.1111/jth.15054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
251 Alessandrino F, Smith DA, Tirumani SH, Ramaiya NH. Cancer genome landscape: a radiologist's guide to cancer genome medicine with imaging correlates. Insights Imaging 2019;10:111. [PMID: 31781977 DOI: 10.1186/s13244-019-0800-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
252 Lu J, Zhang Y, Lou Y, Yan B, Zou B, Hu M, Wang Y, Chen Y, Yang Z, Wang H, Zhang W, Han B. ctDNA-Profiling-Based UBL Biological Process Mutation Status as a Predictor of Atezolizumab Response Among TP53-Negative NSCLC Patients. Front Genet 2021;12:723670. [PMID: 34557222 DOI: 10.3389/fgene.2021.723670] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
253 Zimmerman L, Zelichov O, Aizenmann A, Barbash Z, Vidne M, Tarcic G. A Novel System for Functional Determination of Variants of Uncertain Significance using Deep Convolutional Neural Networks. Sci Rep 2020;10:4192. [PMID: 32144301 DOI: 10.1038/s41598-020-61173-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
254 Lu P, Foley J, Zhu C, McNamara K, Sirinukunwattana K, Vennam S, Varma S, Fehri H, Srivastava A, Zhu S, Rittscher J, Mallick P, Curtis C, West R. Transcriptome and genome evolution during HER2-amplified breast neoplasia. Breast Cancer Res 2021;23:73. [PMID: 34266469 DOI: 10.1186/s13058-021-01451-6] [Reference Citation Analysis]
255 [DOI: 10.1101/415133] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
256 Marshall JDS, Whitecross DE, Mellor P, Anderson DH. Impact of p85α Alterations in Cancer. Biomolecules 2019;9:E29. [PMID: 30650664 DOI: 10.3390/biom9010029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
257 Aldersley J, Lorenz DR, Mouw KW, D'Andrea AD, Gabuzda D. Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes. Mol Cancer Res 2021;19:1308-21. [PMID: 33883185 DOI: 10.1158/1541-7786.MCR-20-0884] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
258 Lovejoy CA, Takai K, Huh MS, Picketts DJ, de Lange T. ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity. PLoS Biol 2020;18:e3000594. [PMID: 31895940 DOI: 10.1371/journal.pbio.3000594] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
259 Gong M, Li Y, Ye X, Zhang L, Wang Z, Xu X, Shen Y, Zheng C. Loss-of-function mutations in KEAP1 drive lung cancer progression via KEAP1/NRF2 pathway activation. Cell Commun Signal 2020;18:98. [PMID: 32576270 DOI: 10.1186/s12964-020-00568-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 6.5] [Reference Citation Analysis]
260 Tseng LL, Cheng HH, Yeh TS, Huang SC, Syu YY, Chuu CP, Yuh CH, Kung HJ, Wang WC. Targeting the histone demethylase PHF8-mediated PKCα-Src-PTEN axis in HER2-negative gastric cancer. Proc Natl Acad Sci U S A 2020;117:24859-66. [PMID: 32958674 DOI: 10.1073/pnas.1919766117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
261 Jia K, Cui C, Gao Y, Zhou Y, Cui Q. An analysis of aging-related genes derived from the Genotype-Tissue Expression project (GTEx). Cell Death Discov 2018;4:26. [PMID: 30155276 DOI: 10.1038/s41420-018-0093-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
262 Huang A, Garraway LA, Ashworth A, Weber B. Synthetic lethality as an engine for cancer drug target discovery. Nat Rev Drug Discov 2020;19:23-38. [DOI: 10.1038/s41573-019-0046-z] [Cited by in Crossref: 99] [Cited by in F6Publishing: 85] [Article Influence: 33.0] [Reference Citation Analysis]
263 Raynaud F, Mina M, Ciriello G. Dynamic Emergence of Observed and Hidden Intra-tumor Heterogeneity. iScience 2019;21:157-67. [PMID: 31655256 DOI: 10.1016/j.isci.2019.10.018] [Reference Citation Analysis]
264 Lin L, Sun J, Wang J. Lung cancer and intraocular metastasis in gestation: Clinical experiences of a rare case. Thorac Cancer 2020;11:2723-6. [PMID: 32691515 DOI: 10.1111/1759-7714.13572] [Reference Citation Analysis]
265 Chen X, Aifantis I. The effect of chromatin states on cancer: big data lead the way. Lancet Haematol 2018;5:e237-8. [PMID: 29859610 DOI: 10.1016/S2352-3026(18)30066-8] [Reference Citation Analysis]
266 Roy S, Kumar R, Mittal V, Gupta D. Classification models for Invasive Ductal Carcinoma Progression, based on gene expression data-trained supervised machine learning. Sci Rep 2020;10:4113. [PMID: 32139710 DOI: 10.1038/s41598-020-60740-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Middleton G, Fletcher P, Popat S, Savage J, Summers Y, Greystoke A, Gilligan D, Cave J, O'Rourke N, Brewster A, Toy E, Spicer J, Jain P, Dangoor A, Mackean M, Forster M, Farley A, Wherton D, Mehmi M, Sharpe R, Mills TC, Cerone MA, Yap TA, Watkins TBK, Lim E, Swanton C, Billingham L. The National Lung Matrix Trial of personalized therapy in lung cancer. Nature 2020;583:807-12. [PMID: 32669708 DOI: 10.1038/s41586-020-2481-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 15.5] [Reference Citation Analysis]
268 Gumpinger AC, Lage K, Horn H, Borgwardt K. Prediction of cancer driver genes through network-based moment propagation of mutation scores. Bioinformatics 2020;36:i508-15. [PMID: 32657361 DOI: 10.1093/bioinformatics/btaa452] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
269 Raimondi F, Russell RB. Studying how genetic variants affect mechanism in biological systems. Essays Biochem 2018;62:575-82. [PMID: 30315099 DOI: 10.1042/EBC20180021] [Reference Citation Analysis]
270 Vellichirammal NN, Albahrani A, Li Y, Guda C. Identification of Fusion Transcripts from Unaligned RNA-Seq Reads Using ChimeRScope. Methods Mol Biol 2020;2079:13-25. [PMID: 31728959 DOI: 10.1007/978-1-4939-9904-0_2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
271 Rosendahl Huber A, Van Hoeck A, Van Boxtel R. The Mutagenic Impact of Environmental Exposures in Human Cells and Cancer: Imprints Through Time. Front Genet 2021;12:760039. [PMID: 34745228 DOI: 10.3389/fgene.2021.760039] [Reference Citation Analysis]
272 Marquardt S, Pavlopoulou A, Takan I, Dhar P, Pützer BM, Logotheti S. A Systems-Based Key Innovation-Driven Approach Infers Co-option of Jaw Developmental Programs During Cancer Progression. Front Cell Dev Biol 2021;9:682619. [PMID: 34150777 DOI: 10.3389/fcell.2021.682619] [Reference Citation Analysis]
273 Bailey MH, Meyerson WU, Dursi LJ, Wang LB, Dong G, Liang WW, Weerasinghe A, Li S, Li Y, Kelso S, Saksena G, Ellrott K, Wendl MC, Wheeler DA, Getz G, Simpson JT, Gerstein MB, Ding L; MC3 Working Group., PCAWG novel somatic mutation calling methods working group., PCAWG Consortium. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nat Commun 2020;11:4748. [PMID: 32958763 DOI: 10.1038/s41467-020-18151-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
274 Jurisic V. Multiomic analysis of cytokines in immuno-oncology. Expert Review of Proteomics 2020;17:663-74. [DOI: 10.1080/14789450.2020.1845654] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
275 Mas-Ponte D, Supek F. DNA mismatch repair promotes APOBEC3-mediated diffuse hypermutation in human cancers. Nat Genet 2020;52:958-68. [PMID: 32747826 DOI: 10.1038/s41588-020-0674-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
276 Gillette MA, Satpathy S, Cao S, Dhanasekaran SM, Vasaikar SV, Krug K, Petralia F, Li Y, Liang WW, Reva B, Krek A, Ji J, Song X, Liu W, Hong R, Yao L, Blumenberg L, Savage SR, Wendl MC, Wen B, Li K, Tang LC, MacMullan MA, Avanessian SC, Kane MH, Newton CJ, Cornwell M, Kothadia RB, Ma W, Yoo S, Mannan R, Vats P, Kumar-Sinha C, Kawaler EA, Omelchenko T, Colaprico A, Geffen Y, Maruvka YE, da Veiga Leprevost F, Wiznerowicz M, Gümüş ZH, Veluswamy RR, Hostetter G, Heiman DI, Wyczalkowski MA, Hiltke T, Mesri M, Kinsinger CR, Boja ES, Omenn GS, Chinnaiyan AM, Rodriguez H, Li QK, Jewell SD, Thiagarajan M, Getz G, Zhang B, Fenyö D, Ruggles KV, Cieslik MP, Robles AI, Clauser KR, Govindan R, Wang P, Nesvizhskii AI, Ding L, Mani DR, Carr SA; Clinical Proteomic Tumor Analysis Consortium. Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma. Cell 2020;182:200-225.e35. [PMID: 32649874 DOI: 10.1016/j.cell.2020.06.013] [Cited by in Crossref: 79] [Cited by in F6Publishing: 72] [Article Influence: 79.0] [Reference Citation Analysis]
277 Yasuda T, Sanada M, Nishijima D, Kanamori T, Iijima Y, Hattori H, Saito A, Miyoshi H, Ishikawa Y, Asou N, Usuki K, Hirabayashi S, Kato M, Ri M, Handa H, Ishida T, Shibayama H, Abe M, Iriyama C, Karube K, Nishikori M, Ohshima K, Kataoka K, Yoshida K, Shiraishi Y, Goto H, Adachi S, Kobayashi R, Kiyoi H, Miyazaki Y, Ogawa S, Kurahashi H, Yokoyama H, Manabe A, Iida S, Tomita A, Horibe K. Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study. Cancer Sci 2020;111:3367-78. [PMID: 32619037 DOI: 10.1111/cas.14552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
278 Yogodzinski C, Arab A, Pritchard JR, Goodarzi H, Gilbert LA. A global cancer data integrator reveals principles of synthetic lethality, sex disparity and immunotherapy. Genome Med 2021;13:167. [PMID: 34663427 DOI: 10.1186/s13073-021-00987-8] [Reference Citation Analysis]
279 Varnier R, Le Saux O, Chabaud S, Garin G, Sohier E, Wang Q, Paindavoine S, Pérol D, Baudet C, Attignon V, Pissaloux D, Heudel P, You B, Leyronnas C, Collard O, Trédan O, Bonnin N, Long J, Jacquin JP, Cassier PA, Derbel O, Freyer G, Viari A, Blay JY, Ray-Coquard I. Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme. Eur J Cancer 2019;118:156-65. [PMID: 31351267 DOI: 10.1016/j.ejca.2019.06.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
280 Yang H, Wei Q, Li D, Wang Z. Cancer classification based on chromatin accessibility profiles with deep adversarial learning model. PLoS Comput Biol 2020;16:e1008405. [PMID: 33166290 DOI: 10.1371/journal.pcbi.1008405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
281 Sun Y, Tang X, Ye B, Ding K. DNA and RNA Sequencing Recapitulated Aberrant Tumor Metabolism in Liver Cancer Cell Lines. J Hepatocell Carcinoma 2021;8:823-36. [PMID: 34350138 DOI: 10.2147/JHC.S318724] [Reference Citation Analysis]
282 Park KJ. Clinical Interpretation Challenges of Germline-Shared Somatic Variants in Cancer. Lab Med 2021:lmab020. [PMID: 34184037 DOI: 10.1093/labmed/lmab020] [Reference Citation Analysis]
283 Elman JS, Ni TK, Mengwasser KE, Jin D, Wronski A, Elledge SJ, Kuperwasser C. Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing. Cell Rep 2019;28:3435-3449.e5. [PMID: 31553912 DOI: 10.1016/j.celrep.2019.08.060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
284 Petrosino M, Novak L, Pasquo A, Chiaraluce R, Turina P, Capriotti E, Consalvi V. Analysis and Interpretation of the Impact of Missense Variants in Cancer. Int J Mol Sci 2021;22:5416. [PMID: 34063805 DOI: 10.3390/ijms22115416] [Reference Citation Analysis]
285 Melloy PG. The anaphase-promoting complex: A key mitotic regulator associated with somatic mutations occurring in cancer. Genes Chromosomes Cancer 2020;59:189-202. [PMID: 31652364 DOI: 10.1002/gcc.22820] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
286 Mohsen H, Gunasekharan V, Qing T, Seay M, Surovtseva Y, Negahban S, Szallasi Z, Pusztai L, Gerstein MB. Network propagation-based prioritization of long tail genes in 17 cancer types. Genome Biol 2021;22:287. [PMID: 34620211 DOI: 10.1186/s13059-021-02504-x] [Reference Citation Analysis]
287 He CY, Qiu MZ, Yang XH, Zhou DL, Ma JJ, Long YK, Ye ZL, Xu BH, Zhao Q, Jin Y, Lu SX, Wang ZQ, Guan WL, Zhao BW, Zhou ZW, Shao JY, Xu RH. Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosis. Clin Transl Med 2020;10:353-62. [PMID: 32508039 DOI: 10.1002/ctm2.32] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
288 Luo S, Zhu S, Liao J, Zhang Y, Hou X, Luo T, Zhao E, Xu J, Pang L, Liang X, Xiao Y, Li X. IDH clonal heterogeneity segregates a subgroup of non-1p/19q codeleted gliomas with unfavourable clinical outcome. Neuropathol Appl Neurobiol 2021;47:394-405. [PMID: 33098109 DOI: 10.1111/nan.12671] [Reference Citation Analysis]
289 Sayılgan JF, Haliloğlu T, Gönen M. Protein dynamics analysis identifies candidate cancer driver genes and mutations in TCGA data. Proteins 2021;89:721-30. [PMID: 33550612 DOI: 10.1002/prot.26054] [Reference Citation Analysis]
290 Bley N. Finding the mutations that drive resistance. Elife 2020;9:e57678. [PMID: 32408944 DOI: 10.7554/eLife.57678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
291 Reyna MA, Chitra U, Elyanow R, Raphael BJ. NetMix: A Network-Structured Mixture Model for Reduced-Bias Estimation of Altered Subnetworks. J Comput Biol 2021;28:469-84. [PMID: 33400606 DOI: 10.1089/cmb.2020.0435] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
292 Kabadi A, McDonnell E, Frank CL, Drowley L. Applications of Functional Genomics for Drug Discovery. SLAS Discov 2020;25:823-42. [PMID: 32026742 DOI: 10.1177/2472555220902092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
293 Liu R, Gao Q, Foltz SM, Fowles JS, Yao L, Wang JT, Cao S, Sun H, Wendl MC, Sethuraman S, Weerasinghe A, Rettig MP, Storrs EP, Yoon CJ, Wyczalkowski MA, McMichael JF, Kohnen DR, King J, Goldsmith SR, O'Neal J, Fulton RS, Fronick CC, Ley TJ, Jayasinghe RG, Fiala MA, Oh ST, DiPersio JF, Vij R, Ding L. Co-evolution of tumor and immune cells during progression of multiple myeloma. Nat Commun 2021;12:2559. [PMID: 33963182 DOI: 10.1038/s41467-021-22804-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
294 Forman A, Sotelo J. Tumor-Based Genetic Testing and Familial Cancer Risk. Cold Spring Harb Perspect Med 2020;10:a036590. [PMID: 31570381 DOI: 10.1101/cshperspect.a036590] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
295 Chai AWY, Yee PS, Price S, Yee SM, Lee HM, Tiong VK, Gonçalves E, Behan FM, Bateson J, Gilbert J, Tan AC, McDermott U, Garnett MJ, Cheong SC. Genome-wide CRISPR screens of oral squamous cell carcinoma reveal fitness genes in the Hippo pathway. Elife 2020;9:e57761. [PMID: 32990596 DOI: 10.7554/eLife.57761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
296 Centore RC, Sandoval GJ, Soares LMM, Kadoch C, Chan HM. Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies. Trends Genet 2020;36:936-50. [PMID: 32873422 DOI: 10.1016/j.tig.2020.07.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 11.0] [Reference Citation Analysis]
297 Shah PA, Huang C, Li Q, Kazi SA, Byers LA, Wang J, Johnson FM, Frederick MJ. NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma. Cells 2020;9:E2677. [PMID: 33322834 DOI: 10.3390/cells9122677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
298 Liu C, Han Z, Zhang ZK, Nussinov R, Cheng F. A network-based deep learning methodology for stratification of tumor mutations. Bioinformatics 2021:btaa1099. [PMID: 33416857 DOI: 10.1093/bioinformatics/btaa1099] [Reference Citation Analysis]
299 Wang W, Malyutina A, Pessia A, Saarela J, Heckman CA, Tang J. Combined gene essentiality scoring improves the prediction of cancer dependency maps. EBioMedicine 2019;50:67-80. [PMID: 31732481 DOI: 10.1016/j.ebiom.2019.10.051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
300 Chin RI, Chen K, Usmani A, Chua C, Harris PK, Binkley MS, Azad TD, Dudley JC, Chaudhuri AA. Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA). Mol Diagn Ther 2019;23:311-31. [PMID: 30941670 DOI: 10.1007/s40291-019-00390-5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 20.0] [Reference Citation Analysis]
301 Li J, Wuethrich A, Dey S, Lane RE, Sina AAI, Wang J, Wang Y, Puttick S, Koo KM, Trau M. The Growing Impact of Micro/Nanomaterial‐Based Systems in Precision Oncology: Translating “Multiomics” Technologies. Adv Funct Mater 2020;30:1909306. [DOI: 10.1002/adfm.201909306] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
302 Oka S, Hayashi M, Taguchi K, Hidaka M, Tsuzuki T, Sekiguchi M. ROS control in human iPS cells reveals early events in spontaneous carcinogenesis. Carcinogenesis 2019. [DOI: 10.1093/carcin/bgz081] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
303 Verma A, Halder A, Marathe S, Purwar R, Srivastava S. A proteogenomic approach to target neoantigens in solid tumors. Expert Rev Proteomics 2020;17:797-812. [PMID: 33491499 DOI: 10.1080/14789450.2020.1881889] [Reference Citation Analysis]
304 Petralia F, Tignor N, Reva B, Koptyra M, Chowdhury S, Rykunov D, Krek A, Ma W, Zhu Y, Ji J, Calinawan A, Whiteaker JR, Colaprico A, Stathias V, Omelchenko T, Song X, Raman P, Guo Y, Brown MA, Ivey RG, Szpyt J, Guha Thakurta S, Gritsenko MA, Weitz KK, Lopez G, Kalayci S, Gümüş ZH, Yoo S, da Veiga Leprevost F, Chang HY, Krug K, Katsnelson L, Wang Y, Kennedy JJ, Voytovich UJ, Zhao L, Gaonkar KS, Ennis BM, Zhang B, Baubet V, Tauhid L, Lilly JV, Mason JL, Farrow B, Young N, Leary S, Moon J, Petyuk VA, Nazarian J, Adappa ND, Palmer JN, Lober RM, Rivero-Hinojosa S, Wang LB, Wang JM, Broberg M, Chu RK, Moore RJ, Monroe ME, Zhao R, Smith RD, Zhu J, Robles AI, Mesri M, Boja E, Hiltke T, Rodriguez H, Zhang B, Schadt EE, Mani DR, Ding L, Iavarone A, Wiznerowicz M, Schürer S, Chen XS, Heath AP, Rokita JL, Nesvizhskii AI, Fenyö D, Rodland KD, Liu T, Gygi SP, Paulovich AG, Resnick AC, Storm PB, Rood BR, Wang P; Children’s Brain Tumor Network., Clinical Proteomic Tumor Analysis Consortium. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer. Cell 2020;183:1962-1985.e31. [PMID: 33242424 DOI: 10.1016/j.cell.2020.10.044] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
305 Chung KM, Singh J, Lawres L, Dorans KJ, Garcia C, Burkhardt DB, Robbins R, Bhutkar A, Cardone R, Zhao X, Babic A, Vayrynen SA, Dias Costa A, Nowak JA, Chang DT, Dunne RF, Hezel AF, Koong AC, Wilhelm JJ, Bellin MD, Nylander V, Gloyn AL, McCarthy MI, Kibbey RG, Krishnaswamy S, Wolpin BM, Jacks T, Fuchs CS, Muzumdar MD. Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma. Cell 2020; 181: 832-847. e18. [PMID: 32304665 DOI: 10.1016/j.cell.2020.03.062] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
306 Selenica P, Raj N, Kumar R, Brown DN, Arqués O, Reidy D, Klimstra D, Snuderl M, Serrano J, Palmer HG, Weigelt B, Reis-Filho JS, Scaltriti M. Solid pseudopapillary neoplasms of the pancreas are dependent on the Wnt pathway. Mol Oncol 2019;13:1684-92. [PMID: 30972907 DOI: 10.1002/1878-0261.12490] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
307 McDermott U. Large-scale compound screens and pharmacogenomic interactions in cancer. Curr Opin Genet Dev 2019;54:12-6. [PMID: 30852338 DOI: 10.1016/j.gde.2019.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
308 Izzi V, Lakkala J, Devarajan R, Kääriäinen A, Koivunen J, Heljasvaara R, Pihlajaniemi T. Pan-Cancer analysis of the expression and regulation of matrisome genes across 32 tumor types. Matrix Biol Plus 2019;1:100004. [PMID: 33543003 DOI: 10.1016/j.mbplus.2019.04.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 7.7] [Reference Citation Analysis]
309 Hodzic E, Shrestha R, Zhu K, Cheng K, Collins CC, Cenk Sahinalp S. Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks. Gigascience 2019;8:giz024. [PMID: 30978274 DOI: 10.1093/gigascience/giz024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
310 Ülgen E, Sezerman OU. driveR: a novel method for prioritizing cancer driver genes using somatic genomics data. BMC Bioinformatics 2021;22:263. [PMID: 34030627 DOI: 10.1186/s12859-021-04203-7] [Reference Citation Analysis]
311 Chen C, Shi C, Huang X, Zheng J, Zhu Z, Li Q, Qiu S, Huang Z, Zhuang Z, Wu R, Liu P, Wu F, Lin S, Li B, Zhang X, Chen Q. Molecular Profiles and Metastasis Markers in Chinese Patients with Gastric Carcinoma. Sci Rep 2019;9:13995. [PMID: 31570735 DOI: 10.1038/s41598-019-50171-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
312 Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, Fan H, Shen H, Way GP, Greene CS, Liu Y, Akbani R, Feng B, Donehower LA, Miller C, Shen Y, Karimi M, Chen H, Kim P, Jia P, Shinbrot E, Zhang S, Liu J, Hu H, Bailey MH, Yau C, Wolf D, Zhao Z, Weinstein JN, Li L, Ding L, Mills GB, Laird PW, Wheeler DA, Shmulevich I, Monnat RJ Jr, Xiao Y, Wang C; Cancer Genome Atlas Research Network. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep 2018;23:239-254.e6. [PMID: 29617664 DOI: 10.1016/j.celrep.2018.03.076] [Cited by in Crossref: 302] [Cited by in F6Publishing: 268] [Article Influence: 100.7] [Reference Citation Analysis]
313 Zhou Y, Zhao J, Fang J, Martin W, Li L, Nussinov R, Chan TA, Eng C, Cheng F. My personal mutanome: a computational genomic medicine platform for searching network perturbing alleles linking genotype to phenotype. Genome Biol 2021;22:53. [PMID: 33514395 DOI: 10.1186/s13059-021-02269-3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
314 Allen-Petersen BL, Sears RC. Mission Possible: Advances in MYC Therapeutic Targeting in Cancer. BioDrugs 2019;33:539-53. [PMID: 31392631 DOI: 10.1007/s40259-019-00370-5] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 25.5] [Reference Citation Analysis]
315 Warburton A, Markowitz TE, Katz JP, Pipas JM, McBride AA. Recurrent integration of human papillomavirus genomes at transcriptional regulatory hubs. NPJ Genom Med 2021;6:101. [PMID: 34848725 DOI: 10.1038/s41525-021-00264-y] [Reference Citation Analysis]
316 Bezzecchi E, Bernardini A, Ronzio M, Miccolo C, Chiocca S, Dolfini D, Mantovani R. NF-Y Subunits Overexpression in HNSCC. Cancers (Basel) 2021;13:3019. [PMID: 34208636 DOI: 10.3390/cancers13123019] [Reference Citation Analysis]
317 Wu HH, Hua X, Shi J, Chatterjee N, Zhu B. Utilizing patient information to identify subtype heterogeneity of cancer driver genes. Stat Methods Med Res 2021;:9622802211055854. [PMID: 34816788 DOI: 10.1177/09622802211055854] [Reference Citation Analysis]
318 Vyse S, Thway K, Huang PH, Jones RL. Next-generation sequencing for the management of sarcomas with no known driver mutations. Curr Opin Oncol 2021;33:315-22. [PMID: 33927108 DOI: 10.1097/CCO.0000000000000741] [Reference Citation Analysis]
319 Wang LB, Karpova A, Gritsenko MA, Kyle JE, Cao S, Li Y, Rykunov D, Colaprico A, Rothstein JH, Hong R, Stathias V, Cornwell M, Petralia F, Wu Y, Reva B, Krug K, Pugliese P, Kawaler E, Olsen LK, Liang WW, Song X, Dou Y, Wendl MC, Caravan W, Liu W, Cui Zhou D, Ji J, Tsai CF, Petyuk VA, Moon J, Ma W, Chu RK, Weitz KK, Moore RJ, Monroe ME, Zhao R, Yang X, Yoo S, Krek A, Demopoulos A, Zhu H, Wyczalkowski MA, McMichael JF, Henderson BL, Lindgren CM, Boekweg H, Lu S, Baral J, Yao L, Stratton KG, Bramer LM, Zink E, Couvillion SP, Bloodsworth KJ, Satpathy S, Sieh W, Boca SM, Schürer S, Chen F, Wiznerowicz M, Ketchum KA, Boja ES, Kinsinger CR, Robles AI, Hiltke T, Thiagarajan M, Nesvizhskii AI, Zhang B, Mani DR, Ceccarelli M, Chen XS, Cottingham SL, Li QK, Kim AH, Fenyö D, Ruggles KV, Rodriguez H, Mesri M, Payne SH, Resnick AC, Wang P, Smith RD, Iavarone A, Chheda MG, Barnholtz-Sloan JS, Rodland KD, Liu T, Ding L; Clinical Proteomic Tumor Analysis Consortium. Proteogenomic and metabolomic characterization of human glioblastoma. Cancer Cell 2021;39:509-528.e20. [PMID: 33577785 DOI: 10.1016/j.ccell.2021.01.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 16.0] [Reference Citation Analysis]
320 Cuadrado A, Rojo AI, Wells G, Hayes JD, Cousin SP, Rumsey WL, Attucks OC, Franklin S, Levonen AL, Kensler TW, Dinkova-Kostova AT. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat Rev Drug Discov. 2019;18:295-317. [PMID: 30610225 DOI: 10.1038/s41573-018-0008-x] [Cited by in Crossref: 346] [Cited by in F6Publishing: 332] [Article Influence: 115.3] [Reference Citation Analysis]
321 Llabata P, Mitsuishi Y, Choi PS, Cai D, Francis JM, Torres-Diz M, Udeshi ND, Golomb L, Wu Z, Zhou J, Svinkina T, Aguilera-Jimenez E, Liu Y, Carr SA, Sanchez-Cespedes M, Meyerson M, Zhang X. Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung Adenocarcinoma. Mol Cancer Res 2020;18:574-84. [PMID: 31862696 DOI: 10.1158/1541-7786.MCR-19-0657] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
322 Tilleman L, Heindryckx B, Deforce D, Van Nieuwerburgh F. Pan-cancer pharmacogenetics: targeted sequencing panels or exome sequencing? Pharmacogenomics 2020;21:1073-84. [PMID: 33019866 DOI: 10.2217/pgs-2020-0035] [Reference Citation Analysis]
323 Molina-Arcas M, Samani A, Downward J. Drugging the Undruggable: Advances on RAS Targeting in Cancer. Genes (Basel) 2021;12:899. [PMID: 34200676 DOI: 10.3390/genes12060899] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
324 Stein Y, Aloni-Grinstein R, Rotter V. Mutant p53 oncogenicity: dominant-negative or gain-of-function? Carcinogenesis 2020;41:1635-47. [PMID: 33159515 DOI: 10.1093/carcin/bgaa117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
325 Schrörs B, Boegel S, Albrecht C, Bukur T, Bukur V, Holtsträter C, Ritzel C, Manninen K, Tadmor AD, Vormehr M, Sahin U, Löwer M. Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model. Front Oncol 2020;10:1195. [PMID: 32793490 DOI: 10.3389/fonc.2020.01195] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
326 Chaudhuri AA, Pellini B, Pejovic N, Chauhan PS, Harris PK, Szymanski JJ, Smith ZL, Arora VK. Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management. JCO Precis Oncol 2020;4:PO. [PMID: 32923907 DOI: 10.1200/PO.20.00060] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
327 Xiang Y, Ye Y, Zhang Z, Han L. Maximizing the Utility of Cancer Transcriptomic Data. Trends Cancer 2018;4:823-37. [PMID: 30470304 DOI: 10.1016/j.trecan.2018.09.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
328 Chiang YT, Chien YC, Lin YH, Wu HH, Lee DF, Yu YL. The Function of the Mutant p53-R175H in Cancer. Cancers (Basel) 2021;13:4088. [PMID: 34439241 DOI: 10.3390/cancers13164088] [Reference Citation Analysis]
329 Xue Y, Morris JL, Yang K, Fu Z, Zhu X, Johnson F, Meehan B, Witkowski L, Yasmeen A, Golenar T, Coatham M, Morin G, Monast A, Pilon V, Fiset PO, Jung S, Gonzalez AV, Camilleri-Broet S, Fu L, Postovit LM, Spicer J, Gotlieb WH, Guiot MC, Rak J, Park M, Lockwood W, Foulkes WD, Prudent J, Huang S. SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria. Nat Commun 2021;12:5404. [PMID: 34518526 DOI: 10.1038/s41467-021-25260-9] [Reference Citation Analysis]
330 Deniger DC, Pasetto A, Robbins PF, Gartner JJ, Prickett TD, Paria BC, Malekzadeh P, Jia L, Yossef R, Langhan MM, Wunderlich JR, Danforth DN, Somerville RPT, Rosenberg SA. T-cell Responses to TP53 "Hotspot" Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers. Clin Cancer Res 2018;24:5562-73. [PMID: 29853601 DOI: 10.1158/1078-0432.CCR-18-0573] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 16.3] [Reference Citation Analysis]
331 Xie J, Kusnadi EP, Furic L, Selth LA. Regulation of mRNA Translation by Hormone Receptors in Breast and Prostate Cancer. Cancers (Basel) 2021;13:3254. [PMID: 34209750 DOI: 10.3390/cancers13133254] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
332 Lyne AM, Laplane L, Perié L. To portray clonal evolution in blood cancer, count your stem cells. Blood 2021;137:1862-70. [PMID: 33512426 DOI: 10.1182/blood.2020008407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
333 Burke JE. Structural Basis for Regulation of Phosphoinositide Kinases and Their Involvement in Human Disease. Molecular Cell 2018;71:653-73. [DOI: 10.1016/j.molcel.2018.08.005] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 19.3] [Reference Citation Analysis]
334 Harris KL, Myers MB, McKim KL, Elespuru RK, Parsons BL. Rationale and Roadmap for Developing Panels of Hotspot Cancer Driver Gene Mutations as Biomarkers of Cancer Risk. Environ Mol Mutagen 2020;61:152-75. [PMID: 31469467 DOI: 10.1002/em.22326] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
335 Mina M, Iyer A, Tavernari D, Raynaud F, Ciriello G. Discovering functional evolutionary dependencies in human cancers. Nat Genet 2020;52:1198-207. [DOI: 10.1038/s41588-020-0703-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
336 Wu CH, Hsieh CS, Chang YC, Huang CC, Yeh HT, Hou MF, Chung YC, Tu SH, Chang KJ, Chattopadhyay A, Lai LC, Lu TP, Li YH, Tsai MH, Chuang EY. Differential whole-genome doubling and homologous recombination deficiencies across breast cancer subtypes from the Taiwanese population. Commun Biol 2021;4:1052. [PMID: 34504292 DOI: 10.1038/s42003-021-02597-x] [Reference Citation Analysis]
337 Dunwell TL, Dailey SC, Ottestad AL, Yu J, Becker PW, Scaife S, Richman SD, Wood HM, Slaney H, Bottomley D, Yang X, Xiao H, Wahl SGF, Grønberg BH, Dai H, Fu G. Adaptor Template Oligo-Mediated Sequencing (ATOM-Seq) is a new ultra-sensitive UMI-based NGS library preparation technology for use with cfDNA and cfRNA. Sci Rep 2021;11:3138. [PMID: 33542447 DOI: 10.1038/s41598-021-82737-9] [Reference Citation Analysis]
338 Sadhwani A, Chang HW, Behrooz A, Brown T, Auvigne-Flament I, Patel H, Findlater R, Velez V, Tan F, Tekiela K, Wulczyn E, Yi ES, Mermel CH, Hanks D, Chen PC, Kulig K, Batenchuk C, Steiner DF, Cimermancic P. Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images. Sci Rep 2021;11:16605. [PMID: 34400666 DOI: 10.1038/s41598-021-95747-4] [Reference Citation Analysis]
339 Zolotovskaia MA, Tkachev VS, Seryakov AP, Kuzmin DV, Kamashev DE, Sorokin MI, Roumiantsev SA, Buzdin AA. Mutation Enrichment and Transcriptomic Activation Signatures of 419 Molecular Pathways in Cancer. Cancers (Basel) 2020;12:E271. [PMID: 31979117 DOI: 10.3390/cancers12020271] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
340 Bacolla A, Ye Z, Ahmed Z, Tainer JA. Cancer mutational burden is shaped by G4 DNA, replication stress and mitochondrial dysfunction. Prog Biophys Mol Biol 2019;147:47-61. [PMID: 30880007 DOI: 10.1016/j.pbiomolbio.2019.03.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
341 Kim J, Jang G, Sim SH, Park IH, Kim K, Park C. SMARCA4 Depletion Induces Cisplatin Resistance by Activating YAP1-Mediated Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer. Cancers (Basel) 2021;13:5474. [PMID: 34771636 DOI: 10.3390/cancers13215474] [Reference Citation Analysis]
342 Dao Trong P, Jungwirth G, Yu T, Pusch S, Unterberg A, Herold-Mende C, Warta R. Large-Scale Drug Screening in Patient-Derived IDHmut Glioma Stem Cells Identifies Several Efficient Drugs among FDA-Approved Antineoplastic Agents. Cells 2020;9:E1389. [PMID: 32503220 DOI: 10.3390/cells9061389] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
343 Wang G, Wu M, Durham AC, Mason NJ, Roth DB. Canine Oncopanel: A capture-based, NGS platform for evaluating the mutational landscape and detecting putative driver mutations in canine cancers. Vet Comp Oncol 2021. [PMID: 34286913 DOI: 10.1111/vco.12746] [Reference Citation Analysis]
344 Zhang H, Song Y, Du Z, Li X, Zhang J, Chen S, Chen F, Li T, Zhan Q. Exome sequencing identifies new somatic alterations and mutation patterns of tongue squamous cell carcinoma in a Chinese population. J Pathol 2020;251:353-64. [PMID: 32432340 DOI: 10.1002/path.5467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
345 Testa U, Pelosi E, Castelli G. Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profiling. Expert Rev Mol Diagn 2021;:1-24. [PMID: 34894979 DOI: 10.1080/14737159.2022.2017774] [Reference Citation Analysis]
346 Vestergaard LK, Oliveira DNP, Høgdall CK, Høgdall EV. Next Generation Sequencing Technology in the Clinic and Its Challenges. Cancers (Basel) 2021;13:1751. [PMID: 33916923 DOI: 10.3390/cancers13081751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
347 Dou Y, Kawaler EA, Cui Zhou D, Gritsenko MA, Huang C, Blumenberg L, Karpova A, Petyuk VA, Savage SR, Satpathy S, Liu W, Wu Y, Tsai CF, Wen B, Li Z, Cao S, Moon J, Shi Z, Cornwell M, Wyczalkowski MA, Chu RK, Vasaikar S, Zhou H, Gao Q, Moore RJ, Li K, Sethuraman S, Monroe ME, Zhao R, Heiman D, Krug K, Clauser K, Kothadia R, Maruvka Y, Pico AR, Oliphant AE, Hoskins EL, Pugh SL, Beecroft SJI, Adams DW, Jarman JC, Kong A, Chang HY, Reva B, Liao Y, Rykunov D, Colaprico A, Chen XS, Czekański A, Jędryka M, Matkowski R, Wiznerowicz M, Hiltke T, Boja E, Kinsinger CR, Mesri M, Robles AI, Rodriguez H, Mutch D, Fuh K, Ellis MJ, DeLair D, Thiagarajan M, Mani DR, Getz G, Noble M, Nesvizhskii AI, Wang P, Anderson ML, Levine DA, Smith RD, Payne SH, Ruggles KV, Rodland KD, Ding L, Zhang B, Liu T, Fenyö D; Clinical Proteomic Tumor Analysis Consortium. Proteogenomic Characterization of Endometrial Carcinoma. Cell 2020;180:729-748.e26. [PMID: 32059776 DOI: 10.1016/j.cell.2020.01.026] [Cited by in Crossref: 74] [Cited by in F6Publishing: 72] [Article Influence: 37.0] [Reference Citation Analysis]
348 Lan Y, Liu W, Zhang W, Hu J, Zhu X, Wan L, A S, Ping Y, Xiao Y. Transcriptomic heterogeneity of driver gene mutations reveals novel mutual exclusivity and improves exploration of functional associations. Cancer Med 2021;10:4977-93. [PMID: 34076361 DOI: 10.1002/cam4.4039] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
349 Murray D, Petrey D, Honig B. Integrating 3D structural information into systems biology. J Biol Chem 2021;296:100562. [PMID: 33744294 DOI: 10.1016/j.jbc.2021.100562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
350 Bollaert E, de Rocca Serra A, Demoulin JB. The HMG box transcription factor HBP1: a cell cycle inhibitor at the crossroads of cancer signaling pathways. Cell Mol Life Sci 2019;76:1529-39. [PMID: 30683982 DOI: 10.1007/s00018-019-03012-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
351 Wang H, Wang X, Xu L, Zhang J, Cao H. Integrated analysis of the E2F transcription factors across cancer types. Oncol Rep 2020;43:1133-46. [PMID: 32323836 DOI: 10.3892/or.2020.7504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
352 Park S, Supek F, Lehner B. Higher order genetic interactions switch cancer genes from two-hit to one-hit drivers. Nat Commun 2021;12:7051. [PMID: 34862370 DOI: 10.1038/s41467-021-27242-3] [Reference Citation Analysis]
353 Kim YJ, Sweet SMM, Egertson JD, Sedgewick AJ, Woo S, Liao WL, Merrihew GE, Searle BC, Vaske C, Heaton R, MacCoss MJ, Hembrough T. Data-Independent Acquisition Mass Spectrometry To Quantify Protein Levels in FFPE Tumor Biopsies for Molecular Diagnostics. J Proteome Res 2019;18:426-35. [PMID: 30481034 DOI: 10.1021/acs.jproteome.8b00699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
354 Cutigi JF, Evangelista AF, Reis RM, Simao A. A computational approach for the discovery of significant cancer genes by weighted mutation and asymmetric spreading strength in networks. Sci Rep 2021;11:23551. [PMID: 34876593 DOI: 10.1038/s41598-021-02671-8] [Reference Citation Analysis]
355 Ma C, Storer CE, Chandran U, LaFramboise WA, Petrosko P, Frank M, Hartman DJ, Pantanowitz L, Haritunians T, Head RD, Liu TC. Crohn's disease-associated ATG16L1 T300A genotype is associated with improved survival in gastric cancer. EBioMedicine 2021;67:103347. [PMID: 33906066 DOI: 10.1016/j.ebiom.2021.103347] [Reference Citation Analysis]
356 Satpathy S, Krug K, Jean Beltran PM, Savage SR, Petralia F, Kumar-Sinha C, Dou Y, Reva B, Kane MH, Avanessian SC, Vasaikar SV, Krek A, Lei JT, Jaehnig EJ, Omelchenko T, Geffen Y, Bergstrom EJ, Stathias V, Christianson KE, Heiman DI, Cieslik MP, Cao S, Song X, Ji J, Liu W, Li K, Wen B, Li Y, Gümüş ZH, Selvan ME, Soundararajan R, Visal TH, Raso MG, Parra ER, Babur Ö, Vats P, Anand S, Schraink T, Cornwell M, Rodrigues FM, Zhu H, Mo CK, Zhang Y, da Veiga Leprevost F, Huang C, Chinnaiyan AM, Wyczalkowski MA, Omenn GS, Newton CJ, Schurer S, Ruggles KV, Fenyö D, Jewell SD, Thiagarajan M, Mesri M, Rodriguez H, Mani SA, Udeshi ND, Getz G, Suh J, Li QK, Hostetter G, Paik PK, Dhanasekaran SM, Govindan R, Ding L, Robles AI, Clauser KR, Nesvizhskii AI, Wang P, Carr SA, Zhang B, Mani DR, Gillette MA; Clinical Proteomic Tumor Analysis Consortium. A proteogenomic portrait of lung squamous cell carcinoma. Cell 2021;184:4348-4371.e40. [PMID: 34358469 DOI: 10.1016/j.cell.2021.07.016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
357 Fang LT, Zhu B, Zhao Y, Chen W, Yang Z, Kerrigan L, Langenbach K, de Mars M, Lu C, Idler K, Jacob H, Zheng Y, Ren L, Yu Y, Jaeger E, Schroth GP, Abaan OD, Talsania K, Lack J, Shen TW, Chen Z, Stanbouly S, Tran B, Shetty J, Kriga Y, Meerzaman D, Nguyen C, Petitjean V, Sultan M, Cam M, Mehta M, Hung T, Peters E, Kalamegham R, Sahraeian SME, Mohiyuddin M, Guo Y, Yao L, Song L, Lam HYK, Drabek J, Vojta P, Maestro R, Gasparotto D, Kõks S, Reimann E, Scherer A, Nordlund J, Liljedahl U, Jensen RV, Pirooznia M, Li Z, Xiao C, Sherry ST, Kusko R, Moos M, Donaldson E, Tezak Z, Ning B, Tong W, Li J, Duerken-Hughes P, Catalanotti C, Maheshwari S, Shuga J, Liang WS, Keats J, Adkins J, Tassone E, Zismann V, McDaniel T, Trent J, Foox J, Butler D, Mason CE, Hong H, Shi L, Wang C, Xiao W; Somatic Mutation Working Group of Sequencing Quality Control Phase II Consortium. Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing. Nat Biotechnol 2021;39:1151-60. [PMID: 34504347 DOI: 10.1038/s41587-021-00993-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
358 Wu S, Fukumoto T, Lin J, Nacarelli T, Wang Y, Ong D, Liu H, Fatkhutdinov N, Zundell JA, Karakashev S, Zhou W, Schwartz LE, Tang HY, Drapkin R, Liu Q, Huntsman DG, Kossenkov AV, Speicher DW, Schug ZT, Van Dang C, Zhang R. Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma. Nat Cancer 2021;2:189-200. [PMID: 34085048 DOI: 10.1038/s43018-020-00160-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
359 Song K, Li Q, Gao W, Lu S, Shen Q, Liu X, Wu Y, Wang B, Lin H, Chen G, Zhang J. AlloDriver: a method for the identification and analysis of cancer driver targets. Nucleic Acids Res 2019;47:W315-21. [PMID: 31069394 DOI: 10.1093/nar/gkz350] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
360 Smith JC, Sheltzer JM. Systematic identification of mutations and copy number alterations associated with cancer patient prognosis. Elife 2018;7:e39217. [PMID: 30526857 DOI: 10.7554/eLife.39217] [Cited by in Crossref: 52] [Cited by in F6Publishing: 29] [Article Influence: 13.0] [Reference Citation Analysis]
361 Ferrand J, Rondinelli B, Polo SE. Histone Variants: Guardians of Genome Integrity. Cells 2020;9:E2424. [PMID: 33167489 DOI: 10.3390/cells9112424] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
362 Wu B, Lu X, Shen H, Yuan X, Wang X, Yin N, Sun L, Shen P, Hu C, Jiang H, Wang D. Intratumoral heterogeneity and genetic characteristics of prostate cancer. Int J Cancer 2020;146:3369-78. [PMID: 32159858 DOI: 10.1002/ijc.32961] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
363 Bailey CG, Gupta S, Metierre C, Amarasekera PMS, O'Young P, Kyaw W, Laletin T, Francis H, Semaan C, Sharifi Tabar M, Singh KP, Mullighan CG, Wolkenhauer O, Schmitz U, Rasko JEJ. Structure-function relationships explain CTCF zinc finger mutation phenotypes in cancer. Cell Mol Life Sci 2021. [PMID: 34657170 DOI: 10.1007/s00018-021-03946-z] [Reference Citation Analysis]
364 Maru Y, Hippo Y. Two-Way Development of the Genetic Model for Endometrial Tumorigenesis in Mice: Current and Future Perspectives. Front Genet 2021;12:798628. [PMID: 34956336 DOI: 10.3389/fgene.2021.798628] [Reference Citation Analysis]
365 Dhamija S, Yang CM, Seiler J, Myacheva K, Caudron-herger M, Wieland A, Abdelkarim M, Sharma Y, Riester M, Groß M, Maurer J, Diederichs S. A pan-cancer analysis reveals nonstop extension mutations causing SMAD4 tumour suppressor degradation. Nat Cell Biol 2020;22:999-1010. [DOI: 10.1038/s41556-020-0551-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
366 Armendáriz-Castillo I, López-Cortés A, García-Cárdenas J, Guevara-Ramírez P, Leone PE, Pérez-Villa A, Yumiceba V, Zambrano AK, Guerrero S, Paz-Y-Miño C. TCGA Pan-Cancer Genomic Analysis of Alternative Lengthening of Telomeres (ALT) Related Genes. Genes (Basel) 2020;11:E834. [PMID: 32708340 DOI: 10.3390/genes11070834] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
367 Wu Y, Zhu H, Wu H. PTEN in Regulating Hematopoiesis and Leukemogenesis. Cold Spring Harb Perspect Med 2020;10:a036244. [PMID: 31712222 DOI: 10.1101/cshperspect.a036244] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
368 Zeng Z, Vo A, Li X, Shidfar A, Saldana P, Blanco L, Xuei X, Luo Y, Khan SA, Clare SE. Somatic genetic aberrations in benign breast disease and the risk of subsequent breast cancer. NPJ Breast Cancer 2020;6:24. [PMID: 32566745 DOI: 10.1038/s41523-020-0165-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
369 Saha G, Singh R, Mandal A, Das S, Chattopadhyay E, Panja P, Roy P, DeSarkar N, Gulati S, Ghatak S, Ghosh S, Banerjee S, Roy B, Ghosh S, Chaudhuri D, Arora N, Biswas NK, Sikdar N. A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients. Mol Med 2020;26:59. [PMID: 32552660 DOI: 10.1186/s10020-020-00183-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
370 Nichols CA, Gibson WJ, Brown MS, Kosmicki JA, Busanovich JP, Wei H, Urbanski LM, Curimjee N, Berger AC, Gao GF, Cherniack AD, Dhe-Paganon S, Paolella BR, Beroukhim R. Loss of heterozygosity of essential genes represents a widespread class of potential cancer vulnerabilities. Nat Commun 2020;11:2517. [PMID: 32433464 DOI: 10.1038/s41467-020-16399-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
371 Koehler A, Karve A, Desai P, Arbiser J, Plas DR, Qi X, Read RD, Sasaki AT, Gawali VS, Toukam DK, Bhattacharya D, Kallay L, Pomeranz Krummel DA, Sengupta S. Reuse of Molecules for Glioblastoma Therapy. Pharmaceuticals (Basel) 2021;14:99. [PMID: 33525329 DOI: 10.3390/ph14020099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
372 Onishi I, Yamamoto K, Kinowaki Y, Kitagawa M, Kurata M. To Discover the Efficient and Novel Drug Targets in Human Cancers Using CRISPR/Cas Screening and Databases. Int J Mol Sci 2021;22:12322. [PMID: 34830205 DOI: 10.3390/ijms222212322] [Reference Citation Analysis]
373 Antao NV, Marcet-Ortega M, Cifani P, Kentsis A, Foley EA. A Cancer-Associated Missense Mutation in PP2A-Aα Increases Centrosome Clustering during Mitosis. iScience 2019;19:74-82. [PMID: 31357169 DOI: 10.1016/j.isci.2019.07.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
374 Schick S, Grosche S, Kohl KE, Drpic D, Jaeger MG, Marella NC, Imrichova H, Lin JG, Hofstätter G, Schuster M, Rendeiro AF, Koren A, Petronczki M, Bock C, Müller AC, Winter GE, Kubicek S. Acute BAF perturbation causes immediate changes in chromatin accessibility. Nat Genet 2021;53:269-78. [PMID: 33558760 DOI: 10.1038/s41588-021-00777-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 18.0] [Reference Citation Analysis]
375 Sterling J, Menezes SV, Abbassi RH, Munoz L. Histone lysine demethylases and their functions in cancer. Int J Cancer 2021;148:2375-88. [DOI: 10.1002/ijc.33375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
376 Frąk M, Krawczyk P, Kalinka E, Milanowski J. Molecular and Clinical Premises for the Combination Therapy Consisting of Radiochemotherapy and Immunotherapy in Non-Small Cell Lung Cancer Patients. Cancers (Basel) 2021;13:1222. [PMID: 33799560 DOI: 10.3390/cancers13061222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
377 [DOI: 10.1101/413047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
378 Ko PJ, Dixon SJ. Protein palmitoylation and cancer. EMBO Rep. 2018;19. [PMID: 30232163 DOI: 10.15252/embr.201846666] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 16.0] [Reference Citation Analysis]
379 Malekzadeh P, Pasetto A, Robbins PF, Parkhurst MR, Paria BC, Jia L, Gartner JJ, Hill V, Yu Z, Restifo NP, Sachs A, Tran E, Lo W, Somerville RP, Rosenberg SA, Deniger DC. Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers. J Clin Invest 2019;129:1109-14. [PMID: 30714987 DOI: 10.1172/JCI123791] [Cited by in Crossref: 87] [Cited by in F6Publishing: 66] [Article Influence: 29.0] [Reference Citation Analysis]
380 Khalighi S, Singh S, Varadan V. Untangling a complex web: Computational analyses of tumor molecular profiles to decode driver mechanisms. J Genet Genomics 2020;47:595-609. [PMID: 33423960 DOI: 10.1016/j.jgg.2020.11.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
381 Carey VJ, Ramos M, Stubbs BJ, Gopaulakrishnan S, Oh S, Turaga N, Waldron L, Morgan M. Global Alliance for Genomics and Health Meets Bioconductor: Toward Reproducible and Agile Cancer Genomics at Cloud Scale. JCO Clin Cancer Inform 2020;4:472-9. [PMID: 32453635 DOI: 10.1200/CCI.19.00111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
382 Quintanilha JCF, Wang J, Sibley AB, Xu W, Espin-Garcia O, Jiang C, Etheridge AS, Ratain MJ, Lenz HJ, Bertagnolli M, Kindler HL, Dickler MN, Venook A, Liu G, Owzar K, Lin D, Innocenti F. Genome-wide association studies of survival in 1520 cancer patients treated with bevacizumab-containing regimens. Int J Cancer 2022;150:279-89. [PMID: 34528705 DOI: 10.1002/ijc.33810] [Reference Citation Analysis]
383 Krasny L, Huang PH. Data-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology. Mol Omics 2021;17:29-42. [PMID: 33034323 DOI: 10.1039/d0mo00072h] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
384 López-Cortés A, Cabrera-Andrade A, Vázquez-Naya JM, Pazos A, Gonzáles-Díaz H, Paz-Y-Miño C, Guerrero S, Pérez-Castillo Y, Tejera E, Munteanu CR. Prediction of breast cancer proteins involved in immunotherapy, metastasis, and RNA-binding using molecular descriptors and artificial neural networks. Sci Rep 2020;10:8515. [PMID: 32444848 DOI: 10.1038/s41598-020-65584-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
385 Kagan J, Moritz RL, Mazurchuk R, Lee JH, Kharchenko PV, Rozenblatt-Rosen O, Ruppin E, Edfors F, Ginty F, Goltsev Y, Wells JA, LaCava J, Riesterer JL, Germain RN, Shi T, Chee MS, Budnik BA, Yates JR 3rd, Chait BT, Moffitt JR, Smith RD, Srivastava S. National Cancer Institute Think-Tank Meeting Report on Proteomic Cartography and Biomarkers at the Single-Cell Level: Interrogation of Premalignant Lesions. J Proteome Res 2020;19:1900-12. [PMID: 32163288 DOI: 10.1021/acs.jproteome.0c00021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
386 Su Y, Xiang H, Xie H, Yu Y, Dong S, Yang Z, Zhao N. Application of BERT to Enable Gene Classification Based on Clinical Evidence. Biomed Res Int 2020;2020:5491963. [PMID: 33083472 DOI: 10.1155/2020/5491963] [Reference Citation Analysis]
387 Richardson RB, Anghel CV, Deng DS. Profound synchrony of age-specific incidence rates and tumor suppression for different cancer types as revealed by the multistage-senescence model of carcinogenesis. Aging (Albany NY) 2021;13:23545-78. [PMID: 34695806 DOI: 10.18632/aging.203651] [Reference Citation Analysis]
388 Katase N, Nagano K, Fujita S. DKK3 expression and function in head and neck squamous cell carcinoma and other cancers. J Oral Biosci 2020;62:9-15. [PMID: 32032750 DOI: 10.1016/j.job.2020.01.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
389 Ebadi AR, Soleimani A, Ghaderzadeh A. Providing an optimized model to detect driver genes from heterogeneous cancer samples using restriction in subspace learning. Sci Rep 2021;11:9171. [PMID: 33911156 DOI: 10.1038/s41598-021-88548-2] [Reference Citation Analysis]
390 Perez-Romero CA, Weytjens B, Decap D, Swings T, Michiels J, De Maeyer D, Marchal K. IAMBEE: a web-service for the identification of adaptive pathways from parallel evolved clonal populations. Nucleic Acids Res 2019;47:W151-7. [PMID: 31127271 DOI: 10.1093/nar/gkz451] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
391 Yoon T, Lee H. Shedding light on complexity of protein–protein interactions in cancer. Current Opinion in Chemical Biology 2019;53:75-81. [DOI: 10.1016/j.cbpa.2019.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
392 Opasic L, Zhou D, Werner B, Dingli D, Traulsen A. How many samples are needed to infer truly clonal mutations from heterogenous tumours? BMC Cancer 2019;19:403. [PMID: 31035962 DOI: 10.1186/s12885-019-5597-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
393 Zhao W, Wu J, Chen S, Zhou Z. Shared neoantigens: ideal targets for off-the-shelf cancer immunotherapy. Pharmacogenomics 2020;21:637-45. [DOI: 10.2217/pgs-2019-0184] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
394 Fujimoto A, Wong JH, Yoshii Y, Akiyama S, Tanaka A, Yagi H, Shigemizu D, Nakagawa H, Mizokami M, Shimada M. Whole-genome sequencing with long reads reveals complex structure and origin of structural variation in human genetic variations and somatic mutations in cancer. Genome Med 2021;13:65. [PMID: 33910608 DOI: 10.1186/s13073-021-00883-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
395 Turdo A, Veschi V, Gaggianesi M, Chinnici A, Bianca P, Todaro M, Stassi G. Meeting the Challenge of Targeting Cancer Stem Cells. Front Cell Dev Biol. 2019;7:16. [PMID: 30834247 DOI: 10.3389/fcell.2019.00016] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 18.3] [Reference Citation Analysis]
396 D'Ambrosio C, Erriquez J, Arigoni M, Capellero S, Mittica G, Ghisoni E, Borella F, Katsaros D, Privitera S, Ribotta M, Maldi E, Di Nardo G, Berrino E, Venesio T, Ponzone R, Vaira M, Hall D, Jimenez-Linan M, Paterson AL, Calogero RA, Brenton JD, Valabrega G, Di Renzo MF, Olivero M. PIK3R1W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma. Cells 2020;9:E442. [PMID: 32075097 DOI: 10.3390/cells9020442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
397 Li F, Gao L, Wang P, Hu Y. Identifying Cancer Specific Driver Modules Using a Network-Based Method. Molecules 2018;23:E1114. [PMID: 29738475 DOI: 10.3390/molecules23051114] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
398 Hoda RS, Brogi E, Dos Anjos CH, Grabenstetter A, Ventura K, Patil S, Selenica P, Weigelt B, Reis-Filho JS, Traina T, Robson M, Norton L, Wen HY. Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma. Mod Pathol 2020;33:2221-32. [PMID: 32612248 DOI: 10.1038/s41379-020-0606-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
399 Flatmark K, Torgunrud A, Fleten KG, Davidson B, Juul HV, Mensali N, Lund-Andersen C, Inderberg EM. Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei. J Immunother Cancer 2021;9:e003109. [PMID: 34711663 DOI: 10.1136/jitc-2021-003109] [Reference Citation Analysis]
400 Yu W, Huang W, Yang Y, Qiu R, Zeng Y, Hou Y, Sun G, Shi H, Leng S, Feng D, Chen Y, Wang S, Teng X, Yu H, Wang Y. GATA3 recruits UTX for gene transcriptional activation to suppress metastasis of breast cancer. Cell Death Dis 2019;10:832. [PMID: 31685800 DOI: 10.1038/s41419-019-2062-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
401 Shi MJ, Meng XY, Fontugne J, Chen CL, Radvanyi F, Bernard-Pierrot I. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer. Genome Med 2020;12:85. [PMID: 32988402 DOI: 10.1186/s13073-020-00781-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
402 Freeman-Cook KD, Hoffman RL, Behenna DC, Boras B, Carelli J, Diehl W, Ferre RA, He YA, Hui A, Huang B, Huser N, Jones R, Kephart SE, Lapek J, McTigue M, Miller N, Murray BW, Nagata A, Nguyen L, Niessen S, Ninkovic S, O'Doherty I, Ornelas MA, Solowiej J, Sutton SC, Tran K, Tseng E, Visswanathan R, Xu M, Zehnder L, Zhang Q, Zhang C, Dann S. Discovery of PF-06873600, a CDK2/4/6 Inhibitor for the Treatment of Cancer. J Med Chem 2021;64:9056-77. [PMID: 34110834 DOI: 10.1021/acs.jmedchem.1c00159] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
403 Bacolla A, Sengupta S, Ye Z, Yang C, Mitra J, De-Paula RB, Hegde ML, Ahmed Z, Mort M, Cooper DN, Mitra S, Tainer JA. Heritable pattern of oxidized DNA base repair coincides with pre-targeting of repair complexes to open chromatin. Nucleic Acids Res 2021;49:221-43. [PMID: 33300026 DOI: 10.1093/nar/gkaa1120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
404 Mu S, Shi D, Ai L, Fan F, Peng F, Sun C, Hu Y. International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma. Front Immunol 2021;12:732006. [PMID: 34745101 DOI: 10.3389/fimmu.2021.732006] [Reference Citation Analysis]
405 Kinsler G, Geiler-Samerotte K, Petrov DA. Fitness variation across subtle environmental perturbations reveals local modularity and global pleiotropy of adaptation. Elife 2020;9:e61271. [PMID: 33263280 DOI: 10.7554/eLife.61271] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
406 McCarthy DJ, Rostom R, Huang Y, Kunz DJ, Danecek P, Bonder MJ, Hagai T, Lyu R, Wang W, Gaffney DJ, Simons BD, Stegle O, Teichmann SA; HipSci Consortium. Cardelino: computational integration of somatic clonal substructure and single-cell transcriptomes. Nat Methods 2020;17:414-21. [PMID: 32203388 DOI: 10.1038/s41592-020-0766-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
407 Long J, Chen P, Lin J, Bai Y, Yang X, Bian J, Lin Y, Wang D, Yang X, Zheng Y, Sang X, Zhao H. DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma. Theranostics. 2019;9:7251-7267. [PMID: 31695766 DOI: 10.7150/thno.31155] [Cited by in Crossref: 17] [Cited by in F6Publishing: 26] [Article Influence: 5.7] [Reference Citation Analysis]
408 Gracilla DE, Korla PK, Lai MT, Chiang AJ, Liou WS, Sheu JJ. Overexpression of wild type or a Q311E mutant MB21D2 promotes a pro-oncogenic phenotype in HNSCC. Mol Oncol 2020;14:3065-82. [PMID: 32979859 DOI: 10.1002/1878-0261.12806] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
409 Atak ZK, Taskiran II, Demeulemeester J, Flerin C, Mauduit D, Minnoye L, Hulselmans G, Christiaens V, Ghanem GE, Wouters J, Aerts S. Interpretation of allele-specific chromatin accessibility using cell state-aware deep learning. Genome Res 2021;31:1082-96. [PMID: 33832990 DOI: 10.1101/gr.260851.120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
410 Bum-Erdene K, Liu D, Gonzalez-Gutierrez G, Ghozayel MK, Xu D, Meroueh SO. Small-molecule covalent bond formation at tyrosine creates a binding site and inhibits activation of Ral GTPases. Proc Natl Acad Sci U S A 2020;117:7131-9. [PMID: 32179690 DOI: 10.1073/pnas.1913654117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
411 Zeng Z, Mao C, Vo A, Li X, Nugent JO, Khan SA, Clare SE, Luo Y. Deep learning for cancer type classification and driver gene identification. BMC Bioinformatics 2021;22:491. [PMID: 34689757 DOI: 10.1186/s12859-021-04400-4] [Reference Citation Analysis]
412 Yee NS. Machine intelligence for precision oncology. World J Transl Med 2021; 9(1): 1-10 [DOI: 10.5528/wjtm.v9.i1.1] [Reference Citation Analysis]
413 Cheng K, Nair NU, Lee JS, Ruppin E. Synthetic lethality across normal tissues is strongly associated with cancer risk, onset, and tumor suppressor specificity. Sci Adv 2021;7:eabc2100. [PMID: 33523837 DOI: 10.1126/sciadv.abc2100] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
414 Warner JL, Patt D; Section Editors for the IMIA Yearbook Section on Cancer Informatics. Cancer Informatics in 2018: The Mysteries of the Cancer Genome Continue to Unravel, Deep Learning Approaches the Clinic, and Passive Data Collection Demonstrates Utility. Yearb Med Inform 2019;28:236-8. [PMID: 31419838 DOI: 10.1055/s-0039-1677931] [Reference Citation Analysis]
415 Saghafinia S, Mina M, Riggi N, Hanahan D, Ciriello G. Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors. Cell Rep 2018; 25: 1066-1080. e8. [PMID: 30355485 DOI: 10.1016/j.celrep.2018.09.082] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 25.0] [Reference Citation Analysis]
416 Smith BA, Balanis NG, Nanjundiah A, Sheu KM, Tsai BL, Zhang Q, Park JW, Thompson M, Huang J, Witte ON, Graeber TG. A Human Adult Stem Cell Signature Marks Aggressive Variants across Epithelial Cancers. Cell Rep 2018;24:3353-3366.e5. [PMID: 30232014 DOI: 10.1016/j.celrep.2018.08.062] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 13.0] [Reference Citation Analysis]
417 Salvadores M, Fuster-Tormo F, Supek F. Matching cell lines with cancer type and subtype of origin via mutational, epigenomic, and transcriptomic patterns. Sci Adv 2020;6:eaba1862. [PMID: 32937430 DOI: 10.1126/sciadv.aba1862] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
418 Kunz M, Jeromin J, Fuchs M, Christoph J, Veronesi G, Flentje M, Nietzer S, Dandekar G, Dandekar T. In silico signaling modeling to understand cancer pathways and treatment responses. Briefings in Bioinformatics 2020;21:1115-7. [DOI: 10.1093/bib/bbz033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
419 Felts SJ, Tang X, Willett B, Van Keulen VP, Hansen MJ, Kalari KR, Pease LR. Stochastic changes in gene expression promote chaotic dysregulation of homeostasis in clonal breast tumors. Commun Biol 2019;2:206. [PMID: 31240244 DOI: 10.1038/s42003-019-0460-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
420 Reiter JG, Baretti M, Gerold JM, Makohon-Moore AP, Daud A, Iacobuzio-Donahue CA, Azad NS, Kinzler KW, Nowak MA, Vogelstein B. An analysis of genetic heterogeneity in untreated cancers. Nat Rev Cancer 2019;19:639-50. [PMID: 31455892 DOI: 10.1038/s41568-019-0185-x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 15.3] [Reference Citation Analysis]
421 Nussinov R, Zhang M, Maloney R, Jang H. Drugging multiple same-allele driver mutations in cancer. Expert Opin Drug Discov 2021;16:823-8. [PMID: 33769165 DOI: 10.1080/17460441.2021.1905628] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
422 Hoy JJ, Salinas Parra N, Park J, Kuhn S, Iglesias-Bartolome R. Protein kinase A inhibitor proteins (PKIs) divert GPCR-Gαs-cAMP signaling toward EPAC and ERK activation and are involved in tumor growth. FASEB J 2020;34:13900-17. [PMID: 32830375 DOI: 10.1096/fj.202001515R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
423 Nangalia J, Mitchell E, Green AR. Clonal approaches to understanding the impact of mutations on hematologic disease development. Blood 2019;133:1436-45. [PMID: 30728143 DOI: 10.1182/blood-2018-11-835405] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
424 Amin SB, Anderson KJ, Boudreau CE, Martinez-Ledesma E, Kocakavuk E, Johnson KC, Barthel FP, Varn FS, Kassab C, Ling X, Kim H, Barter M, Lau CC, Ngan CY, Chapman M, Koehler JW, Long JP, Miller AD, Miller CR, Porter BF, Rissi DR, Mazcko C, LeBlanc AK, Dickinson PJ, Packer RA, Taylor AR, Rossmeisl JH Jr, Woolard KD, Heimberger AB, Levine JM, Verhaak RGW. Comparative Molecular Life History of Spontaneous Canine and Human Gliomas. Cancer Cell 2020;37:243-257.e7. [PMID: 32049048 DOI: 10.1016/j.ccell.2020.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
425 Fornalski KW, Dobrzyński L. Modeling of single cell cancer transformation using phase transition theory: application of the Avrami equation. Radiat Environ Biophys 2021. [PMID: 34665303 DOI: 10.1007/s00411-021-00948-0] [Reference Citation Analysis]
426 Halperin RF, Liang WS, Kulkarni S, Tassone EE, Adkins J, Enriquez D, Tran NL, Hank NC, Newell J, Kodira C, Korn R, Berens ME, Kim S, Byron SA. Leveraging Spatial Variation in Tumor Purity for Improved Somatic Variant Calling of Archival Tumor Only Samples. Front Oncol 2019;9:119. [PMID: 30949446 DOI: 10.3389/fonc.2019.00119] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
427 Halaburkova A, Cahais V, Novoloaca A, Araujo MGDS, Khoueiry R, Ghantous A, Herceg Z. Pan-cancer multi-omics analysis and orthogonal experimental assessment of epigenetic driver genes. Genome Res 2020;30:1517-32. [PMID: 32963031 DOI: 10.1101/gr.268292.120] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
428 Repana D, Nulsen J, Dressler L, Bortolomeazzi M, Venkata SK, Tourna A, Yakovleva A, Palmieri T, Ciccarelli FD. The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens. Genome Biol 2019;20:1. [PMID: 30606230 DOI: 10.1186/s13059-018-1612-0] [Cited by in Crossref: 117] [Cited by in F6Publishing: 70] [Article Influence: 39.0] [Reference Citation Analysis]
429 Pirkl M, Beerenwinkel N. Inferring perturbation profiles of cancer samples. Bioinformatics 2021:btab113. [PMID: 33617647 DOI: 10.1093/bioinformatics/btab113] [Reference Citation Analysis]
430 Hennessey RC, Brown KM. Cancer regulatory variation. Current Opinion in Genetics & Development 2021;66:41-9. [DOI: 10.1016/j.gde.2020.11.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
431 Diefenbach RJ, Lee JH, Rizos H. Monitoring Melanoma Using Circulating Free DNA. Am J Clin Dermatol 2019;20:1-12. [PMID: 30374893 DOI: 10.1007/s40257-018-0398-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
432 Diefenbach RJ, Lee JH, Menzies AM, Carlino MS, Long GV, Saw RPM, Howle JR, Spillane AJ, Scolyer RA, Kefford RF, Rizos H. Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA. Cancers (Basel) 2020;12:E2228. [PMID: 32785074 DOI: 10.3390/cancers12082228] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
433 Zeng D, Wu J, Luo H, Li Y, Xiao J, Peng J, Ye Z, Zhou R, Yu Y, Wang G, Huang N, Wu J, Rong X, Sun L, Sun H, Qiu W, Xue Y, Bin J, Liao Y, Li N, Shi M, Kim KM, Liao W. Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer. J Immunother Cancer 2021;9:e002467. [PMID: 34376552 DOI: 10.1136/jitc-2021-002467] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
434 Pérez-Granado J, Piñero J, Furlong LI. ResMarkerDB: a database of biomarkers of response to antibody therapy in breast and colorectal cancer. Database (Oxford) 2019;2019:baz060. [PMID: 31169290 DOI: 10.1093/database/baz060] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
435 de Almeida BP, Vieira AF, Paredes J, Bettencourt-Dias M, Barbosa-Morais NL. Pan-cancer association of a centrosome amplification gene expression signature with genomic alterations and clinical outcome. PLoS Comput Biol 2019;15:e1006832. [PMID: 30856170 DOI: 10.1371/journal.pcbi.1006832] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
436 Luque Paz D, Jouanneau-Courville R, Riou J, Ianotto JC, Boyer F, Chauveau A, Renard M, Chomel JC, Cayssials E, Gallego-Hernanz MP, Pastoret C, Murati A, Courtier F, Rousselet MC, Quintin-Roué I, Cottin L, Orvain C, Thépot S, Chrétien JM, Delneste Y, Ifrah N, Blanchet O, Hunault-Berger M, Lippert E, Ugo V. Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation. Blood Adv 2020;4:4887-97. [PMID: 33035330 DOI: 10.1182/bloodadvances.2020002271] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
437 Kyrochristos ID, Baltagiannis EG, Mitsis M, Roukos DH. Precision in cancer pharmacogenomics. Pharmacogenomics 2020;21:311-6. [PMID: 32242500 DOI: 10.2217/pgs-2020-0011] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
438 Wang A, Hai R. Noncoding RNAs Serve as the Deadliest Universal Regulators of all Cancers. Cancer Genomics Proteomics 2021;18:43-52. [PMID: 33419895 DOI: 10.21873/cgp.20240] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
439 Ruan Y, Wang H, Chen B, Wen H, Wu CI. Mutations Beget More Mutations-Rapid Evolution of Mutation Rate in Response to the Risk of Runaway Accumulation. Mol Biol Evol 2020;37:1007-19. [PMID: 31778175 DOI: 10.1093/molbev/msz283] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
440 Rogozin IB, Roche-Lima A, Lada AG, Belinky F, Sidorenko IA, Glazko GV, Babenko VN, Cooper DN, Pavlov YI. Nucleotide Weight Matrices Reveal Ubiquitous Mutational Footprints of AID/APOBEC Deaminases in Human Cancer Genomes. Cancers (Basel) 2019;11:E211. [PMID: 30759888 DOI: 10.3390/cancers11020211] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
441 Lu J, Zhong R, Lou Y, Hu M, Yang Z, Wang Y, Chen Y, Zou B, Zhang W, Wang H, Han B. TP53 Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer. Front Immunol 2021;12:732125. [PMID: 34603310 DOI: 10.3389/fimmu.2021.732125] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
442 Labuhn M, Perkins K, Matzk S, Varghese L, Garnett C, Papaemmanuil E, Metzner M, Kennedy A, Amstislavskiy V, Risch T, Bhayadia R, Samulowski D, Hernandez DC, Stoilova B, Iotchkova V, Oppermann U, Scheer C, Yoshida K, Schwarzer A, Taub JW, Crispino JD, Weiss MJ, Hayashi Y, Taga T, Ito E, Ogawa S, Reinhardt D, Yaspo ML, Campbell PJ, Roberts I, Constantinescu SN, Vyas P, Heckl D, Klusmann JH. Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome. Cancer Cell 2019;36:123-138.e10. [PMID: 31303423 DOI: 10.1016/j.ccell.2019.06.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
443 Brandes N, Linial N, Linial M. Genetic association studies of alterations in protein function expose recessive effects on cancer predisposition. Sci Rep 2021;11:14901. [PMID: 34290314 DOI: 10.1038/s41598-021-94252-y] [Reference Citation Analysis]
444 Novillo A, Fernández-Santander A, Gaibar M, Galán M, Romero-Lorca A, El Abdellaoui-Soussi F, Gómez-Del Arco P. Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer. Front Oncol 2021;11:633233. [PMID: 33981601 DOI: 10.3389/fonc.2021.633233] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
445 Russo M, Newell JM, Budurlean L, Houser KR, Sheldon K, Kesterson J, Phaeton R, Hossler C, Rosenberg J, DeGraff D, Shuman L, Broach JR, Warrick JI. Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma. Cancer 2020;126:2775-83. [PMID: 32187665 DOI: 10.1002/cncr.32822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
446 Alamir H, Alomari M, Salwati AAA, Saka M, Bangash M, Baeesa S, Alghamdi F, Carracedo A, Schulten HJ, Chaudhary A, Abuzenadah A, Hussein D. In situ characterization of stem cells-like biomarkers in meningiomas. Cancer Cell Int 2018;18:77. [PMID: 29849507 DOI: 10.1186/s12935-018-0571-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
447 Sun H, Cao S, Mashl RJ, Mo CK, Zaccaria S, Wendl MC, Davies SR, Bailey MH, Primeau TM, Hoog J, Mudd JL, Dean DA 2nd, Patidar R, Chen L, Wyczalkowski MA, Jayasinghe RG, Rodrigues FM, Terekhanova NV, Li Y, Lim KH, Wang-Gillam A, Van Tine BA, Ma CX, Aft R, Fuh KC, Schwarz JK, Zevallos JP, Puram SV, Dipersio JF, Davis-Dusenbery B, Ellis MJ, Lewis MT, Davies MA, Herlyn M, Fang B, Roth JA, Welm AL, Welm BE, Meric-Bernstam F, Chen F, Fields RC, Li S, Govindan R, Doroshow JH, Moscow JA, Evrard YA, Chuang JH, Raphael BJ, Ding L; NCI PDXNet Consortium. Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment. Nat Commun 2021;12:5086. [PMID: 34429404 DOI: 10.1038/s41467-021-25177-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
448 Jakubek YA, Chang K, Sivakumar S, Yu Y, Giordano MR, Fowler J, Huff CD, Kadara H, Vilar E, Scheet P. Large-scale analysis of acquired chromosomal alterations in non-tumor samples from patients with cancer. Nat Biotechnol 2020;38:90-6. [PMID: 31685958 DOI: 10.1038/s41587-019-0297-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
449 Huang KL, Wu Y, Primeau T, Wang YT, Gao Y, McMichael JF, Scott AD, Cao S, Wendl MC, Johnson KJ, Ruggles K, Held J, Payne SH, Davies S, Dar A, Kinsinger CR, Mesri M, Rodriguez H, Ellis MJ, Townsend RR, Chen F, Fenyö D, Li S, Liu T, Carr SA, Ding L. Regulated Phosphosignaling Associated with Breast Cancer Subtypes and Druggability. Mol Cell Proteomics 2019;18:1630-50. [PMID: 31196969 DOI: 10.1074/mcp.RA118.001243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
450 Valencia AM, Kadoch C. Chromatin regulatory mechanisms and therapeutic opportunities in cancer. Nat Cell Biol 2019;21:152-61. [PMID: 30602726 DOI: 10.1038/s41556-018-0258-1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 19.3] [Reference Citation Analysis]
451 Kim MH, Kim JH, Lee JM, Choi JW, Jung D, Cho H, Kang H, Hong MH, Heo SJ, Kim SH, Choi EC, Kim DH, Park YM, Kim S, Yoon SO, Koh YW, Cho BC, Kim HR. Molecular subtypes of oropharyngeal cancer show distinct immune microenvironment related with immune checkpoint blockade response. Br J Cancer 2020;122:1649-60. [PMID: 32235905 DOI: 10.1038/s41416-020-0796-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
452 Jaiswal A, Gautam P, Pietilä EA, Timonen S, Nordström N, Akimov Y, Sipari N, Tanoli Z, Fleischer T, Lehti K, Wennerberg K, Aittokallio T. Multi-modal meta-analysis of cancer cell line omics profiles identifies ECHDC1 as a novel breast tumor suppressor. Mol Syst Biol 2021;17:e9526. [PMID: 33750001 DOI: 10.15252/msb.20209526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
453 Malhotra S, Alsulami AF, Heiyun Y, Ochoa BM, Jubb H, Forbes S, Blundell TL. Understanding the impacts of missense mutations on structures and functions of human cancer-related genes: A preliminary computational analysis of the COSMIC Cancer Gene Census. PLoS One 2019;14:e0219935. [PMID: 31323058 DOI: 10.1371/journal.pone.0219935] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
454 Kather JN, Pearson AT, Halama N, Jäger D, Krause J, Loosen SH, Marx A, Boor P, Tacke F, Neumann UP, Grabsch HI, Yoshikawa T, Brenner H, Chang-Claude J, Hoffmeister M, Trautwein C, Luedde T. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat Med 2019;25:1054-6. [PMID: 31160815 DOI: 10.1038/s41591-019-0462-y] [Cited by in Crossref: 221] [Cited by in F6Publishing: 178] [Article Influence: 73.7] [Reference Citation Analysis]
455 Feusier JE, Arunachalam S, Tashi T, Baker MJ, VanSant-Webb C, Ferdig A, Welm BE, Rodriguez-Flores JL, Ours C, Jorde LB, Prchal JT, Mason CC. Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers. Blood Cancer Discov 2021;2:226-37. [PMID: 34027416 DOI: 10.1158/2643-3230.bcd-20-0094] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
456 Robertson H, Dinkova-Kostova AT, Hayes JD. NRF2 and the Ambiguous Consequences of Its Activation during Initiation and the Subsequent Stages of Tumourigenesis. Cancers (Basel) 2020;12:E3609. [PMID: 33276631 DOI: 10.3390/cancers12123609] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
457 Saito Y, Koya J, Araki M, Kogure Y, Shingaki S, Tabata M, McClure MB, Yoshifuji K, Matsumoto S, Isaka Y, Tanaka H, Kanai T, Miyano S, Shiraishi Y, Okuno Y, Kataoka K. Landscape and function of multiple mutations within individual oncogenes. Nature 2020;582:95-9. [PMID: 32494066 DOI: 10.1038/s41586-020-2175-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 14.5] [Reference Citation Analysis]
458 Nussinov R, Jang H, Tsai CJ, Cheng F. Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers. PLoS Comput Biol 2019;15:e1006658. [PMID: 30921324 DOI: 10.1371/journal.pcbi.1006658] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 11.7] [Reference Citation Analysis]
459 Pitt JJ, Riester M, Zheng Y, Yoshimatsu TF, Sanni A, Oluwasola O, Veloso A, Labrot E, Wang S, Odetunde A, Ademola A, Okedere B, Mahan S, Leary R, Macomber M, Ajani M, Johnson RS, Fitzgerald D, Grundstad AJ, Tuteja JH, Khramtsova G, Zhang J, Sveen E, Hwang B, Clayton W, Nkwodimmah C, Famooto B, Obasi E, Aderoju V, Oludara M, Omodele F, Akinyele O, Adeoye A, Ogundiran T, Babalola C, MacIsaac K, Popoola A, Morrissey MP, Chen LS, Wang J, Olopade CO, Falusi AG, Winckler W, Haase K, Van Loo P, Obafunwa J, Papoutsakis D, Ojengbede O, Weber B, Ibrahim N, White KP, Huo D, Olopade OI, Barretina J. Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. Nat Commun 2018;9:4181. [PMID: 30327465 DOI: 10.1038/s41467-018-06616-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
460 Ramos M, Geistlinger L, Oh S, Schiffer L, Azhar R, Kodali H, de Bruijn I, Gao J, Carey VJ, Morgan M, Waldron L. Multiomic Integration of Public Oncology Databases in Bioconductor. JCO Clin Cancer Inform 2020;4:958-71. [PMID: 33119407 DOI: 10.1200/CCI.19.00119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
461 Driehuis E, van Hoeck A, Moore K, Kolders S, Francies HE, Gulersonmez MC, Stigter ECA, Burgering B, Geurts V, Gracanin A, Bounova G, Morsink FH, Vries R, Boj S, van Es J, Offerhaus GJA, Kranenburg O, Garnett MJ, Wessels L, Cuppen E, Brosens LAA, Clevers H. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Proc Natl Acad Sci U S A 2019:201911273. [PMID: 31818951 DOI: 10.1073/pnas.1911273116] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 27.7] [Reference Citation Analysis]
462 Rocca A, Kholodenko BN. Can Systems Biology Advance Clinical Precision Oncology? Cancers (Basel) 2021;13:6312. [PMID: 34944932 DOI: 10.3390/cancers13246312] [Reference Citation Analysis]
463 Vergara IA, Wilmott JS, Long GV, Scolyer RA. Genetic drivers of non-cutaneous melanomas: Challenges and opportunities in a heterogeneous landscape. Exp Dermatol 2021. [PMID: 33455025 DOI: 10.1111/exd.14287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
464 Black JRM, McGranahan N. Genetic and non-genetic clonal diversity in cancer evolution. Nat Rev Cancer 2021;21:379-92. [PMID: 33727690 DOI: 10.1038/s41568-021-00336-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
465 Ke Q, Dinalankara W, Younes L, Geman D, Marchionni L. Efficient representations of tumor diversity with paired DNA-RNA aberrations. PLoS Comput Biol 2021;17:e1008944. [PMID: 34115745 DOI: 10.1371/journal.pcbi.1008944] [Reference Citation Analysis]
466 Viñas R, Andrés-Terré H, Liò P, Bryson K. Adversarial generation of gene expression data. Bioinformatics 2021:btab035. [PMID: 33471074 DOI: 10.1093/bioinformatics/btab035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
467 Bagante F, Spolverato G, Ruzzenente A, Luchini C, Tsilimigras DI, Campagnaro T, Conci S, Corbo V, Scarpa A, Guglielmi A, Pawlik TM. Artificial neural networks for multi-omics classifications of hepato-pancreato-biliary cancers: towards the clinical application of genetic data. Eur J Cancer 2021;148:348-58. [PMID: 33774439 DOI: 10.1016/j.ejca.2021.01.049] [Reference Citation Analysis]
468 Ashford P, Pang CSM, Moya-García AA, Adeyelu T, Orengo CA. A CATH domain functional family based approach to identify putative cancer driver genes and driver mutations. Sci Rep 2019;9:263. [PMID: 30670742 DOI: 10.1038/s41598-018-36401-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
469 Laddach A, Ng JCF, Fraternali F. Pathogenic missense protein variants affect different functional pathways and proteomic features than healthy population variants. PLoS Biol 2021;19:e3001207. [PMID: 33909605 DOI: 10.1371/journal.pbio.3001207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
470 Jiang ZY, Lu MC, You QD. Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Inhibition: An Emerging Strategy in Cancer Therapy. J Med Chem 2019;62:3840-56. [PMID: 30444366 DOI: 10.1021/acs.jmedchem.8b01121] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
471 Shi J, Xu J, Chen YE, Li JS, Cui Y, Shen L, Li JJ, Li W. The concurrence of DNA methylation and demethylation is associated with transcription regulation. Nat Commun 2021;12:5285. [PMID: 34489442 DOI: 10.1038/s41467-021-25521-7] [Reference Citation Analysis]
472 Zhang H, Li D, Zhao X, Pan S, Wu X, Peng S, Huang H, Shi R, Tan Z. Relatively semi-conservative replication and a folded slippage model for short tandem repeats. BMC Genomics 2020;21:563. [PMID: 32807079 DOI: 10.1186/s12864-020-06949-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
473 Agarwal E, Altman BJ, Seo JH, Ghosh JC, Kossenkov AV, Tang HY, Krishn SR, Languino LR, Gabrilovich DI, Speicher DW, Dang CV, Altieri DC. Myc-mediated transcriptional regulation of the mitochondrial chaperone TRAP1 controls primary and metastatic tumor growth. J Biol Chem 2019;294:10407-14. [PMID: 31097545 DOI: 10.1074/jbc.AC119.008656] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
474 Xue Y, San Luis B, Lane DP. Intratumour heterogeneity of p53 expression; causes and consequences. J Pathol 2019;249:274-85. [PMID: 31322742 DOI: 10.1002/path.5328] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
475 Vlachavas EI, Bohn J, Ückert F, Nürnberg S. A Detailed Catalogue of Multi-Omics Methodologies for Identification of Putative Biomarkers and Causal Molecular Networks in Translational Cancer Research. Int J Mol Sci 2021;22:2822. [PMID: 33802234 DOI: 10.3390/ijms22062822] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
476 Huang SC, Ng KF, Chang IY, Chang CJ, Chao YC, Chang SC, Chen MC, Yeh TS, Chen TC. The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes. PLoS One 2021;16:e0245356. [PMID: 33481850 DOI: 10.1371/journal.pone.0245356] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
477 Eiholzer RA, Mehta S, Kazantseva M, Drummond CJ, McKinney C, Young K, Slater D, Morten BC, Avery-Kiejda KA, Lasham A, Fleming N, Morrin HR, Reader K, Royds JA, Landmann M, Petrich S, Reddel R, Huschtscha L, Taha A, Hung NA, Slatter TL, Braithwaite AW. Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk. Cancers (Basel) 2020;12:E2472. [PMID: 32882831 DOI: 10.3390/cancers12092472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
478 Liu Z, Zhao Q, Zuo ZX, Yuan SQ, Yu K, Zhang Q, Zhang X, Sheng H, Ju HQ, Cheng H, Wang F, Xu RH, Liu ZX. Systematic Analysis of the Aberrances and Functional Implications of Ferroptosis in Cancer. iScience 2020;23:101302. [PMID: 32629423 DOI: 10.1016/j.isci.2020.101302] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
479 Vilachã JF, Mitchel SC, Akele MZ, Evans S, Groves MR. Making NSCLC Crystal Clear: How Kinase Structures Revolutionized Lung Cancer Treatment. Crystals 2020;10:725. [DOI: 10.3390/cryst10090725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
480 Ansari-Pour N, Zheng Y, Yoshimatsu TF, Sanni A, Ajani M, Reynier JB, Tapinos A, Pitt JJ, Dentro S, Woodard A, Rajagopal PS, Fitzgerald D, Gruber AJ, Odetunde A, Popoola A, Falusi AG, Babalola CP, Ogundiran T, Ibrahim N, Barretina J, Van Loo P, Chen M, White KP, Ojengbede O, Obafunwa J, Huo D, Wedge DC, Olopade OI. Whole-genome analysis of Nigerian patients with breast cancer reveals ethnic-driven somatic evolution and distinct genomic subtypes. Nat Commun 2021;12:6946. [PMID: 34836952 DOI: 10.1038/s41467-021-27079-w] [Reference Citation Analysis]
481 Schuster SL, Hsieh AC. The Untranslated Regions of mRNAs in Cancer. Trends Cancer 2019;5:245-62. [PMID: 30961831 DOI: 10.1016/j.trecan.2019.02.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
482 Samorodnitsky S, Hoadley KA, Lock EF. A Pan-Cancer and Polygenic Bayesian Hierarchical Model for the Effect of Somatic Mutations on Survival. Cancer Inform 2020;19:1176935120907399. [PMID: 32116467 DOI: 10.1177/1176935120907399] [Reference Citation Analysis]
483 Nones K, Patch AM. The Impact of Next Generation Sequencing in Cancer Research. Cancers (Basel) 2020;12:E2928. [PMID: 33053644 DOI: 10.3390/cancers12102928] [Reference Citation Analysis]
484 Remmerie M, Janssens V. PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer. Front Oncol 2019;9:462. [PMID: 31214504 DOI: 10.3389/fonc.2019.00462] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
485 Carrot-Zhang J, Chambwe N, Damrauer JS, Knijnenburg TA, Robertson AG, Yau C, Zhou W, Berger AC, Huang KL, Newberg JY, Mashl RJ, Romanel A, Sayaman RW, Demichelis F, Felau I, Frampton GM, Han S, Hoadley KA, Kemal A, Laird PW, Lazar AJ, Le X, Oak N, Shen H, Wong CK, Zenklusen JC, Ziv E, Cherniack AD, Beroukhim R; Cancer Genome Atlas Analysis Network. Comprehensive Analysis of Genetic Ancestry and Its Molecular Correlates in Cancer. Cancer Cell 2020;37:639-654.e6. [PMID: 32396860 DOI: 10.1016/j.ccell.2020.04.012] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 20.5] [Reference Citation Analysis]
486 Sasca D, Guezguez B, Kühn MWM. Next generation epigenetic modulators to target myeloid neoplasms. Curr Opin Hematol 2021;28:356-63. [PMID: 34267079 DOI: 10.1097/MOH.0000000000000673] [Reference Citation Analysis]
487 Mygland L, Brinch SA, Strand MF, Olsen PA, Aizenshtadt A, Lund K, Solberg NT, Lycke M, Thorvaldsen TE, Espada S, Misaghian D, Page CM, Agafonov O, Nygård S, Chi NW, Lin E, Tan J, Yu Y, Costa M, Krauss S, Waaler J. Identification of response signatures for tankyrase inhibitor treatment in tumor cell lines. iScience 2021;24:102807. [PMID: 34337362 DOI: 10.1016/j.isci.2021.102807] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
488 Mano H. Cancer genomic medicine in Japan. Proc Jpn Acad Ser B Phys Biol Sci 2020;96:316-21. [PMID: 32788553 DOI: 10.2183/pjab.96.023] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
489 Shah Y, Verma A, Marderstein AR, White J, Bhinder B, Garcia Medina JS, Elemento O. Pan-cancer analysis reveals molecular patterns associated with age. Cell Rep 2021;37:110100. [PMID: 34879281 DOI: 10.1016/j.celrep.2021.110100] [Reference Citation Analysis]
490 Wolf AM. The tumor suppression theory of aging. Mech Ageing Dev 2021;200:111583. [PMID: 34637937 DOI: 10.1016/j.mad.2021.111583] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
491 Wu CH, Yeh HT, Hsieh CS, Huang CC, Chattopadhyay A, Chung YC, Tu SH, Li YH, Lu TP, Lai LC, Hou MF, Chang KJ, Tsai MH, Chuang EY. Evolutionary Trajectories and Genomic Divergence in Localized Breast Cancers after Ipsilateral Breast Tumor Recurrence. Cancers (Basel) 2021;13:1821. [PMID: 33920370 DOI: 10.3390/cancers13081821] [Reference Citation Analysis]
492 Pedro MP, Salinas Parra N, Gutkind JS, Iglesias-Bartolome R. Activation of G-Protein Coupled Receptor-Gαi Signaling Increases Keratinocyte Proliferation and Reduces Differentiation, Leading to Epidermal Hyperplasia. J Invest Dermatol 2020;140:1195-1203.e3. [PMID: 31707029 DOI: 10.1016/j.jid.2019.10.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
493 Nulsen J, Misetic H, Yau C, Ciccarelli FD. Pan-cancer detection of driver genes at the single-patient resolution. Genome Med 2021;13:12. [PMID: 33517897 DOI: 10.1186/s13073-021-00830-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
494 Liñares-Blanco J, Pazos A, Fernandez-Lozano C. Machine learning analysis of TCGA cancer data. PeerJ Comput Sci 2021;7:e584. [PMID: 34322589 DOI: 10.7717/peerj-cs.584] [Reference Citation Analysis]
495 Li G, Yang Z, Wu D, Liu S, Li X, Li T, Li Y, Liang L, Zou W, Wu CI, Wang HY, Lu X. Evolution under spatially heterogeneous selection in solid tumors. Mol Biol Evol 2021:msab335. [PMID: 34850073 DOI: 10.1093/molbev/msab335] [Reference Citation Analysis]
496 Zhang X, Meyerson M. Illuminating the noncoding genome in cancer. Nat Cancer 2020;1:864-72. [DOI: 10.1038/s43018-020-00114-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 6.5] [Reference Citation Analysis]
497 Zheng F, Kelly MR, Ramms DJ, Heintschel ML, Tao K, Tutuncuoglu B, Lee JJ, Ono K, Foussard H, Chen M, Herrington KA, Silva E, Liu SN, Chen J, Churas C, Wilson N, Kratz A, Pillich RT, Patel DN, Park J, Kuenzi B, Yu MK, Licon K, Pratt D, Kreisberg JF, Kim M, Swaney DL, Nan X, Fraley SI, Gutkind JS, Krogan NJ, Ideker T. Interpretation of cancer mutations using a multiscale map of protein systems. Science 2021;374:eabf3067. [PMID: 34591613 DOI: 10.1126/science.abf3067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
498 Dunbar A, Bolton KL, Devlin SM, Sanchez-Vega F, Gao J, Mones JV, Wills J, Kelly D, Farina M, Cordner KB, Park Y, Kishore S, Juluru K, Iyengar NM, Levine RL, Zehir A, Park W, Khorana AA, Soff GA, Mantha S. Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors. Blood 2021;137:2103-13. [PMID: 33270827 DOI: 10.1182/blood.2020007488] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
499 Wang X, Duan H, Li X, Ye X, Huang G, Nie S. A prognostic analysis method for non-small cell lung cancer based on the computed tomography radiomics. Phys Med Biol 2020;65:045006. [PMID: 31962301 DOI: 10.1088/1361-6560/ab6e51] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
500 Carril-Ajuria L, Santos M, Roldán-Romero JM, Rodriguez-Antona C, de Velasco G. Prognostic and Predictive Value of PBRM1 in Clear Cell Renal Cell Carcinoma. Cancers (Basel) 2019;12:E16. [PMID: 31861590 DOI: 10.3390/cancers12010016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
501 Chang YS, Tu SJ, Yen JC, Lee YT, Fang HY, Chang JG. The Fusion Gene Landscape in Taiwanese Patients with Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13:1343. [PMID: 33809651 DOI: 10.3390/cancers13061343] [Reference Citation Analysis]
502 Lin LH, Chou CH, Cheng HW, Chang KW, Liu CJ. Precise Identification of Recurrent Somatic Mutations in Oral Cancer Through Whole-Exome Sequencing Using Multiple Mutation Calling Pipelines. Front Oncol 2021;11:741626. [PMID: 34912705 DOI: 10.3389/fonc.2021.741626] [Reference Citation Analysis]
503 Bianchi JJ, Zhao X, Mays JC, Davoli T. Not all cancers are created equal: Tissue specificity in cancer genes and pathways. Curr Opin Cell Biol 2020;63:135-43. [PMID: 32092639 DOI: 10.1016/j.ceb.2020.01.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
504 Raimondi D, Passemiers A, Fariselli P, Moreau Y. Current cancer driver variant predictors learn to recognize driver genes instead of functional variants. BMC Biol 2021;19:3. [PMID: 33441128 DOI: 10.1186/s12915-020-00930-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
505 Fritz J, Lefebvre O, Fernandez A, Schmidt J, Bagnard D. Prediction of Drug Efficacy in Colon Cancer Preclinical Models Using a Novel Ranking Method of Gene Expression. Cancers (Basel) 2020;12:E149. [PMID: 31936310 DOI: 10.3390/cancers12010149] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
506 Zhu G, Guo YA, Ho D, Poon P, Poh ZW, Wong PM, Gan A, Chang MM, Kleftogiannis D, Lau YT, Tay B, Lim WJ, Chua C, Tan TJ, Koo SL, Chong DQ, Yap YS, Tan I, Ng S, Skanderup AJ. Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden. Nat Commun 2021;12:2229. [PMID: 33850132 DOI: 10.1038/s41467-021-22463-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
507 Liu Z, Liu Y, Qian L, Jiang S, Gai X, Ye S, Chen Y, Wang X, Zhai L, Xu J, Pu C, Li J, He F, Huang M, Tan M. A proteomic and phosphoproteomic landscape of KRAS mutant cancers identifies combination therapies. Mol Cell 2021:S1097-2765(21)00590-6. [PMID: 34375582 DOI: 10.1016/j.molcel.2021.07.021] [Reference Citation Analysis]
508 Lopez-Bigas N, Gonzalez-Perez A. Are carcinogens direct mutagens? Nat Genet 2020;52:1137-8. [PMID: 33128047 DOI: 10.1038/s41588-020-00730-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
509 Sonugür FG, Akbulut H. The Role of Tumor Microenvironment in Genomic Instability of Malignant Tumors. Front Genet 2019;10:1063. [PMID: 31737046 DOI: 10.3389/fgene.2019.01063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
510 Soltis AR, Dalgard CL, Pollard HB, Wilkerson MD. MutEnricher: a flexible toolset for somatic mutation enrichment analysis of tumor whole genomes. BMC Bioinformatics 2020;21:338. [PMID: 32736515 DOI: 10.1186/s12859-020-03695-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
511 Chiara F, Indraccolo S, Trevisan A. Filling the gap between risk assessment and molecular determinants of tumor onset. Carcinogenesis 2021;42:507-16. [PMID: 33319226 DOI: 10.1093/carcin/bgaa135] [Reference Citation Analysis]
512 El-Kenawy A, Benarba B, Neves AF, de Araujo TG, Tan BL, Gouri A. Gene surgery: Potential applications for human diseases. EXCLI J 2019;18:908-30. [PMID: 31762718 DOI: 10.17179/excli2019-1833] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
513 Lazar IM, Karcini A, Ahuja S, Estrada-Palma C. Proteogenomic Analysis of Protein Sequence Alterations in Breast Cancer Cells. Sci Rep 2019;9:10381. [PMID: 31316139 DOI: 10.1038/s41598-019-46897-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
514 Karimi MR, Karimi AH, Abolmaali S, Sadeghi M, Schmitz U. Prospects and challenges of cancer systems medicine: from genes to disease networks. Brief Bioinform 2021:bbab343. [PMID: 34471925 DOI: 10.1093/bib/bbab343] [Reference Citation Analysis]
515 Hong X, Qiao S, Li F, Wang W, Jiang R, Wu H, Chen H, Liu L, Peng J, Wang J, Jia C, Liang X, Dai H, Jiang J, Zhang T, Liao Q, Dai M, Cong L, Han X, Guo D, Liang Z, Li D, Zheng Z, Ye C, Li S, Zhao Y, Wu K, Wu W. Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification system. Gut 2020;69:877-87. [PMID: 31462556 DOI: 10.1136/gutjnl-2018-317233] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
516 Mösch A, Raffegerst S, Weis M, Schendel DJ, Frishman D. Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell Receptors. Front Genet 2019;10:1141. [PMID: 31798635 DOI: 10.3389/fgene.2019.01141] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
517 Schenk A, López S, Kschischo M, McGranahan N. Germline ancestry influences the evolutionary disease course in lung adenocarcinomas. Evol Appl 2020;13:1550-7. [PMID: 32952607 DOI: 10.1111/eva.12964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
518 Pogrebniak KL, Curtis C. Harnessing Tumor Evolution to Circumvent Resistance. Trends Genet 2018;34:639-51. [PMID: 29903534 DOI: 10.1016/j.tig.2018.05.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
519 Waterman DP, Haber JE, Smolka MB. Checkpoint Responses to DNA Double-Strand Breaks. Annu Rev Biochem 2020;89:103-33. [PMID: 32176524 DOI: 10.1146/annurev-biochem-011520-104722] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
520 Liu M, Guo F. Recent updates on cancer immunotherapy. Prec Clin Med. 2018;1:65-74. [PMID: 30687562 DOI: 10.1093/pcmedi/pby011] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 10.8] [Reference Citation Analysis]
521 Selenica P, Conlon N, Gonzalez C, Frosina D, Jungbluth AA, Beets-Tan RGH, Rao MK, Zhang Y, Benayed R, Ladanyi M, Solit DB, Chiang S, Hyman DM, Hensley ML, Soslow RA, Weigelt B, Murali R. Genomic Profiling Aids Classification of Diagnostically Challenging Uterine Mesenchymal Tumors With Myomelanocytic Differentiation. Am J Surg Pathol 2021;45:77-92. [PMID: 32889887 DOI: 10.1097/PAS.0000000000001572] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
522 Condorelli DF, Privitera AP, Barresi V. Chromosomal Density of Cancer Up-Regulated Genes, Aberrant Enhancer Activity and Cancer Fitness Genes Are Associated with Transcriptional Cis-Effects of Broad Copy Number Gains in Colorectal Cancer. Int J Mol Sci 2019;20:E4652. [PMID: 31546890 DOI: 10.3390/ijms20184652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
523 Hess JM, Bernards A, Kim J, Miller M, Taylor-Weiner A, Haradhvala NJ, Lawrence MS, Getz G. Passenger Hotspot Mutations in Cancer. Cancer Cell 2019;36:288-301.e14. [PMID: 31526759 DOI: 10.1016/j.ccell.2019.08.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 14.0] [Reference Citation Analysis]
524 Agajanian S, Oluyemi O, Verkhivker GM. Integration of Random Forest Classifiers and Deep Convolutional Neural Networks for Classification and Biomolecular Modeling of Cancer Driver Mutations. Front Mol Biosci 2019;6:44. [PMID: 31245384 DOI: 10.3389/fmolb.2019.00044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
525 Pinyol R, Torrecilla S, Wang H, Montironi C, Piqué-Gili M, Torres-Martin M, Wei-Qiang L, Willoughby CE, Ramadori P, Andreu-Oller C, Taik P, Lee YA, Moeini A, Peix J, Faure-Dupuy S, Riedl T, Schuehle S, Oliveira CP, Alves VA, Boffetta P, Lachenmayer A, Roessler S, Minguez B, Schirmacher P, Dufour JF, Thung SN, Reeves HL, Carrilho FJ, Chang C, Uzilov AV, Heikenwalder M, Sanyal A, Friedman SL, Sia D, Llovet JM. Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2021:S0168-8278(21)00326-3. [PMID: 33992698 DOI: 10.1016/j.jhep.2021.04.049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
526 Ford KM, Panwala R, Chen DH, Portell A, Palmer N, Mali P. Peptide-tiling screens of cancer drivers reveal oncogenic protein domains and associated peptide inhibitors. Cell Syst 2021;12:716-732.e7. [PMID: 34051140 DOI: 10.1016/j.cels.2021.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
527 Ju Q, Li X, Zhang H, Yan S, Li Y, Zhao Y. NFE2L2 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltration in Brain Lower Grade Glioma: A Pan-Cancer Analysis. Oxid Med Cell Longev 2020;2020:3580719. [PMID: 33101586 DOI: 10.1155/2020/3580719] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
528 Soderquist CR, Hsiao S, Mansukhani MM, Alobeid B, Green PH, Bhagat G. Refractory celiac disease type II: An atypical case highlighting limitations of the current classification system. Hematol Oncol 2020;38:399-405. [PMID: 32010998 DOI: 10.1002/hon.2720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
529 Li F, Teng H, Liu M, Liu B, Zhang D, Xu Z, Wang Y, Zhou H. Prognostic Value of Immune-Related Genes in the Tumor Microenvironment of Bladder Cancer. Front Oncol 2020;10:1302. [PMID: 32850407 DOI: 10.3389/fonc.2020.01302] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
530 Somarribas Patterson LF, Vardhana SA. Metabolic regulation of the cancer-immunity cycle. Trends Immunol 2021;42:975-93. [PMID: 34610889 DOI: 10.1016/j.it.2021.09.002] [Reference Citation Analysis]
531 Imperial R, Nazer M, Ahmed Z, Kam AE, Pluard TJ, Bahaj W, Levy M, Kuzel TM, Hayden DM, Pappas SG, Subramanian J, Masood A. Matched Whole-Genome Sequencing (WGS) and Whole-Exome Sequencing (WES) of Tumor Tissue with Circulating Tumor DNA (ctDNA) Analysis: Complementary Modalities in Clinical Practice. Cancers (Basel) 2019;11:E1399. [PMID: 31546879 DOI: 10.3390/cancers11091399] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
532 Grzadkowski MR, Holly HD, Somers J, Demir E. Systematic interrogation of mutation groupings reveals divergent downstream expression programs within key cancer genes. BMC Bioinformatics 2021;22:233. [PMID: 33957863 DOI: 10.1186/s12859-021-04147-y] [Reference Citation Analysis]
533 Roux B, Vaganay C, Vargas JD, Alexe G, Benaksas C, Pardieu B, Fenouille N, Ellegast JM, Malolepsza E, Ling F, Sodaro G, Ross L, Pikman Y, Conway AS, Tang Y, Wu T, Anderson DJ, Le Moigne R, Zhou HJ, Luciano F, Hartigan CR, Galinsky I, DeAngelo DJ, Stone RM, Auberger P, Schenone M, Carr SA, Guirouilh-Barbat J, Lopez B, Khaled M, Lage K, Hermine O, Hemann MT, Puissant A, Stegmaier K, Benajiba L. Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor. Sci Transl Med 2021;13:eabg1168. [PMID: 33790022 DOI: 10.1126/scitranslmed.abg1168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
534 Porta-Pardo E, Valencia A, Godzik A. Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era. FEBS Lett 2020;594:4233-46. [PMID: 32239503 DOI: 10.1002/1873-3468.13781] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
535 Phaneuf PV, Zielinski DC, Yurkovich JT, Johnsen J, Szubin R, Yang L, Kim SH, Schulz S, Wu M, Dalldorf C, Ozdemir E, Lennen RM, Palsson BO, Feist AM. Escherichia coli Data-Driven Strain Design Using Aggregated Adaptive Laboratory Evolution Mutational Data. ACS Synth Biol 2021;10:3379-95. [PMID: 34762392 DOI: 10.1021/acssynbio.1c00337] [Reference Citation Analysis]
536 Candia J, Bayarsaikhan E, Tandon M, Budhu A, Forgues M, Tovuu LO, Tudev U, Lack J, Chao A, Chinburen J, Wang XW. The genomic landscape of Mongolian hepatocellular carcinoma. Nat Commun 2020;11:4383. [PMID: 32873799 DOI: 10.1038/s41467-020-18186-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
537 Jia A, Xu L, Wang Y. Venn diagrams in bioinformatics. Brief Bioinform 2021:bbab108. [PMID: 33839742 DOI: 10.1093/bib/bbab108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
538 [DOI: 10.1101/2019.12.13.874776] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
539 Siddiqui MQ, Badmalia MD, Patel TR. Bioinformatic Analysis of Structure and Function of LIM Domains of Human Zyxin Family Proteins. Int J Mol Sci 2021;22:2647. [PMID: 33808029 DOI: 10.3390/ijms22052647] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
540 Zhang T, Joubert P, Ansari-Pour N, Zhao W, Hoang PH, Lokanga R, Moye AL, Rosenbaum J, Gonzalez-Perez A, Martínez-Jiménez F, Castro A, Muscarella LA, Hofman P, Consonni D, Pesatori AC, Kebede M, Li M, Gould Rothberg BE, Peneva I, Schabath MB, Poeta ML, Costantini M, Hirsch D, Heselmeyer-Haddad K, Hutchinson A, Olanich M, Lawrence SM, Lenz P, Duggan M, Bhawsar PMS, Sang J, Kim J, Mendoza L, Saini N, Klimczak LJ, Islam SMA, Otlu B, Khandekar A, Cole N, Stewart DR, Choi J, Brown KM, Caporaso NE, Wilson SH, Pommier Y, Lan Q, Rothman N, Almeida JS, Carter H, Ried T, Kim CF, Lopez-Bigas N, Garcia-Closas M, Shi J, Bossé Y, Zhu B, Gordenin DA, Alexandrov LB, Chanock SJ, Wedge DC, Landi MT. Genomic and evolutionary classification of lung cancer in never smokers. Nat Genet 2021;53:1348-59. [PMID: 34493867 DOI: 10.1038/s41588-021-00920-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
541 Cao L, Huang C, Cui Zhou D, Hu Y, Lih TM, Savage SR, Krug K, Clark DJ, Schnaubelt M, Chen L, da Veiga Leprevost F, Eguez RV, Yang W, Pan J, Wen B, Dou Y, Jiang W, Liao Y, Shi Z, Terekhanova NV, Cao S, Lu RJ, Li Y, Liu R, Zhu H, Ronning P, Wu Y, Wyczalkowski MA, Easwaran H, Danilova L, Mer AS, Yoo S, Wang JM, Liu W, Haibe-Kains B, Thiagarajan M, Jewell SD, Hostetter G, Newton CJ, Li QK, Roehrl MH, Fenyö D, Wang P, Nesvizhskii AI, Mani DR, Omenn GS, Boja ES, Mesri M, Robles AI, Rodriguez H, Bathe OF, Chan DW, Hruban RH, Ding L, Zhang B, Zhang H; Clinical Proteomic Tumor Analysis Consortium. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell 2021;184:5031-5052.e26. [PMID: 34534465 DOI: 10.1016/j.cell.2021.08.023] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
542 Brown AL, Li M, Goncearenco A, Panchenko AR. Finding driver mutations in cancer: Elucidating the role of background mutational processes. PLoS Comput Biol 2019;15:e1006981. [PMID: 31034466 DOI: 10.1371/journal.pcbi.1006981] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 10.7] [Reference Citation Analysis]
543 Zhao SG, Chen WS, Li H, Foye A, Zhang M, Sjöström M, Aggarwal R, Playdle D, Liao A, Alumkal JJ, Das R, Chou J, Hua JT, Barnard TJ, Bailey AM, Chow ED, Perry MD, Dang HX, Yang R, Moussavi-Baygi R, Zhang L, Alshalalfa M, Laura Chang S, Houlahan KE, Shiah YJ, Beer TM, Thomas G, Chi KN, Gleave M, Zoubeidi A, Reiter RE, Rettig MB, Witte O, Yvonne Kim M, Fong L, Spratt DE, Morgan TM, Bose R, Huang FW, Li H, Chesner L, Shenoy T, Goodarzi H, Asangani IA, Sandhu S, Lang JM, Mahajan NP, Lara PN, Evans CP, Febbo P, Batzoglou S, Knudsen KE, He HH, Huang J, Zwart W, Costello JF, Luo J, Tomlins SA, Wyatt AW, Dehm SM, Ashworth A, Gilbert LA, Boutros PC, Farh K, Chinnaiyan AM, Maher CA, Small EJ, Quigley DA, Feng FY. The DNA methylation landscape of advanced prostate cancer. Nat Genet 2020;52:778-89. [PMID: 32661416 DOI: 10.1038/s41588-020-0648-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 19.0] [Reference Citation Analysis]
544 Crona J, Beuschlein F. Adrenocortical carcinoma - towards genomics guided clinical care. Nat Rev Endocrinol 2019;15:548-60. [PMID: 31147626 DOI: 10.1038/s41574-019-0221-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
545 Agajanian S, Odeyemi O, Bischoff N, Ratra S, Verkhivker GM. Machine Learning Classification and Structure–Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes. J Chem Inf Model 2018;58:2131-50. [DOI: 10.1021/acs.jcim.8b00414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
546 Chandrashekar P, Ahmadinejad N, Wang J, Sekulic A, Egan JB, Asmann YW, Kumar S, Maley C, Liu L. Somatic selection distinguishes oncogenes and tumor suppressor genes. Bioinformatics 2020;36:1712-7. [PMID: 32176769 DOI: 10.1093/bioinformatics/btz851] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
547 Machado RAC, Stojevski D, De Landtsheer S, Lucarelli P, Baron A, Sauter T, Schaffner-Reckinger E. L-plastin Ser5 phosphorylation is modulated by the PI3K/SGK pathway and promotes breast cancer cell invasiveness. Cell Commun Signal 2021;19:22. [PMID: 33618712 DOI: 10.1186/s12964-021-00710-5] [Reference Citation Analysis]
548 Sajulga R, Mehta S, Kumar P, Johnson JE, Guerrero CR, Ryan MC, Karchin R, Jagtap PD, Griffin TJ. Bridging the Chromosome-centric and Biology/Disease-driven Human Proteome Projects: Accessible and Automated Tools for Interpreting the Biological and Pathological Impact of Protein Sequence Variants Detected via Proteogenomics. J Proteome Res 2018;17:4329-36. [DOI: 10.1021/acs.jproteome.8b00404] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
549 Ashley CW, Da Cruz Paula A, Kumar R, Mandelker D, Pei X, Riaz N, Reis-Filho JS, Weigelt B. Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression. Gynecol Oncol 2019;152:11-9. [PMID: 30415991 DOI: 10.1016/j.ygyno.2018.10.032] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 9.5] [Reference Citation Analysis]
550 Graim K, Gorenshteyn D, Robinson DG, Carriero NJ, Cahill JA, Chakrabarti R, Goldschmidt MH, Durham AC, Funk J, Storey JD, Kristensen VN, Theesfeld CL, Sorenmo KU, Troyanskaya OG. Modeling molecular development of breast cancer in canine mammary tumors. Genome Res 2020. [PMID: 33361113 DOI: 10.1101/gr.256388.119] [Reference Citation Analysis]
551 Wang YL, Gong Y, Lv Z, Li L, Yuan Y. Expression of PD1/PDL1 in gastric cancer at different microsatellite status and its correlation with infiltrating immune cells in the tumor microenvironment. J Cancer 2021;12:1698-707. [PMID: 33613757 DOI: 10.7150/jca.40500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
552 Robertson AG, Yau C, Carrot-Zhang J, Damrauer JS, Knijnenburg TA, Chambwe N, Hoadley KA, Kemal A, Zenklusen JC, Cherniack AD, Beroukhim R, Zhou W. Integrative modeling identifies genetic ancestry-associated molecular correlates in human cancer. STAR Protoc 2021;2:100483. [PMID: 33982016 DOI: 10.1016/j.xpro.2021.100483] [Reference Citation Analysis]
553 Baali I, Erten C, Kazan H. DriveWays: a method for identifying possibly overlapping driver pathways in cancer. Sci Rep 2020;10:21971. [PMID: 33319839 DOI: 10.1038/s41598-020-78852-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
554 Agarwal E, Altman BJ, Ho Seo J, Bertolini I, Ghosh JC, Kaur A, Kossenkov AV, Languino LR, Gabrilovich DI, Speicher DW, Dang CV, Altieri DC. Myc Regulation of a Mitochondrial Trafficking Network Mediates Tumor Cell Invasion and Metastasis. Mol Cell Biol 2019;39:e00109-19. [PMID: 31061095 DOI: 10.1128/MCB.00109-19] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
555 Wang C, Yang J, Luo H, Wang K, Wang Y, Xiao ZX, Tao X, Jiang H, Cai H. CancerTracer: a curated database for intrapatient tumor heterogeneity. Nucleic Acids Res 2020;48:D797-806. [PMID: 31701131 DOI: 10.1093/nar/gkz1061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
556 Verkhivker GM. Biophysical simulations and structure-based modeling of residue interaction networks in the tumor suppressor proteins reveal functional role of cancer mutation hotspots in molecular communication. Biochim Biophys Acta Gen Subj 2019;1863:210-25. [PMID: 30339916 DOI: 10.1016/j.bbagen.2018.10.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
557 Ehsani R, Drabløs F. Enhanced identification of significant regulators of gene expression. BMC Bioinformatics 2020;21:134. [PMID: 32252623 DOI: 10.1186/s12859-020-3468-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
558 Tan A, Huang H, Zhang P, Li S. Network-based cancer precision medicine: A new emerging paradigm. Cancer Letters 2019;458:39-45. [DOI: 10.1016/j.canlet.2019.05.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
559 Xi J, Yuan X, Wang M, Li A, Li X, Huang Q. Inferring subgroup-specific driver genes from heterogeneous cancer samples via subspace learning with subgroup indication. Bioinformatics 2020;36:1855-63. [PMID: 31626284 DOI: 10.1093/bioinformatics/btz793] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
560 Boujemaa M, Hamdi Y, Mejri N, Romdhane L, Ghedira K, Bouaziz H, El Benna H, Labidi S, Dallali H, Jaidane O, Ben Nasr S, Haddaoui A, Rahal K, Abdelhak S, Boussen H, Boubaker MS. Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia. PLoS One 2021;16:e0245362. [PMID: 33503040 DOI: 10.1371/journal.pone.0245362] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
561 [DOI: 10.1101/2020.03.13.991448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
562 Shen JP. Artificial intelligence, molecular subtyping, biomarkers, and precision oncology. Emerg Top Life Sci 2021;5:747-56. [PMID: 34881776 DOI: 10.1042/ETLS20210212] [Reference Citation Analysis]
563 Siva N, Gupta S, Gupta A, Shukla JN, Malik B, Shukla N. Genome-editing approaches and applications: a brief review on CRISPR technology and its role in cancer. 3 Biotech 2021;11:146. [PMID: 33732568 DOI: 10.1007/s13205-021-02680-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
564 Azuaje F. Artificial intelligence for precision oncology: beyond patient stratification. NPJ Precis Oncol 2019;3:6. [PMID: 30820462 DOI: 10.1038/s41698-019-0078-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 11.7] [Reference Citation Analysis]
565 Mun J, Choi G, Lim B. A guide for bioinformaticians: 'omics-based drug discovery for precision oncology. Drug Discov Today 2020:S1359-6446(20)30335-4. [PMID: 32828947 DOI: 10.1016/j.drudis.2020.08.004] [Reference Citation Analysis]
566 Yang W, You N, Jia M, Yeung SJ, Ou W, Yu M, Wang Y, Fu X, Zhang Z, Yang J, Lao Z, Liu Z, Zeng B, Ou Q, Wu X, Shao YW, Hong X, Wang S, Cheng C. Undetectable circulating tumor DNA levels correlate with low risk of recurrence/metastasis in postoperative pathologic stage I lung adenocarcinoma patients. Lung Cancer 2020;146:327-34. [PMID: 32623075 DOI: 10.1016/j.lungcan.2020.06.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
567 Hartman ML, Sztiller-sikorska M, Czyz M. Whole-exome sequencing reveals novel genetic variants associated with diverse phenotypes of melanoma cells. Molecular Carcinogenesis 2019;58:588-602. [DOI: 10.1002/mc.22953] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
568 Watkins TBK, Lim EL, Petkovic M, Elizalde S, Birkbak NJ, Wilson GA, Moore DA, Grönroos E, Rowan A, Dewhurst SM, Demeulemeester J, Dentro SC, Horswell S, Au L, Haase K, Escudero M, Rosenthal R, Bakir MA, Xu H, Litchfield K, Lu WT, Mourikis TP, Dietzen M, Spain L, Cresswell GD, Biswas D, Lamy P, Nordentoft I, Harbst K, Castro-Giner F, Yates LR, Caramia F, Jaulin F, Vicier C, Tomlinson IPM, Brastianos PK, Cho RJ, Bastian BC, Dyrskjøt L, Jönsson GB, Savas P, Loi S, Campbell PJ, Andre F, Luscombe NM, Steeghs N, Tjan-Heijnen VCG, Szallasi Z, Turajlic S, Jamal-Hanjani M, Van Loo P, Bakhoum SF, Schwarz RF, McGranahan N, Swanton C. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature 2020;587:126-32. [PMID: 32879494 DOI: 10.1038/s41586-020-2698-6] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 23.5] [Reference Citation Analysis]
569 Fink S, Zugelder L, Roth B, Brandt E, Meloche S, Izsvák Z, Bargou RC, Stühmer T. A simple approach for multi-targeted shRNA-mediated inducible knockdowns using Sleeping Beauty vectors. PLoS One 2018;13:e0205585. [PMID: 30339711 DOI: 10.1371/journal.pone.0205585] [Reference Citation Analysis]
570 Janz S, Zhan F, Sun F, Cheng Y, Pisano M, Yang Y, Goldschmidt H, Hari P. Germline Risk Contribution to Genomic Instability in Multiple Myeloma. Front Genet 2019;10:424. [PMID: 31139207 DOI: 10.3389/fgene.2019.00424] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
571 Jachimowicz RD, Goergens J, Reinhardt HC. DNA double-strand break repair pathway choice - from basic biology to clinical exploitation. Cell Cycle 2019;18:1423-34. [PMID: 31116084 DOI: 10.1080/15384101.2019.1618542] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
572 Tan DS, Holzner M, Weng M, Srivastava Y, Jauch R. SOX17 in cellular reprogramming and cancer. Seminars in Cancer Biology 2020;67:65-73. [DOI: 10.1016/j.semcancer.2019.08.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
573 Darby CA, Fitch JR, Brennan PJ, Kelly BJ, Bir N, Magrini V, Leonard J, Cottrell CE, Gastier-Foster JM, Wilson RK, Mardis ER, White P, Langmead B, Schatz MC. Samovar: Single-Sample Mosaic Single-Nucleotide Variant Calling with Linked Reads. iScience 2019;18:1-10. [PMID: 31271967 DOI: 10.1016/j.isci.2019.05.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
574 Mamidi TKK, Wu J, Hicks C. Mapping the Germline and Somatic Mutation Interaction Landscape in Indolent and Aggressive Prostate Cancers. J Oncol 2019;2019:4168784. [PMID: 31814827 DOI: 10.1155/2019/4168784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
575 Harris C, Savas J, Ray S, Shanle EK. Yeast-based screening of cancer mutations in the DNA damage response protein Mre11 demonstrates importance of conserved capping domain residues. Mol Biol Rep 2021;48:4107-19. [PMID: 34075539 DOI: 10.1007/s11033-021-06424-8] [Reference Citation Analysis]
576 Ahmed Z, Renart EG, Zeeshan S, Dong X. Advancing clinical genomics and precision medicine with GVViZ: FAIR bioinformatics platform for variable gene-disease annotation, visualization, and expression analysis. Hum Genomics 2021;15:37. [PMID: 34174938 DOI: 10.1186/s40246-021-00336-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
577 Manzella L, Tirrò E, Vitale SR, Puma A, Consoli ML, Tambè L, Pennisi MS, DI Gregorio S, Romano C, Tomarchio C, DI Raimondo F, Stagno F. Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report. In Vivo 2020;34:1481-6. [PMID: 32354950 DOI: 10.21873/invivo.11933] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
578 Chakravarty D, Solit DB. Clinical cancer genomic profiling. Nat Rev Genet 2021;22:483-501. [PMID: 33762738 DOI: 10.1038/s41576-021-00338-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
579 Sürün D, Schneider A, Mircetic J, Neumann K, Lansing F, Paszkowski-Rogacz M, Hänchen V, Lee-Kirsch MA, Buchholz F. Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors. Genes (Basel) 2020;11:E511. [PMID: 32384610 DOI: 10.3390/genes11050511] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
580 Zheng P, Kang Y, Han S, Feng H, Ha F, Long C, Zhou D, Hu G, Chen Z, Wang Z, Wang T, Jia G. A Novel Transcriptome Integrated Network Approach Identifies the Key Driver lncRNA Involved in Cell Cycle With Chromium (VI)-Treated BEAS-2B Cells. Front Genet 2020;11:597803. [PMID: 33519900 DOI: 10.3389/fgene.2020.597803] [Reference Citation Analysis]
581 Cheng Z, Vermeulen M, Rollins-Green M, DeVeale B, Babak T. Cis-regulatory mutations with driver hallmarks in major cancers. iScience 2021;24:102144. [PMID: 33665563 DOI: 10.1016/j.isci.2021.102144] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
582 Grillo E, Ravelli C, Corsini M, Zammataro L, Mitola S. Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants. Biochim Biophys Acta Rev Cancer 2021;1876:188614. [PMID: 34403770 DOI: 10.1016/j.bbcan.2021.188614] [Reference Citation Analysis]
583 Kim SC, Park JW, Seo HY, Kim M, Park JH, Kim GH, Lee JO, Shin YK, Bae JM, Koo BK, Jeong SY, Ku JL. Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses. Adv Sci (Weinh) 2021;:e2103360. [PMID: 34918496 DOI: 10.1002/advs.202103360] [Reference Citation Analysis]
584 Liu Y, Wu Z, Zhou J, Ramadurai DKA, Mortenson KL, Aguilera-Jimenez E, Yan Y, Yang X, Taylor AM, Varley KE, Gertz J, Choi PS, Cherniack AD, Chen X, Bass AJ, Bailey SD, Zhang X. A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer. Nat Commun 2021;12:7139. [PMID: 34880227 DOI: 10.1038/s41467-021-27055-4] [Reference Citation Analysis]
585 Gihawi A, Rallapalli G, Hurst R, Cooper CS, Leggett RM, Brewer DS. SEPATH: benchmarking the search for pathogens in human tissue whole genome sequence data leads to template pipelines. Genome Biol 2019;20:208. [PMID: 31639030 DOI: 10.1186/s13059-019-1819-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
586 [DOI: 10.1101/521054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
587 Sa JK, Hong JY, Lee IK, Kim JS, Sim MH, Kim HJ, An JY, Sohn TS, Lee JH, Bae JM, Kim S, Kim KM, Kim ST, Park SH, Park JO, Lim HY, Kang WK, Her NG, Lee Y, Cho HJ, Shin YJ, Kim M, Koo H, Kim M, Seo YJ, Kim JY, Choi MG, Nam DH, Lee J. Comprehensive pharmacogenomic characterization of gastric cancer. Genome Med 2020;12:17. [PMID: 32070411 DOI: 10.1186/s13073-020-0717-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
588 García-Nieto PE, Morrison AJ, Fraser HB. The somatic mutation landscape of the human body. Genome Biol 2019;20:298. [PMID: 31874648 DOI: 10.1186/s13059-019-1919-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
589 Azad TD, Chaudhuri AA, Fang P, Qiao Y, Esfahani MS, Chabon JJ, Hamilton EG, Yang YD, Lovejoy A, Newman AM, Kurtz DM, Jin M, Schroers-Martin J, Stehr H, Liu CL, Hui AB, Patel V, Maru D, Lin SH, Alizadeh AA, Diehn M. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer. Gastroenterology 2020;158:494-505.e6. [PMID: 31711920 DOI: 10.1053/j.gastro.2019.10.039] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 13.3] [Reference Citation Analysis]
590 Zhang Y, Wu X, Zhang C, Wang J, Fei G, Di X, Lu X, Feng L, Cheng S, Yang A. Dissecting expression profiles of gastric precancerous lesions and early gastric cancer to explore crucial molecules in intestinal-type gastric cancer tumorigenesis. J Pathol 2020;251:135-46. [PMID: 32207854 DOI: 10.1002/path.5434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
591 Liu J, Ma H, Meng L, Liu X, Lv Z, Zhang Y, Wang J. Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer. Front Mol Biosci 2021;8:675651. [PMID: 34095228 DOI: 10.3389/fmolb.2021.675651] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
592 López-Cortés A, Paz-Y-Miño C, Guerrero S, Cabrera-Andrade A, Barigye SJ, Munteanu CR, González-Díaz H, Pazos A, Pérez-Castillo Y, Tejera E. OncoOmics approaches to reveal essential genes in breast cancer: a panoramic view from pathogenesis to precision medicine. Sci Rep 2020;10:5285. [PMID: 32210335 DOI: 10.1038/s41598-020-62279-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
593 Riddiford N, Siudeja K, van den Beek M, Boumard B, Bardin AJ. Evolution and genomic signatures of spontaneous somatic mutation in Drosophila intestinal stem cells. Genome Res 2021;31:1419-32. [PMID: 34168010 DOI: 10.1101/gr.268441.120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
594 Mousavi N, Shleizer-Burko S, Yanicky R, Gymrek M. Profiling the genome-wide landscape of tandem repeat expansions. Nucleic Acids Res 2019;47:e90. [PMID: 31194863 DOI: 10.1093/nar/gkz501] [Cited by in Crossref: 48] [Cited by in F6Publishing: 30] [Article Influence: 16.0] [Reference Citation Analysis]
595 Condorelli DF, Spampinato G, Valenti G, Musso N, Castorina S, Barresi V. Positive Caricature Transcriptomic Effects Associated with Broad Genomic Aberrations in Colorectal Cancer. Sci Rep 2018;8:14826. [PMID: 30287863 DOI: 10.1038/s41598-018-32884-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
596 Gussow AB, Koonin EV, Auslander N. Identification of combinations of somatic mutations that predict cancer survival and immunotherapy benefit. NAR Cancer 2021;3:zcab017. [PMID: 34027407 DOI: 10.1093/narcan/zcab017] [Reference Citation Analysis]
597 Lee W, Wang Z, Saffern M, Jun T, Huang KL. Genomic and molecular features distinguish young adult cancer from later-onset cancer. Cell Rep 2021;37:110005. [PMID: 34788626 DOI: 10.1016/j.celrep.2021.110005] [Reference Citation Analysis]
598 Lee SY, Kim JJ, Miller KM. Bromodomain proteins: protectors against endogenous DNA damage and facilitators of genome integrity. Exp Mol Med 2021;53:1268-77. [PMID: 34548613 DOI: 10.1038/s12276-021-00673-0] [Reference Citation Analysis]
599 Tong Z, Zhou Y, Wang J. Identifying potential drug targets in hepatocellular carcinoma based on network analysis and one-class support vector machine. Sci Rep 2019;9:10442. [PMID: 31320657 DOI: 10.1038/s41598-019-46540-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
600 Guardia T, Eason M, Kontrogianni-Konstantopoulos A. Obscurin: A multitasking giant in the fight against cancer. Biochim Biophys Acta Rev Cancer 2021;1876:188567. [PMID: 34015411 DOI: 10.1016/j.bbcan.2021.188567] [Reference Citation Analysis]
601 Oh JH, Sung CO. Comprehensive characteristics of somatic mutations in the normal tissues of patients with cancer and existence of somatic mutant clones linked to cancer development. J Med Genet 2021;58:433-41. [PMID: 32719100 DOI: 10.1136/jmedgenet-2020-106905] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
602 Liu J, Tokheim C, Lee JD, Gan W, North BJ, Liu XS, Pandolfi PP, Wei W. Genetic fusions favor tumorigenesis through degron loss in oncogenes. Nat Commun 2021;12:6704. [PMID: 34795215 DOI: 10.1038/s41467-021-26871-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
603 Barnoud T, Indeglia A, Murphy ME. Shifting the paradigms for tumor suppression: lessons from the p53 field. Oncogene 2021;40:4281-90. [PMID: 34103683 DOI: 10.1038/s41388-021-01852-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
604 Maheden K, Bashth OS, Shakiba N. Evening the playing field: microenvironmental control over stem cell competition during fate programming. Curr Opin Genet Dev 2021;70:66-75. [PMID: 34153929 DOI: 10.1016/j.gde.2021.05.008] [Reference Citation Analysis]
605 Mair B, Moffat J, Boone C, Andrews BJ. Genetic interaction networks in cancer cells. Curr Opin Genet Dev 2019;54:64-72. [PMID: 30974317 DOI: 10.1016/j.gde.2019.03.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
606 Gronke K, Hernández PP, Zimmermann J, Klose CSN, Kofoed-Branzk M, Guendel F, Witkowski M, Tizian C, Amann L, Schumacher F, Glatt H, Triantafyllopoulou A, Diefenbach A. Interleukin-22 protects intestinal stem cells against genotoxic stress. Nature 2019;566:249-53. [PMID: 30700914 DOI: 10.1038/s41586-019-0899-7] [Cited by in Crossref: 117] [Cited by in F6Publishing: 118] [Article Influence: 39.0] [Reference Citation Analysis]
607 Chen Z, Wen W, Beeghly-Fadiel A, Shu XO, Díez-Obrero V, Long J, Bao J, Wang J, Liu Q, Cai Q, Moreno V, Zheng W, Guo X. Identifying Putative Susceptibility Genes and Evaluating Their Associations with Somatic Mutations in Human Cancers. Am J Hum Genet 2019;105:477-92. [PMID: 31402092 DOI: 10.1016/j.ajhg.2019.07.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
608 Du Y, Cai M, Xing X, Ji J, Yang E, Wu J. PINA 3.0: mining cancer interactome. Nucleic Acids Res 2021;49:D1351-7. [PMID: 33231689 DOI: 10.1093/nar/gkaa1075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
609 Erten C, Houdjedj A, Kazan H. Ranking cancer drivers via betweenness-based outlier detection and random walks. BMC Bioinformatics 2021;22:62. [PMID: 33568049 DOI: 10.1186/s12859-021-03989-w] [Reference Citation Analysis]
610 Heong V, Tay D, Goh SE, Wee B, Tan TZ, Soo R, Pang B, Lim D, Gopinathan A, Ow S, Chee CE, Goh BC, Lee SC, Yong WP, Wong A, Omar MFM, Soong R, Tan DS. Whole Exome Sequencing of Multi-Regional Biopsies from Metastatic Lesions to Evaluate Actionable Truncal Mutations Using a Single-Pass Percutaneous Technique. Cancers (Basel) 2020;12:E1599. [PMID: 32560395 DOI: 10.3390/cancers12061599] [Reference Citation Analysis]
611 Toomey S, Carr A, Mezynski MJ, Elamin Y, Rafee S, Cremona M, Morgan C, Madden S, Abdul-Jalil KI, Gately K, Farrelly A, Kay EW, Kennedy S, O'Byrne K, Grogan L, Breathnach O, Morris PG, Eustace AJ, Fay J, Cummins R, O'Grady A, Kalachand R, O'Donovan N, Kelleher F, O'Reilly A, Doherty M, Crown J, Hennessy BT. Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samples. J Transl Med 2020;18:99. [PMID: 32087721 DOI: 10.1186/s12967-020-02273-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
612 Wong KM, King DA, Schwartz EK, Herrera RE, Morrison AJ. Retinoblastoma protein regulates carcinogen susceptibility at heterochromatic cancer driver loci. Life Sci Alliance 2022;5:e202101134. [PMID: 34983823 DOI: 10.26508/lsa.202101134] [Reference Citation Analysis]
613 Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;. [PMID: 33514910 DOI: 10.1038/s41571-020-00462-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 68] [Article Influence: 48.0] [Reference Citation Analysis]
614 Roos A, Byron SA. Genomics-Enabled Precision Medicine for Cancer. Cancer Treat Res 2019;178:137-69. [PMID: 31209844 DOI: 10.1007/978-3-030-16391-4_5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
615 [DOI: 10.1101/2021.02.28.433268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
616 Fatnassi-Mersni G, Arfaoui AT, Cherni M, Jones M, Zeglaoui F, Ouzari HI, Rammeh S. Molecular and immunohistochemical analysis of BRAF gene in primary cutaneous melanoma: Discovery of novel mutations. J Cutan Pathol 2020;47:794-9. [PMID: 32285462 DOI: 10.1111/cup.13710] [Reference Citation Analysis]
617 Auslander N, Wolf YI, Koonin EV. In silico learning of tumor evolution through mutational time series. Proc Natl Acad Sci U S A 2019;116:9501-10. [PMID: 31015295 DOI: 10.1073/pnas.1901695116] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
618 Zhou Y, Lih TM, Pan J, Höti N, Dong M, Cao L, Hu Y, Cho KC, Chen SY, Eguez RV, Gabrielson E, Chan DW, Zhang H, Li QK. Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets. J Hematol Oncol 2020;13:170. [PMID: 33287876 DOI: 10.1186/s13045-020-01013-x] [Reference Citation Analysis]
619 El-Sayes N, Vito A, Mossman K. Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy. Cancers (Basel) 2021;13:806. [PMID: 33671881 DOI: 10.3390/cancers13040806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
620 McCann C, Kerr EM. Metabolic Reprogramming: A Friend or Foe to Cancer Therapy? Cancers (Basel) 2021;13:3351. [PMID: 34283054 DOI: 10.3390/cancers13133351] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
621 Chatrath A, Kiran M, Kumar P, Ratan A, Dutta A. The Germline Variants rs61757955 and rs34988193 Are Predictive of Survival in Lower Grade Glioma Patients. Mol Cancer Res 2019;17:1075-86. [PMID: 30651372 DOI: 10.1158/1541-7786.MCR-18-0996] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
622 Peinado P, Andrades A, Cuadros M, Rodriguez MI, Coira IF, Garcia DJ, Álvarez-Perez JC, Baliñas-Gavira C, Arenas AM, Patiño-Mercau JR, Sanjuan-Hidalgo J, Romero OA, Montuenga LM, Carretero J, Sanchez-Cespedes M, Medina PP. Comprehensive Analysis of SWI/SNF Inactivation in Lung Adenocarcinoma Cell Models. Cancers (Basel) 2020;12:E3712. [PMID: 33321963 DOI: 10.3390/cancers12123712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
623 Bavafaye Haghighi E, Knudsen M, Elmedal Laursen B, Besenbacher S. Hierarchical Classification of Cancers of Unknown Primary Using Multi-Omics Data. Cancer Inform 2019;18:1176935119872163. [PMID: 31516310 DOI: 10.1177/1176935119872163] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
624 Paull EO, Aytes A, Jones SJ, Subramaniam PS, Giorgi FM, Douglass EF, Tagore S, Chu B, Vasciaveo A, Zheng S, Verhaak R, Abate-Shen C, Alvarez MJ, Califano A. A modular master regulator landscape controls cancer transcriptional identity. Cell 2021;184:334-351.e20. [PMID: 33434495 DOI: 10.1016/j.cell.2020.11.045] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
625 Lundberg A, Lindström LS, Parker JS, Löverli E, Perou CM, Bergh J, Tobin NP. A pan-cancer analysis of the frequency of DNA alterations across cell cycle activity levels. Oncogene 2020;39:5430-40. [PMID: 32581248 DOI: 10.1038/s41388-020-1367-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
626 [DOI: 10.1101/2021.01.13.426413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
627 Jang HJ, Lee A, Kang J, Song IH, Lee SH. Prediction of genetic alterations from gastric cancer histopathology images using a fully automated deep learning approach. World J Gastroenterol 2021; 27(44): 7687-7704 [PMID: 34908807 DOI: 10.3748/wjg.v27.i44.7687] [Reference Citation Analysis]
628 Perez BS, Wong KM, Schwartz EK, Herrera RE, King DA, García-Nieto PE, Morrison AJ. Genome-wide profiles of UV lesion susceptibility, repair, and mutagenic potential in melanoma. Mutat Res 2021;823:111758. [PMID: 34333390 DOI: 10.1016/j.mrfmmm.2021.111758] [Reference Citation Analysis]
629 Corbett RD, Eveleigh R, Whitney J, Barai N, Bourgey M, Chuah E, Johnson J, Moore RA, Moradin N, Mungall KL, Pereira S, Reuter MS, Thiruvahindrapuram B, Wintle RF, Ragoussis J, Strug LJ, Herbrick JA, Aziz N, Jones SJM, Lathrop M, Scherer SW, Staffa A, Mungall AJ. A Distributed Whole Genome Sequencing Benchmark Study. Front Genet 2020;11:612515. [PMID: 33335541 DOI: 10.3389/fgene.2020.612515] [Reference Citation Analysis]
630 Alharbi AB, Schmitz U, Bailey CG, Rasko JEJ. CTCF as a regulator of alternative splicing: new tricks for an old player. Nucleic Acids Res 2021:gkab520. [PMID: 34181707 DOI: 10.1093/nar/gkab520] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
631 Sahoo SS, Pastor VB, Goodings C, Voss RK, Kozyra EJ, Szvetnik A, Noellke P, Dworzak M, Starý J, Locatelli F, Masetti R, Schmugge M, De Moerloose B, Catala A, Kállay K, Turkiewicz D, Hasle H, Buechner J, Jahnukainen K, Ussowicz M, Polychronopoulou S, Smith OP, Fabri O, Barzilai S, de Haas V, Baumann I, Schwarz-Furlan S, Niewisch MR, Sauer MG, Burkhardt B, Lang P, Bader P, Beier R, Müller I, Albert MH, Meisel R, Schulz A, Cario G, Panda PK, Wehrle J, Hirabayashi S, Derecka M, Durruthy-Durruthy R, Göhring G, Yoshimi-Noellke A, Ku M, Lebrecht D, Erlacher M, Flotho C, Strahm B, Niemeyer CM, Wlodarski MW; European Working Group of MDS in Children (EWOG-MDS). Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes. Nat Med 2021;27:1806-17. [PMID: 34621053 DOI: 10.1038/s41591-021-01511-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
632 Nagashima T, Yamaguchi K, Urakami K, Shimoda Y, Ohnami S, Ohshima K, Tanabe T, Naruoka A, Kamada F, Serizawa M, Hatakeyama K, Matsumura K, Ohnami S, Maruyama K, Mochizuki T, Kusuhara M, Shiomi A, Ohde Y, Terashima M, Uesaka K, Onitsuka T, Nishimura S, Hirashima Y, Hayashi N, Kiyohara Y, Tsubosa Y, Katagiri H, Niwakawa M, Takahashi K, Kashiwagi H, Nakagawa M, Ishida Y, Sugino T, Takahashi M, Akiyama Y. Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients. Cancer Sci 2020;111:687-99. [PMID: 31863614 DOI: 10.1111/cas.14290] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
633 Varga J, Kube M, Luck K, Schick S. The BAF chromatin remodeling complexes: structure, function, and synthetic lethalities. Biochem Soc Trans 2021;49:1489-503. [PMID: 34431497 DOI: 10.1042/BST20190960] [Reference Citation Analysis]
634 Macrae TA, Ramalho-Santos M. The deubiquitinase Usp9x regulates PRC2-mediated chromatin reprogramming during mouse development. Nat Commun 2021;12:1865. [PMID: 33767158 DOI: 10.1038/s41467-021-21910-0] [Reference Citation Analysis]
635 Giordano TJ. Genomic Applications in Thyroid Cancer. In: Netto GJ, Kaul KL, editors. Genomic Applications in Pathology. Cham: Springer International Publishing; 2019. pp. 325-34. [DOI: 10.1007/978-3-319-96830-8_24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
636 Gopaulakrishnan S, Pollack S, Stubbs BJ, Pagès H, Readey J, Davis S, Waldron L, Morgan M, Carey V. restfulSE: A semantically rich interface for cloud-scale genomics with Bioconductor. F1000Res 2019;8:21. [PMID: 30828438 DOI: 10.12688/f1000research.17518.1] [Reference Citation Analysis]
637 Brandes N, Linial N, Linial M. Quantifying gene selection in cancer through protein functional alteration bias. Nucleic Acids Res 2019;47:6642-55. [PMID: 31334812 DOI: 10.1093/nar/gkz546] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
638 Hellmann MD, Nabet BY, Rizvi H, Chaudhuri AA, Wells DK, Dunphy MPS, Chabon JJ, Liu CL, Hui AB, Arbour KC, Luo J, Preeshagul IR, Moding EJ, Almanza D, Bonilla RF, Sauter JL, Choi H, Tenet M, Abu-Akeel M, Plodkowski AJ, Perez Johnston R, Yoo CH, Ko RB, Stehr H, Gojenola L, Wakelee HA, Padda SK, Neal JW, Chaft JE, Kris MG, Rudin CM, Merghoub T, Li BT, Alizadeh AA, Diehn M. Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC. Clin Cancer Res 2020;26:2849-58. [PMID: 32046999 DOI: 10.1158/1078-0432.CCR-19-3418] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
639 He X, Zhang Y, Yuan D, Han X, He J, Duan X, Liu S, Wang X, Niu B. DIVIS: Integrated and Customizable Pipeline for Cancer Genome Sequencing Analysis and Interpretation. Front Oncol 2021;11:672597. [PMID: 34168993 DOI: 10.3389/fonc.2021.672597] [Reference Citation Analysis]
640 Esposito M, Ganesan S, Kang Y. Emerging strategies for treating metastasis. Nat Cancer 2021;2:258-70. [PMID: 33899000 DOI: 10.1038/s43018-021-00181-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
641 Luo A, Chen Y. Label-Free Interactome Analysis Revealed an Essential Role of CUL3-KEAP1 Complex in Mediating the Ubiquitination and Degradation of PHD2. J Proteome Res 2020;19:260-8. [PMID: 31763849 DOI: 10.1021/acs.jproteome.9b00513] [Reference Citation Analysis]
642 Watanabe T, Nanamiya H, Kojima M, Nomura S, Furukawa S, Soeda S, Tanaka D, Isogai T, Imai JI, Watanabe S, Fujimori K. Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma. Transl Oncol 2021;14:101010. [PMID: 33450701 DOI: 10.1016/j.tranon.2021.101010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]